RADA Electronic Industries Ltd. Annual Report 2017

← All annual reports

FY2017 Annual Report · RADA Electronic Industries Ltd.

Loading PDF…

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 20-F

[ ]

[X]

REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES
EXCHANGE ACT OF 1934

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934

For the fiscal year ended December 31, 2017

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE

For the transition period from __________ to __________

ACT OF 1934

[ ]

SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
Date of event requiring this shell company report.

Commission file number: 0-15375

RADA ELECTRONIC INDUSTRIES LTD.
(Exact name of Registrant as specified in its charter
and translation of Registrant’s name Into English)

Israel
(Jurisdiction of incorporation or organization)

7 Giborei Israel Street, Netanya 4250407, Israel
(Address of principal executive offices)

Avi Israel - CFO,
+972 9 892 1122 (phone), + 972 9 885 5885 (fax)
7 Giborei Israel Street, Netanya 4250407, Israel
(Name, telephone, facsimile number and address of company contact person)

Securities registered or to be registered pursuant to Section 12(b) of the Act:

Title of each class
Ordinary Shares, NIS 0.030 Par Value

Name of each exchange on which registered
NASDAQ Capital Market

Securities registered or to be registered pursuant to Section 12(g) of the Act: None

Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: None

Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the
period covered by the annual report:

Ordinary Shares, par value NIS 0.030 per share… 31,392,040
(As of December 31, 2017)

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

Yes [ ] No [X]

If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports
pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes [ ] No [X]

Yes [X] No [ ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any,
every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (232.405 of this
chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post
such files).

Yes [X] No [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an
emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” and “emerging growth
company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer [ ]
Emerging growth company [ ]

Accelerated filer [ ]
Non-accelerated filer [X]

If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards† provided pursuant to Section 13(a) of the Exchange Act. [ ]

† The term “new or revised financial accounting standard” refers to any update issued by the Financial Accounting
Standards Board to its Accounting Standards Codification after April 5, 2012.

Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in
this filing:

U.S. GAAP [X]

International Financial Reporting Standards
as issued by the International Accounting
Standards Board [ ]

Other [ ]

If “Other” has been checked in response to the previous question, indicate by check mark which financial statement item
the registrant has elected to follow:

If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of
the Exchange Act).

Item 17 [ ] Item 18 [ ]

This annual report on Form 20-F is incorporated by reference into the registrant’s Registration Statements on Form F-3
File Nos. 333-212643, 333-216973 and 333-220304, and Form S-8 Registration Statement File No. 333-212284.

Yes [ ] No [X]

INTRODUCTION

We are an Israel based defense electronics company. We specialize in the development, manufacturing, marketing and
sales of military avionics systems and inertial navigation systems for manned and unmanned aircraft, and tactical land
radars for force and border protection applications.

Our shares are traded on the NASDAQ Capital Market under the symbol “RADA.” As used in this annual report, the
terms “we,” “us” and “our” mean RADA Electronic Industries Ltd. and its subsidiaries, unless otherwise indicated.

Our consolidated financial statements appearing in this annual report are prepared in U.S. dollars and in accordance with
generally accepted accounting principles in the United States, or U.S. GAAP. All references in this annual report to
“dollars” or “$” are to U.S. dollars and all references in this annual report to “NIS” are to New Israeli Shekels.

Statements made in this annual report concerning the contents of any contract, agreement or other document are
summaries of such contracts, agreements or documents and are not complete descriptions of all of their terms. If we filed
any of these documents as an exhibit to this annual report or to any previous filing with the Securities and Exchange
Commission, or the SEC, you may read the document itself for a complete recitation of its terms.

Except for the historical information contained in this annual report, the statements contained in this annual report are
“forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, and the Private Securities Litigation
Reform Act of 1995, as amended, with respect to our business, financial condition and results of operations. Such
forward-looking statements reflect our current view with respect to future events and financial results. We urge you to
consider that statements which use the terms “anticipate,” “believe,” “do not believe,” “expect,” “plan,” “intend,”
“estimate,” and similar expressions are intended to identify forward-looking statements. We remind readers that forward-
looking statements are merely predictions and therefore inherently subject to uncertainties and other factors and involve
known and unknown risks that could cause the actual results, performance, levels of activity, or our achievements, or
industry results, to be materially different from any future results, performance, levels of activity, or our achievements
expressed or implied by such forward-looking statements. Such forward-looking statements are also included in Item 4 –
“Information on the Company” and Item 5 – “Operating and Financial Review and Prospects.” Readers are cautioned not
to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Except as required by
applicable law, including the securities laws of the United States, we undertake no obligation to publicly release any
update or revision to any forward-looking statements to reflect new information, future events or circumstances, or
otherwise after the date hereof. We have attempted to identify significant uncertainties and other factors affecting forward-
looking statements in the Risk Factors section that appears in Item 3D. “Key Information - Risk Factors.”

TABLE OF CONTENTS

Page No.
1

PART I

ITEM 1.
ITEM 2.
ITEM 3.

ITEM 4.

Selected Financial Data
Capitalization and Indebtedness
Reasons for the Offer and Use of Proceeds
Risk Factors

IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS
OFFER STATISTICS AND EXPECTED TIMETABLE
KEY INFORMATION
A.
B.
C.
D.
INFORMATION ON THE COMPANY
A.
B.
C.
D.

History and Development of the Company
Business Overview
Organizational Structure
Property, Plants and Equipment
ITEM 4A. UNRESOLVED STAFF COMMENTS
ITEM 5.

Major Shareholders
Related Party Transactions
Interests of Experts and Counsel

Consolidated Statements and Other Financial Information
Significant Changes

Directors and Senior Management
Compensation
Board Practices
Employees
Share Ownership

Operating Results
Liquidity and Capital Resources
Research and Development, Patents and Licenses
Trend Information
Off-Balance Sheet Arrangements
Tabular Disclosure of Contractual Obligations

OPERATING AND FINANCIAL REVIEW AND PROSPECTS
A.
B.
C.
D.
E.
F.
DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES
A.
B.
C.
D.
E.
MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS
A.
B.
C.
FINANCIAL INFORMATION
A.
B.
THE OFFER AND LISTING
Offer and Listing Details
A.
Plan of Distribution
B.
Markets
C.
Selling Shareholders
D.
Dilution
E.
F.
Expense of the Issue
ADDITIONAL INFORMATION
A.
B.
C.
D.
E.
F.
G.
H.
I.
QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISKS
DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES

Share Capital
Memorandum and Articles of Association
Material Contracts
Exchange Controls
Taxation
Dividend and Paying Agents
Statement by Experts
Documents on Display
Subsidiary Information

ITEM 6.

ITEM 7.

ITEM 8.

ITEM 9.

ITEM 10.

ITEM 11.
ITEM 12.

1
1
1
1
2
2
2
14
14
14
22
22
22
22
22
30
33
33
33
34
34
34
37
39
47
48
49
49
51
52
52
52
52
53
53
53
53
54
54
54
54
54
54
57
57
57
64
64
64
64
64
65

PART II

ITEM 13.
ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF

DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES

PROCEEDS
CONTROLS AND PROCEDURES
RESERVED.

ITEM 15.
ITEM 16.
ITEM 16A. AUDIT COMMITTEE FINANCIAL EXPERT
ITEM 16B. CODE OF ETHICS
ITEM 16C. PRINCIPAL ACCOUNTANT FEES AND SERVICES
ITEM 16D. EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES
ITEM 16E. PURCHASE OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS
ITEM 16F. CHANGES IN REGISTRANT’S CERTIFYING ACCOUNTANT
ITEM 16G. CORPORATE GOVERNANCE
ITEM 16H. MINE SAFETY DISCLOSURE

PART III

ITEM 17.
ITEM 18.
ITEM 19.

FINANCIAL STATEMENTS
FINANCIAL STATEMENTS
EXHIBITS

iii

65
65
66
66
66
67
67
67
68
68
68

69
69
69

PART I

ITEM 1.

IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS

Not applicable.

ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE

Not applicable.

ITEM 3. KEY INFORMATION

A. Selected Financial Data

We derived the following consolidated statements of operations data for the years ended December 31, 2015, 2016 and
2017 and the consolidated balance sheet data as of December 31, 2016 and 2017 from our audited consolidated financial
statements, included elsewhere in this annual report. We derived the consolidated statements of operations data for the
years ended December 31, 2013 and 2014, and the consolidated balance sheet data as of December 31, 2013, 2014 and
2015 from our audited consolidated financial statements that are not included in this annual report. (See Item 4A.
“Discontinued Operations”).

Revenues
Cost of revenues
Gross profit

Research and development, net
Marketing and selling
General and administrative
Goodwill impairment
Operating income (loss)
Financial expense, net
Net income (loss) from continuing
operations
Net income (loss) from discontinued
operations
Net income (loss)
Net income (loss) attributable to non-
controlling interest from discontinued
operations
Net income (loss) attributable to RADA
Electronic Industries’ shareholders
Basic net income (loss) per Ordinary share
attributable for RADA Electronic
Industries’ shareholders
Diluted net income (loss) per Ordinary
share attributable for RADA Electronic
Industries’ shareholders
Weighted average number of shares used
to compute basic net income (loss) per
share
Weighted average number of shares used
to compute diluted net income (loss) per
share

2013

21,007 $
16,609
4,398
1,459
1,958
1,683
-
(702)
1,901

(2,603)

(40)
(2,643)

(8)

(2,635)

2014

Year Ended December 31,
2015
(U.S. dollars in thousands)

2016

21,625 $
15,284
6,341
789
2,392
1,667
-
1,493
1,256

237

(36)
201

(7)

208

14,074 $
11,665
2,409
693
2,357
1,513
587
(2,741)
3,577

12,821 $
11,379
1,442
758
2,269
1,814
-
(3,399)
1,521

(6,318)

(4,920)

(179)
(6,497)

13
(4,907)

(36)

(6,461)

(4,910)

2017

26,182
17,919
8,263
1,575
2,137
2,568
-
1,983
156

1,827

515
2,342

103

2,239

(0.60) $

0.02 $

(0.53) $

(0.35) $

0.07

(0.60) $

0.02 $

(0.53) $

(0.35) $

0.06

4,459

8,945

11,904

14,029

24,957

4,459

8,945

11,904

14,029

28,127

2013

2014

As of December 31,
2015
(U.S. dollars in thousands)

2016

2017

(152) $

22,007

35 $

20,097

6,522 $

18,576

11,106 $
20,987

25,641
36,030

7,194
3,000

3,350

6,709
3,000

3,547

-
3,090

8,507

-
3,175

-
-

10,516

28,526

BALANCE SHEET DATA:
Working capital (deficiency)
Total assets
Short-term credits and current maturities
of long-term loans
Convertible note - short term

Shareholders’ equity

B. Capitalization and Indebtedness

Not applicable.

C. Reasons for the Offer and Use of Proceeds

Not applicable.

D. Risk Factors

Investing in our ordinary shares involves a high degree of risk and uncertainty. You should carefully consider the risks
and uncertainties described below before investing in our ordinary shares. Our business, prospects, financial condition
and results of operations could be adversely affected due to any of the following risks. In that case, the value of our
ordinary shares could decline, and you could lose all or part of your investment.

Risks Related to Our Business and Our Industry

We have a history of operating losses and although we returned to profitability in 2017, we may not be able to sustain
profitable operations in the future. To the extent that we continue to incur operating losses in the future, we may not
have sufficient working capital to fund our operations.

We incurred operating losses in three of the five years ended December 31, 2017. Although we achieved an operating
profit of $ 1.9 million in the year ended December 31, 2017, we may not be able to achieve or sustain profitable operations
in the future or generate positive cash flows from operations. As of December 31, 2017, our accumulated deficit was $77
million and we had cash, cash equivalents and short-term bank deposits of $12.4 million, compared to cash, cash
equivalents and short-term bank deposits of $1.2 million as of December 31, 2016. Based on our current operations, we
believe our existing funds will be sufficient to fund our operations in 2018. To the extent that we incur operating losses in
the future or are unable to generate free cash flows from our business, we may not have sufficient working capital to fund
our operations and will be required to obtain additional financing. Such financing may not be available, or if available,
may not be on terms satisfactory to us. If adequate funds are not available to us, our business, and results of operations and
financial condition will be adversely affected.

We may need to raise additional capital in the future, which may substantially dilute the holdings of our shareholders.

In order to obtain working capital for our operations and to repay the outstanding debt due to our then principal
shareholder, we completed a follow-on public offering of 3,455,284 ordinary shares, offered at a price to the public of
$2.46 per share on July 30, 2015. We then entered into an investment transaction with DBSI Investments Ltd., or DBSI,
on May 18, 2016, according to which we sold 8,510,638 ordinary shares to DBSI for $4 million, reflecting a price per
share of $0.47. We also issued to DBSI, without additional consideration, warrants to purchase 4,255,319 ordinary shares
at an exercise price per share of $0.47 (or $2 million in the aggregate) exercisable for a period of 24 months and warrants
to purchase 3,636,363 ordinary shares at an exercise price per share of $0.55 (or $2 million in the aggregate) exercisable
for a period of 48 months. DBSI also agreed to provide our company with a three-year $3,175,000 convertible loan
bearing interest of Libor plus 6%, which was funded on June 16, 2016 and was used to repay the outstanding convertible
loan and accrued interest owed to an entity owned by our former principal shareholder, Mr. Howard Yeung. In November
2016, we sold 1,904,762 of our ordinary shares to The Phoenix Insurance Company Ltd. and its affiliate, Shotfut-
Menayot-Israel-HaPhoenix Amitim Ltd., two Israeli institutional investors, at a price of $1.05 per share, or approximately
$2 million in the aggregate. At the same time, DBSI invested an additional $1 million in our company through the exercise
of 2,127,660 warrants. On August 23, 2017 we sold 4,604,500 of our ordinary shares to Israeli institutional investors, at a
price of $2.15 per share, pursuant to prospectus and an agreement dated August 18, 2017, entered into with each of the
investors. As of March 2018, DBSI has paid us 4 million to exercise warrants to purchase 7,891,683 ordinary shares. In
August 2017, DBSI converted the convertible loan and purchased 1,322,917 ordinary shares. We may need additional
working capital in the future to fund our operations. Such financing may not be available, or if available, may not be on
terms satisfactory to us. If adequate funds are not available to us, our business, and results of operations and financial
condition will be adversely affected.

Competition in the market for defense electronics is intense. Our products may not achieve market acceptance, which
could adversely affect our business, financial condition and results of operations.

The market for our products is highly competitive and we may not be able to compete effectively in our market. Our
principal competitors in the defense electronics market, include Elbit Systems Ltd., United Technologies Aerospace
Systems, Honeywell International Inc., Israel Aerospace Industries Ltd., or IAI, Northrop Grumman Corporation, Sagem
Avionics LLC, Thales Group, Zodiac Aerospace Group and SRC Inc. We expect to continue to face competition from
these and other competitors. Most of our competitors are larger and have substantially greater resources than us, including
financial, technological, marketing and distribution capabilities, and enjoy greater market recognition than we do. These
competitors are able to achieve greater economies of scale and may be less vulnerable to price competition than us. We
may not be able to offer our products as part of integrated systems to the same extent as our competitors or successfully
develop or introduce new products that are more cost effective or offer better performance than those of our competitors.
Failure to do so could adversely affect our business, financial condition and results of operations.

We may not be able to implement our growth strategy which could adversely affect our business, financial condition
and results of operations.

In line with our growth strategy, we entered into a number of strategic relationships with Embraer S.A., or Embraer,
Hindustan Aeronautics Ltd., or HAL, IAI, Lockheed Martin Corporation, or Lockheed Martin, Boeing Defense, Space &
Security, or Boeing, Rafael Advanced Defense Systems Ltd., or Rafael, IMI Systems Ltd., or IMI, and Leonardo DRS, or
DRS and SAZE Technologies LLC., or SAZE, to increase our penetration into the defense electronics market. We are
currently investing and intend to continue to invest significant resources to develop these relationships and additional new
relationships. Should our relationships fail to materialize into significant agreements or should we fail to work efficiently
with these companies, we may lose sales and marketing opportunities and our business, results of operations and financial
condition could be adversely affected.

Our growth is dependent in part on the development of new products, based on internal research and development. We
may not accurately identify market needs before we invest in the development of a new product. In addition, we might
face difficulties or delays in the development process that will result in our inability to timely offer products that satisfy
the market and competing products may emerge during the development and certification process.

While we have met with initial success in the introduction of our advanced ground radars for tactical applications such
as defense forces protection and border protection, there can be no assurance that we will succeed in obtaining general
market acceptance or that we will ever recover our investment in this new product family.

We have developed a number of radar hardware platforms for use in combat vehicles and tactical protection applications
for defense forces and border protection. In December 2014, we announced the first significant order for this product
family, a $4.5 million order from the Israel Ministry of Defense. To date, we have received over $20 million in orders for
our ground radar products, but cannot assure you that our ground radars will achieve broad market acceptance.

Reductions in defense budgets worldwide may cause a reduction in our revenues, which would adversely affect our
business, operating results and financial condition.

Substantially all of our revenues are derived from the sale of products with military applications. These revenues totaled
approximately $26.1 million, or 100% of our revenues in 2017, $12.8 million, or 100% of our revenues, in the year ended
December 31, 2016 and $14.1 million, or 99.9% of our revenues, in the year ended December 31, 2015. The defense
budgets of a number of countries have declined and may be reduced in the future. Declines in defense budgets may result
in reduced demand for our products and manufacturing services. This would result in reduction in our core business’
revenues and adversely affect our business, results of operations and financial condition.

Unfavorable national and global economic conditions could have a material adverse effect on our business, operating
results and financial condition.

During periods of slowing economic activity, our customers may reduce their demand for our products, technology and
professional services, which would reduce our sales, and our business, operating results and financial condition may be
adversely affected. The global and domestic economies continue to face a number of economic challenges, including
threatened sovereign defaults, credit downgrades, restricted credit for businesses and consumers and potentially falling
demand for a variety of products and services. These developments, or the perception that any of them could occur, could
result in longer sales cycles, slower adoption of new technologies and increased price competition for our products and
services. We could also be exposed to credit risk and payment delinquencies on our accounts receivable, which are not
covered by collateral.

Significant portions of our operations are conducted outside the markets in which our products and solutions are
manufactured or generally sold, and accordingly, we often export a substantial number of products into such markets. We
may, therefore, be denied access to potential customers or suppliers or denied the ability to ship products from any of our
subsidiaries into the countries in which we currently operate or wish to operate, as a result of economic, legislative,
political and military conditions, including hostilities and acts of terrorism, in such countries.

We may also be required in the future to increase our reserves for doubtful accounts. In addition, the fair value of some of
our assets may decrease as a result of an uncertain economy and as a result, we may be required to record impairment
charges in the future. If global economic and market conditions or economic conditions in key markets remain uncertain
or weaken further, our financial condition and operating results may be materially adversely affected.

Sales of our products are subject to governmental procurement procedures and practices; termination, reduction or
modification of contracts with our customers or a substantial decrease in our customers’ budgets may adversely affect
our business, operating results and financial condition.

Our products are primarily sold to governmental agencies, governmental authorities and government-owned companies,
many of which have complex and time-consuming procurement procedures. A substantial time often elapses from the time
we begin marketing a product until we actually sell that product to a particular customer. In addition, our sales to
governmental agencies, authorities and companies are directly affected by these customers’ budgetary constraints and the
priority given in their budgets to the procurement of our products. A decrease in governmental funding for our customers’
budgets would adversely affect our results of operations. This risk is heightened during periods of global economic
slowdown. Accordingly, governmental purchases of our systems, products and services may decline in the future as the
governmental purchasing agencies may terminate, reduce or modify contracts or subcontracts if:

● their requirements or budgetary constraints change;

● they cancel multi-year contracts and related orders if funds become unavailable;

● they shift spending priorities into other areas or for other products; or

● they adjust contract costs and fees on the basis of audits.

Any such event may have a material adverse effect on us.

Further, our business with the State of Israel and other governmental entities is, in general, subject to delays in funding
and performance of contracts and the termination for convenience (among other reasons) of contracts or subcontracts with
governmental entities. The termination, reduction or modification of our contracts or subcontracts with the Government of
Israel in the event of change in requirements, policies or budgetary constraints would have an adverse effect on our
business, operating results and financial condition.

If we do not receive the governmental approvals necessary for the export of our products, our revenues may decrease.
Similarly, if our suppliers and partners do not receive government approvals necessary to export their products or
designs to us, our revenues may decrease and we may fail to implement our growth strategy.

Israel’s defense export policy regulates the sale of our systems and products. Current Israeli policy encourages export to
approved customers of defense systems and products, such as ours, as long as the export is consistent with Israeli
government policy. A license is required to initiate marketing activities. We are also required to obtain a specific export
license for any hardware exported from Israel. We may not be able to receive all the required permits and licenses for
which we may apply in the future. If we do not receive the required permits for which we apply, our revenues may
decrease.

We are subject to laws regulating export of “dual use” items (items that are typically sold in the commercial market, but
that also may be used in the defense market) and defense export control legislation. Additionally, our participation in
governmental procurement processes in Israel and other countries is subject to specific regulations governing the conduct
of the process of procuring defense contracts. Furthermore, solicitations for procurements by governmental purchasing
agencies in Israel and other countries are governed by laws, regulations and procedures relating to procurement integrity,
including avoiding conflicts of interest and corruption in the procurement process. We may not be able to respond quickly
and effectively to changing laws and regulations and any failure to comply with such laws and regulations may subject us
to significant liability and penalties.

We depend on sales to key customers and the loss of one or more of our key customers would result in a loss of a
significant amount of our revenues, which would adversely affect our business, financial condition and results of
operations.

A significant portion of our revenues is derived from a small number of customers. During the years ended December 31,
2017 and 2016, 74% and 83% of our revenues, respectively, were attributable to seven customers. We anticipate that a
significant portion of our future revenues will continue to be derived from sales to a small number of customers. No
assurances can be given that our customers will continue to purchase our products, that we will be successful in any bid
for new contracts to provide such products, or that if we are granted subsequent orders, such orders would be of a scope
comparable to the sales that we have experienced to date. If our principal customers do not continue to purchase products
from us at current levels or if we do not retain such customers and we are not able to derive sufficient revenues from sales
to new customers to compensate for their loss, our revenues would be reduced and adversely affect our business, cash
flows, financial condition and results of operations.

We depend on suppliers of components for our products and if we are unable to obtain these components when needed,
we could experience delays in the manufacturing of our products and our financial results could be adversely affected.

We acquire most of the components for the manufacturing of our products from suppliers and subcontractors, most of
whom are located in Israel and the United States. A number of these suppliers are currently the sole source of one or more
components upon which we are dependent. Suppliers of some of the components for manufacturing require us to place
orders with significant lead-time to assure supply in accordance with our manufacturing requirements. Delays in supply
may significantly hurt our ability to fulfill our contractual obligations and may significantly hurt our business and result of
operations. In addition, we may not be able to continue to obtain such components from these suppliers on satisfactory
commercial terms. Temporary disruptions of our manufacturing operations would ensue if we were required to obtain
components from alternative sources, which may have an adverse effect on our financial results.

Rapid technological changes may adversely affect the market acceptance of our products and could adversely affect
our business, financial condition and results of operations.

The defense electronics market in which we compete is subject to technological changes, introduction of new products,
change in customer demands and evolving industry standards. Our future success will depend upon our ability to keep
pace with technological developments and to timely address the increasingly sophisticated needs of our customers by
supporting existing and new technologies and by developing and introducing enhancements to our current products and
new products. We may not be successful in developing and marketing enhancements to our products that will respond to
technological change, evolving industry standards or customer requirements. In addition, we may experience difficulties
that could delay or prevent the successful development, introduction and sale of such enhancements and such
enhancements may not adequately meet the requirements of the market and may not achieve any significant degrees of
market acceptance. If release dates of our new products or enhancements are delayed or, if when released, they fail to
achieve market acceptance, our business, operating results and financial condition may be adversely affected.

We enter into fixed-price contracts that could expose us to losses in the event we fail to properly estimate our costs.

We enter into firm fixed-price contracts. If our initial cost estimates are incorrect, we can lose money on these contracts.
Because many of these contracts involve new technologies, unforeseen events, such as technological difficulties and other
cost overruns, can result in the contract pricing becoming less favorable or even unprofitable to us and have an adverse
impact on our financial results.

Breaches of network or information technology security, natural disasters or terrorist attacks could have an adverse
effect on our business.

Cyber-attacks or other breaches of network or IT security, natural disasters, terrorist acts or acts of war may cause
equipment failures or disrupt our systems and operations. We may be subject to attempts to breach the security of our
networks and IT infrastructure through cyber attack, malware, computer viruses and other means of unauthorized access.
The potential liabilities associated with these events could exceed the insurance coverage we maintain. Our inability to
operate our facilities as a result of such events, even for a limited period of time, may result in significant expenses or loss
of market share to other competitors in the defense electronics market. In addition, a failure to protect the privacy of
customer and employee confidential data against breaches of network or IT security could result in damage to our
reputation. To date, we have not been subject to cyber-attacks or other cyber incidents which, individually or in the
aggregate, resulted in a material impact to our operations or financial condition.

We are subject to risks associated with international operations; we generate a significant portion of our sales from
customers located in countries that may be adversely affected by political or economic instability and corruption.

We are aviation and defense company with worldwide operations. Although 79% of our sales are in Israel and North
America, we expect to derive an increasing portion of our sales and future growth from other regions such as Latin
America, India and Central and Eastern Europe, which may be more susceptible to political or economic instability. In
addition, in many less-developed markets, we rely heavily on third-party representatives, consultants and other agents for
business development, marketing and distribution of our products. Many of these third-parties do not have internal
compliance resources comparable to ours. Business activities in many of these markets have historically been more
susceptible to corruption. If our efforts to screen third party agents and detect cases of potential misconduct fail, we could
be held responsible for the noncompliance of these third parties under applicable laws and regulations, which may
adversely affect our reputation and our business, financial condition or results of operations.

Exports accounted for 76% of our revenues in 2017, 43% of our revenues in 2016 and 57% of our revenues in 2015. Our
reliance on export sales subjects us to many risks inherent in engaging in international business, including:

● Limitations and disruptions resulting from the imposition of government controls;

● Changes in regulatory requirements;

● Export license requirements;

● Economic or political instability;

● Trade restrictions;

● Changes in tariffs;

● Currency fluctuations;

● Longer receivable collection periods and greater difficulty in accounts receivable collection;

● Greater difficulty in safeguarding intellectual property;

● Difficulties in managing overseas subsidiaries and international operations; and

● Potential adverse tax consequences.

We may not be able to sustain or increase revenues from international operations and may encounter significant
difficulties, in connection with the sale of our products in international markets. Any of those events may adversely affect
our business, operating results and financial condition.

Significant political developments could have a materially adverse effect on us. In the United States, potential or actual
changes in fiscal, defense appropriations, tax and labor policies could have uncertain and unexpected consequences that
may materially impact our business, results of operations and financial condition. In the U.K., “Brexit,” the referendum in
which voters approved an exit from the European Union, or E.U., could lead to legal uncertainty and potentially divergent
national laws and regulations which could adversely affect our business and financial condition. While the U.K. and the
E.U. are expected to reach an agreement by 2019 regarding the U.K.’s formal exit from the E.U., political changes in the
U.K. following the “Brexit” referendum and other factors leave it unclear when exactly the U.K. will exit and on what
terms.

In addition, as a company registered with the SEC, we are subject to the regulations imposed by the Foreign Corrupt
Practices Act, or FCPA, which generally prohibits registrants and their intermediaries from making improper payments to
foreign officials, for the purpose of obtaining or keeping business or obtaining an improper business benefit. We have
adopted proactive procedures to promote compliance with the FCPA, but we may be held liable for actions taken by our
strategic or local partners or agents even though these partners may not themselves be subject to the FCPA. Any
determination that we have violated the FCPA could materially and adversely affect our business, results of operations,
and cash flows.

Currency exchange rate fluctuations in the world markets in which we conduct business could have a material adverse
effect on our business, results of operations and financial condition.

Most of our revenues are in dollars or are linked to the dollar, while a portion of our expenses, principally salaries and
related personnel expenses, are incurred in other currencies, particularly in NIS. Therefore, our costs in such other
currencies, as expressed in dollars, are influenced by the exchange rate between the dollar and the relevant currency. We
are also exposed to the risk that the rate of inflation in Israel will exceed the rate of depreciation of the NIS in relation to
the dollar or that the timing of this depreciation lags behind inflation in Israel. This would have the effect of increasing the
dollar cost of our operations. In the past, the NIS exchange rate with the dollar and other foreign currencies has fluctuated,
generally reflecting inflation rate differentials. We cannot predict any future trends in the rate of inflation in Israel or the
rate of depreciation or appreciation of the NIS against the dollar. If the dollar cost of our operations in Israel increases, our
dollar-measured results of operations will be adversely affected. We engage in currency hedging transactions intended to
partly reduce the effect of fluctuations in foreign currency exchange rates on our results of operations. However, such
transactions may not materially reduce the effect of fluctuations in foreign currency exchange rates on our results of
operations.

Claims that our products infringe upon the intellectual property of third parties may require us to incur significant
costs, enter into licensing agreements or license substitute technology.

Third parties may assert infringement claims against us or claims that we have violated a patent or infringed on a
copyright, trademark or other proprietary right belonging to them. Any infringement claim, even one without merit, could
result in the expenditure of significant financial and managerial resources to defend against the claim. Moreover, a
successful claim of product infringement against us or a settlement could require us to pay substantial amounts or obtain a
license to continue to use the technology that is the subject of the claim, or otherwise restrict or prohibit our use of the
technology. We might not be able to obtain a license from the third party asserting the claim on commercially reasonable
terms, if at all. We also may not be able to obtain a license from another provider of suitable alternative technology to
permit us to continue offering the product. Infringement claims asserted against us could have a material adverse effect on
our business, operating results and financial condition.

We are required to comply with “conflict minerals” rules which impose costs on us, may make our supply chain more
complex, and could adversely impact our business.

We are subject to the requirements of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, or the
Dodd-Frank Act, that will require us to perform due diligence, disclose and report whether our products contain conflict
minerals. President Trump’s administration has indicated that the Dodd-Frank Act will be under further scrutiny and some
of the provisions of the Dodd-Frank Act may be revised, repealed or amended. In April 2017, the SEC announced that it
was suspending enforcement of portions of the conflict minerals regulations enacted under the Dodd-Frank Act following
a ruling by the U.S. Court of Appeals for the District of Columbia Circuit. The implementation of these requirements and
any changes effected by the Trump administration could adversely affect the sourcing, availability and pricing of the
materials used in the manufacture of components used in our products. In addition, we will likely incur additional costs to
comply with the disclosure requirements, including costs related to conducting diligence procedures to determine the
sources of conflict minerals that may be used in or necessary to the production of our products and, if applicable, potential
changes to our products, processes or sources of supply as a consequence of such verification activities. It is also possible
that we may face reputational harm if we determine that certain of our products contain minerals not determined to be
conflict-free or if we are unable to alter our products, processes or sources of supply to avoid use of such materials.
Furthermore, we may encounter challenges in satisfying those customers that require that all of the components of our
products be certified as conflict free, and if we cannot satisfy these customers, they may choose a competitor’s products.

We may fail to maintain effective internal controls in accordance with Section 404 of the Sarbanes-Oxley Act of 2002,
which could have an adverse effect on our financial results and the market price of our ordinary shares.

The Sarbanes-Oxley Act of 2002 imposes certain duties on us and our executives and directors. Our efforts to comply with
the requirements of Section 404(a) of the Sarbanes-Oxley Act of 2002 governing internal controls and procedures for
financial reporting, which started, in connection with our 2007 Annual Report on form 20-F, have resulted in increased
general and administrative expense and a diversion of management time and attention, and we expect these efforts to
require the continued commitment of significant resources. We may identify material weaknesses or significant
deficiencies in our assessments of our internal controls over financial reporting. Failure to maintain effective internal
controls over financial reporting could result in investigation or sanctions by regulatory authorities and could have a
material adverse effect on our operating results, investor confidence in our reported financial information and the market
price of our ordinary shares.

Risk Factors Related to Our Ordinary Shares

Because one of our shareholders, DBSI, holds approximately 27.37% of our outstanding shares, investors may not be
able to affect the outcome of shareholder votes.

DBSI currently beneficially owns 9,001,364 of our ordinary shares, or approximately 27.37% of our outstanding shares.
For as long as DBSI, or any shareholder, holds a significant interest in our company, it may have the ability to exercise a
controlling influence over our business and affairs, including any determinations with respect to potential mergers or other
business combinations involving us, our acquisition or disposition of assets, our incurrence of indebtedness, our issuance
of any additional ordinary shares or other equity securities, our repurchase or redemption of ordinary shares and our
payment of dividends. Similarly, as long as DBSI has a controlling interest in our company, it will have the power to
determine or significantly influence the outcome of matters submitted to a vote of our shareholders, including the power to
elect all of the members of our board of directors (except external directors, within the meaning of Israeli law), or prevent
an acquisition or any other change in control of us. Because the interests of our controlling shareholders may differ from
the interests of our other shareholders, actions taken by it with respect to us may not be favorable to our other
shareholders.

If we fail to maintain compliance with NASDAQ’s continued listing requirements, our shares may be delisted from the
NASDAQ Capital Market.

To continue to be listed on the NASDAQ Capital Market, we need to satisfy a number of conditions, including minimum
shareholders’ equity of at least $2.5 million and a minimum closing bid price per share of $1.00. On October 1, 2015, we
received notification from NASDAQ for not maintaining a minimum bid price of US$1.00 per share for 30 consecutive
business days (Listing Rule 5550(a) (2)). We were given 180 calendar days, or until March 29, 2016, to regain
compliance. On March 30, 2016, we received notification from NASDAQ that we are eligible for an additional 180
calendar days to regain compliance. Following a reverse split of our ordinary shares, on September 29, 2016, we regained
compliance with Listing Rule 5550(a)(2) and our shares continued to be listed on the NASDAQ Capital Market.

If in the future, our share price drops again and remains under $1.00 for 30 consecutive business days, and if we are
ultimately delisted from NASDAQ, trading in our ordinary shares would be conducted on a market where an investor
would likely find it significantly more difficult to dispose of, or to obtain accurate quotations as to the value of, our
ordinary shares.

Our share price has been volatile in the past and may decline in the future.

Our ordinary shares have experienced significant market price and volume fluctuations in the past and may experience
significant market price and volume fluctuations in the future in response to factors such as the following, some of which
are beyond our control:

● Quarterly variations in our operating results;

● Operating results that vary from the expectations of securities analysts and investors;

● Changes in expectations as to our future financial performance, including financial estimates by securities

analysts and investors;

● Announcements of technological innovations or new products by us or our competitors;

● Announcements by us or our competitors of significant contracts, acquisitions, strategic partnerships, joint

ventures or capital commitments;

● Changes in the status of our intellectual property rights;

● Announcements by third parties of significant claims or proceedings against us;

● Additions or departures of key personnel;

● Future sales of our ordinary shares;

● Delisting of our shares from the NASDAQ Capital Market; and

● Stock market price and volume fluctuations.

Domestic and international stock markets often experience extreme price and volume fluctuations. Market fluctuations, as
well as general political and economic conditions, such as a recession or interest rate or currency rate fluctuations or
political events or hostilities in or surrounding Israel, could adversely affect the market price of our ordinary shares.

In the past, securities class action litigation has often been brought against companies following periods of volatility in the
market price of its securities. We may in the future be the target of similar litigation. Securities litigation could result in
substantial costs and divert management’s attention and resources both of which could have a material adverse effect on
our business and results of operations.

Substantial future sales of our ordinary shares by our principal shareholders may depress our share price.

If our principal shareholders, sell substantial amounts of their ordinary shares, including shares registered under effective
registration statements and shares issuable upon the exercise of outstanding warrants, or if the perception exists that our
principal shareholders may sell a substantial number of our ordinary shares, the market price of our ordinary shares may
fall. Any substantial sales of our shares in the public market also might make it more difficult for us to sell equity or
equity related securities in the future at a time and on terms we deem appropriate.

We do not intend to pay dividends.

We have never declared or paid cash dividends on our ordinary shares and do not expect to do so in the foreseeable future.
The declaration of dividends is subject to the discretion of our board of directors and will depend on various factors,
including our operating results, financial condition, future prospects and any other factors deemed relevant by our board of
directors. You should not rely on an investment in our company if you require dividend income from your investment in
our company. The success of your investment will likely depend entirely upon any future appreciation of the market price
of our ordinary shares, which is uncertain and unpredictable. There is no guarantee that our ordinary shares will appreciate
in value or even maintain the price at which you purchased your ordinary shares.

We may be classified as a passive foreign investment company, or PFIC, which would subject our U.S. investors to
adverse tax rules.

U.S. holders of our ordinary shares may face income tax risks. We have been advised that we may have been a “passive
foreign investment company” (“PFIC”) for the 2017 taxable year. Our treatment as a PFIC could result in a reduction in
the after-tax return to U.S. Holders (as defined below in Item 10E. “Additional Information – Taxation”) of our ordinary
shares and would likely cause a reduction in the value of such shares. A foreign corporation will be treated as a PFIC for
U.S. federal income tax purposes if either (1) at least 75% of its gross income for any taxable year consists of certain types
of “passive income,” or (2) at least 50% of the average value of the corporation’s gross assets produce, or are held for the
production of, such “passive income.” For purposes of these tests, “passive income” includes dividends, interest, gains
from the sale or exchange of investment property and rents and royalties other than rents and royalties that are received
from unrelated parties in connection with the active conduct of a trade or business. For purposes of these tests, income
derived from the performance of services does not constitute “passive income.” If we are treated as a PFIC, U.S. Holders
of ordinary shares would be subject to a special adverse U.S. federal income tax regime with respect to the income derived
by us, the distributions they receive from us, and the gain, if any, they derive from the sale or other disposition of their
ordinary shares. In particular, dividends paid by us, if any, would not be treated as “qualified dividend income,” eligible
for preferential tax rates in the hands of non-corporate U.S. shareholders. Since PFIC status depends upon the composition
of our income and the market value of our assets from time to time, even if we were not a PFIC in 2017, there can be no
assurance that we will not become a PFIC in any future taxable year. U.S. Holders should carefully read Item 10E.
“Additional Information – Taxation” for a more complete discussion of the U.S. federal income tax risks related to owning
and disposing of our ordinary shares.

Risks Relating to Our Location in Israel

Political, economic and military instability in Israel may disrupt our operations and negatively affect our business
condition, harm our results of operations and adversely affect our share price.

We are incorporated under the laws of, and our principal executive offices and manufacturing and research and
development facilities are located in the State of Israel. As a result, political, economic and military conditions affecting
Israel directly influence us. Any major hostilities involving Israel, a full or partial mobilization of the reserve forces of the
Israeli army, the interruption or curtailment of trade between Israel and its present trading partners, or a significant
downturn in the economic or financial condition of Israel could adversely affect our business, financial condition and
results of operations.

Conflicts in North Africa and the Middle East, including in Egypt and Syria which border Israel, have resulted in
continued political uncertainty and violence in the region. Efforts to improve Israel’s relationship with the Palestinian
Authority have failed to result in a permanent solution, and there have been numerous periods of hostility in recent years.
In addition, relations between Israel and Iran continue to be seriously strained, especially with regard to Iran’s nuclear
program. Such instability may affect the local and global economy, could negatively affect business conditions and,
therefore, could adversely affect our operations. To date, these matters have not had any material effect on our business
and results of operations; however, the regional security situation and worldwide perceptions of it are outside our control
and there can be no assurance that these matters will not negatively affect our business, financial condition and results of
operations in the future.

Furthermore, we could be adversely affected by the interruption or reduction of trade between Israel and its trading
partners. Some countries, companies and organizations continue to participate in a boycott of Israeli companies and others
doing business with Israel or with Israeli companies. As a result, we are precluded from marketing our products to these
countries, companies and organizations. Foreign government defense export policies towards Israel could also make it
more difficult for us to obtain the export authorizations necessary for our activities. Also, over the past several years there
have been calls in Europe and elsewhere to reduce trade with Israel. Restrictive laws, policies or practices directed
towards Israel or Israeli businesses may have an adverse impact on our operations, our financial results or the expansion of
our business.

Our results of operations may be negatively affected by the obligation of our personnel to perform military service.

Some of our employees in Israel are obligated to perform annual military reserve duty and are subject to being called for
active duty under emergency circumstances. If a military conflict or war arises, these individuals could be required to
serve in the military for extended periods of time. Our operations could be disrupted by the absence for a significant
period of one or more of our executive officers or key employees or a significant number of other employees due to
military service. Any disruption in our operations could adversely affect our business.

We may not be able to enforce covenants not-to-compete under current Israeli law.

We have non-competition agreements with most of our employees, many of which are governed by Israeli law. These
agreements generally prohibit our employees from competing with us or working for our competitors for a specified
period following termination of their employment. However, Israeli courts are reluctant to enforce non-compete
undertakings of former employees and tend, if at all, to enforce those provisions for relatively brief periods of time in
restricted geographical areas and only when the employee has unique value specific to that employer’s business and not
just regarding the professional development of the employee. Any such inability to enforce non-compete covenants may
cause us to lose any competitive advantage resulting from advantages provided to us by such confidential information.

We may become subject to claims for remuneration or royalties for assigned service invention rights by our employees,
which could result in litigation and adversely affect our business.

A significant portion of our intellectual property has been developed by our Israeli employees in the course of their
employment for us. Under the Israeli Patent Law, 5727-1967, or Israeli Patent Law, inventions conceived by an employee
during the term and as part of the scope of his or her employment with a company are regarded as “service inventions,”
which belong to the employer, absent a specific agreement between the employee and employer giving the employee
service invention rights. The Israeli Patent Law also provides that if there is no such agreement between an employer and
an employee, the Israeli Compensation and Royalties Committee, or C&R Committee, a body constituted under the Israeli
Patent Law, shall determine whether the employee is entitled to remuneration for his inventions. The C&R Committee
(decisions of which have been upheld by the Israeli Supreme Court) has held that employees may be entitled to
remuneration for their service inventions despite having specifically waived any such rights. Further, the C&R Committee
has not yet set specific guidelines regarding the method for calculating this remuneration or the criteria or circumstances
under which an employee’s waiver of his right to remuneration will be disregarded. We generally enter into intellectual
property assignment agreements with our employees pursuant to which such employees assign to us all rights to any
inventions created in the scope of their employment or engagement with us. Although our employees have agreed to
assign to us service invention rights and have specifically waived their right to receive any special remuneration for such
assignment beyond their regular salary and benefits, we may face claims demanding remuneration in consideration for
assigned inventions. As a consequence of such claims, we could be required to pay additional remuneration or royalties to
our current or former employees, or be forced to litigate such claims, which could negatively affect our business.

Service and enforcement of legal process on us and our directors and officers may be difficult to obtain.

Service of process upon our directors and officers and the Israeli experts named in this annual report, most of who reside
outside the U.S., may be difficult to obtain within the U.S. Furthermore, since substantially most our assets, our directors
and officers and the Israeli experts named in this annual report are located outside the U.S., any judgment obtained in the
U.S. against us or these individuals or entities may not be collectible within the U.S.

There is doubt as to the enforceability of civil liabilities under the Securities Act and the Securities Exchange Act in
original actions instituted in Israel. However, subject to certain time limitations and other conditions, Israeli courts may
enforce final judgments of U.S. courts for liquidated amounts in civil matters, including judgments based upon the civil
liability provisions of those Acts.

The rights and responsibilities of our shareholders are governed by Israeli law and differ in some respects from those
of a typical U.S. corporation.

We are incorporated under Israeli law and the rights and responsibilities of holders of our ordinary shares are governed by
our articles of association and by Israeli law. These rights and responsibilities differ in some respects from the rights and
responsibilities of shareholders in typical U.S. corporations. In particular, a shareholder of an Israeli company has a duty
to act in good faith in exercising his or her rights and fulfilling his or her obligations toward the company and other
shareholders and to refrain from abusing his power in the company, including, among other things, in voting at the general
meeting of shareholders on certain matters. Israeli law provides that these duties are applicable to shareholder votes at the
general meeting with respect to, among other things, amendments to a company’s articles of association, increases in a
company’s authorized share capital, mergers and actions and transactions involving interests of officers, directors or other
interested parties which require the shareholders’ approval. In addition, a controlling shareholder of an Israeli company or
a shareholder who knows that he or she possesses the power to determine the outcome of a vote at a meeting of our
shareholders, or who has, by virtue of the company’s articles of association, the power to appoint or prevent the
appointment of an office holder in the company, or any other power with respect to the company, has a duty of fairness
toward the company. However, Israeli law does not define the substance of this duty of fairness. There is little case law
available to assist in understanding the implications of these provisions that govern shareholder behavior.

Israeli government programs and tax benefits may be terminated or reduced in the future.

We participate from time to time in programs of the Israeli Innovation Authority (formerly the Office of the Chief
Scientist) of the Israeli Ministry of Economy, or Innovation Authority, for which we receive funding for the development
of technologies and products. The benefits available under these programs depend on meeting specified conditions. For
more information about these programs see Item 5. “Operating and financial review and prospects – Research &
Developments – Israeli Innovation Authority.” If we fail to comply with these conditions, we may be required to pay
additional penalties, make refunds and may be denied future benefits. From time to time, the government of Israel has
discussed reducing or eliminating the benefits available under these programs, and therefore these benefits may not be
available to us in the future at their current levels or at all.

As a foreign private issuer whose shares are listed on the NASDAQ Capital Market, we may follow certain home
country corporate governance practices instead of certain NASDAQ requirements.

As a foreign private issuer whose shares are listed on the NASDAQ Capital Market, we are permitted to follow certain
home country corporate governance practices instead of certain requirements of The NASDAQ Stock Market Rules.
Among other things, as a foreign private issuer we may follow home country practice with regard to the composition of
the board of directors, director nomination procedure, and quorum at shareholders’ meetings. In addition, we may follow
our home country law, instead of the NASDAQ Stock Market Rules, which require that we obtain shareholder approval
for certain dilutive events such as for the establishment or amendment of certain equity based compensation plans, an
issuance that will result in a change of control of the company, certain transactions other than a public offering involving
issuances of a 20% or more interest in the company, and certain acquisitions of the stock or assets of another company. A
foreign private issuer that elects to follow a home country practice instead of NASDAQ requirements must submit to
NASDAQ in advance a written statement from an independent counsel in such issuer’s home country certifying that the
issuer’s practices are not prohibited by the home country’s laws. In addition, a foreign private issuer must disclose in its
annual reports filed with the SEC each such requirement that it does not follow and describe the home country practice
followed by the issuer instead of any such requirement. Accordingly, our shareholders may not be afforded the same
protection as provided under NASDAQ’s corporate governance rules.

ITEM 4. INFORMATION ON THE COMPANY

A. History and Development of the Company

We were incorporated under the laws of the State of Israel on December 8, 1970. We are a public limited liability
company under the Israeli Companies Law 1999-5759, or the Israeli Companies Law, and operate under this law and
associated legislation. Our registered offices and principal place of business are located at 7 Giborei Israel Street, Netanya
4250407, Israel, and our telephone number is +972-9-892-1111. Our website address is www.rada.com. The information
on our website is not incorporated by reference into this annual report.

We develop, manufacture and sell defense electronics, including avionics solutions (including avionics for unmanned
aerial vehicles and airborne inertial navigation systems), airborne data/video recording and management systems and
tactical land-based radars for defense forces and for border protection systems. In addition, while we continue to sell and
support our legacy commercial aviation products and services, in 2016 we decided to actively pursue the sale of our
Chinese subsidiary, Beijing Hua Rui Aircraft Maintenance and Service, Co., Ltd., known as CACS, which is the main
platform of our test and repair shop activity. The results presented in this annual report were adjusted to present CACS’
results in a separate line as “Discontinued Operations.”

B. Business Overview

Industry Overview

Our activity is primarily focused on the defense electronics market. This is a growing market and is currently a large part
of the defense industry. The defense electronics market reflects two contradictory trends, the proliferation of defense
electronics, which has been offset by the significant reduction in the price of electronic systems which is reducing the
dollar value of the market. Today, new military vehicles of all kinds are equipped with significantly more electronic
systems than they used to carry in the past. The increasing usage of advanced electronics in modern vehicles, including
upgrades of existing technology and the growing use of unmanned vehicles of all kinds, have provided significant growth
to the market.

Today’s advanced defense electronics systems typically incorporate components that are derived from the industrial or the
consumer electronics markets, especially from the telecom and automotive markets. Most of the defense electronics
systems are built with commercial components and even with sub-systems, which reduce the overall price, and at the same
time generate complex obsolescence issues.

Purchasers of defense electronics products are either governments or major integrators. Engagement in business
relationships with these customers is complex, has a long sales cycle and requires long-term commitments for future
support of delivered hardware. Production batches of such products are usually small.

Suppliers of defense electronic systems are either providers of sub-systems to major integrators and platform
manufacturers or are providers of integrated systems to the industry or to the armed forces. These companies are typically
very large and have diversified product offerings.

New products in the defense electronic market are usually developed utilizing internal and customer sponsored research
and development funds and are tailored to specific customer needs. In many cases, the customer who pays for the design
and adaptation limits the use of intellectual property that was funded by it for other applications, due to either commercial
or security reasons.

Products and Services

We primarily sell state-of-the-art defense electronics products. We may also provide end-to-end solutions for one or more
systems. Our current product lines are:

● Military Avionics (Data/video recorders, core avionics for aircraft and UAVs) and airborne Inertial

Navigation Systems;

● Tactical Radars for defense forces and border protection systems (land based).

While we continued to support our legacy commercial aviation test stations, in 2016 we decided to sell CACS, our main
platform for our test and repair shop activity.

Military Avionics

We are active in the field of mission data & video recording, management, and post-mission analysis and debriefing for
fighter and trainer aircrafts. Over the past 25 years we have developed, fielded and supported a wide range of solid-state
digital recorders, cameras and debriefing systems for aerospace and military applications, including:

● Flight data recorders, or FDR, for fighter aircraft;

● Digital video/audio/data recorders, or DVDR (with data transfer functions);

● High-rate (no compression) data recorders, or HRDR, for aircraft and airborne pods;

● Video recorders and airborne data servers, or VRDS, the latest approach to avionic data management;

● HD-DVDR, high definition digital video/audio/data recording for fighter and trainer aircrafts.

● A wide range of head-up-displays color video cameras, or HCVC, for fighter aircraft; and

● A variety of ground debriefing solutions, or GDS.

Featuring state-of-the-art technologies, our digital recorders are designed for military applications. Our high-performance
recorders provide simultaneous, high-capacity video (both analog and digital/HD), audio and data recording, high
throughput and mass storage handling capabilities, supporting rapid dissemination and real-time playback. Our video
recorders implement MPEG-2 and/or MPEG-4 (H.264) compression formats, supporting up to 128GB of solid state
memory, facilitating continuous recording over extended mission durations. Recent upgrades to our recorders provide the
ability to record high-definition video formats and advanced ARINC-818 protocols, over copper and also fiber optics
lines.

Our GDS feature synchronized video, audio, data, and air combat maneuvering debriefing. GDS vary from personal,
laptop-size debriefing units, through robust desktop multi-channel systems supporting the mission debriefing of four-
aircraft formations up to large-scale simultaneous debriefing systems. These network-based systems support large
numbers of participants operating from different locations, and provide advanced data management features.

We have been a developer and manufacturer of core avionics systems for over 30 years. We currently offer a wide
spectrum of military avionics systems designed for integration in new and upgraded military aircraft and UAVs
worldwide. Our avionics solutions range from fully integrated avionics suites, through core avionics subsystems, to tailor-
made “built-to-spec” units, backed by our teams of experts dedicated to providing global technical and maintenance
support.

Our avionics systems are easily adapted to western, eastern, and indigenous-origin platforms of all kinds. In particular, our
avionics for UAVs are extremely compact through modern board connectivity solutions, use of innovative conductive
cooling techniques, withstand extreme environmental conditions and are very reliable and affordable.

We offer the following avionics solutions:

● Mission data recorders and debriefing solutions (as described above);

● Weapon management systems;

● Data interface and processing computers;

● HUD video cameras;

● Avionics for UAVs (Interface control processors, engine control computers, Payload management computers

and others);

● R-100F: FOG-based, navigation-grade embedded GPS-INS for fighters and helicopters;

● R-200M: Compact, MEMS-based, multiple-sensor aided INS for UAVs and backup INS for manned aircraft;

● MAVINS – Modular Avionics and MEMS-Based INS: A specially-designed, compact integrated solution for

UAVs.

Our airborne products and system solutions are fully qualified and operated by leading air forces and prime integrators
worldwide, such as the Israeli Air Force, or IAF, Lockheed Martin, Boeing Company, HAL, Embraer, IAI, Rafael, the
Chilean Air Force, Indra Systemas S.A., and many others. Our units are installed onboard F-16, F-15, T-6, A-4, Jaguar,
MiG-27, Su-30MKI, Dhruv Helicopter, MiG-29, Super-Tucano and other aircraft, and onboard a continuously-growing
number of UAVs.

Tactical Radars for defense forces and border protection systems (land based). We develop advanced ground-based
radars for tactical applications such as defense forces protection and border protection. Our pulse Doppler, software-
defined radars are solid-state, fully digital, incorporate active electronically scanned array, or AESA antenna, are compact,
mobile and highly reliable, provide hemispheric spatial coverage and multi-mission capabilities, operate on-the-move, or
OTM, and demonstrate unprecedented performance-to-price ratio.

The asymmetric and irregular conflicts in which modern armies are engaged in recent years dictate the needs for
instantaneous and real-time intelligence, minimal cycle time for target acquisition, highly accurate weapons with minimal
collateral damage and discrimination between hostiles and civilians. Our tactical radars, which move with the
maneuvering combat units in the field and operate OTM, provide the real-time knowledge of whether and from where they
are threatened, detect all relevant threats, whether unfriendly fire or drones/UAVs/fighters/helicopters from any angle
(including very high angles), discriminate among threats and provide the needed intelligence for any course of action,
whether counter-fire or avoidance. The performance-over-price ratio of our radars makes them ideal solutions to the
current needs and requirements of maneuver forces.

We have developed various radar hardware platforms: the compact hemispheric radar, or CHR, which is tailored for use in
combat vehicles and short-range protection applications; and a family of multi-mission hemispheric radars, or MHRs,
which are tailored for use in force and border protection applications. We offer the MHR, the enhanced MHR, or eMHR,
and the improved and enhanced MHR, or ieMHR; all share the same basic characteristics, but differ in range, size, weight,
and price. For each radar platform we implement several operational missions by changing the radar operational
parameters.

The current operational missions of the CHR are the following:

● The RPS-10 radar sensors for active protection systems, or APS, detect all relevant threats that may be fired
at combat vehicles, including RPGs, anti-tank guided missiles (ATGMs) and projectiles and provide 360°
hemispheric coverage. The system delivers threat data to the APS, enabling it to neutralize threats.

● The RPS-12 short-range hemispheric air surveillance radar system can detect, classify and track aerial
vehicles at ranges of up to 10km, with emphasis on small UAVs. Mobile or stationary, the system can be
integrated with any C4I system and other radars and sensors, and can operate either as a stand-alone, or as
part of a large-scale surveillance system.

● The RPS-14 radar system for perimeter and border protection can detect, identify, and track aerial and
surface intruders including slow and small aircraft, vehicles, vessels, and pedestrians at tactical ranges. The
RPS-14 can operate either as a stand-alone, or as part of a large-scale surveillance system.

● The RPS-15 comprehensive hostile fire management system for combat vehicle detects, tracks, classifies,
and locates direct and elevated threats fired at combat vehicles, allowing the mobile force to successfully
complete its mission while operating in a hostile environment.

The current operational missions of the MHR family of radar platforms are the following:

● The RPS-40/70/80 hostile fire detection radar systems detect, track, classify and locate direct and elevated
threats fired at stationary or mobile forces. They compute the Point-Of-Origin (POO) and Point-Of-Impact
(POI) of the threats, which may be rockets, artillery, mortars, ATGMs, RPGs, and more other threats. The
systems can be integrated with any protection and Command, Control, Communications, Computers and
Intelligence (C4I) system and be installed at stationary bases and posts, or onboard fighting vehicles.

● The RPS-42/72/82 tactical hemispheric air surveillance radar systems can detect, classify and track all types
of aerial vehicles, including fighters, helicopters, UAVs, transport aircraft, etc. at tactical ranges. Mobile or
stationary, the systems can be integrated with any C4I system and other radars and sensors, and can operate
either as a stand-alone, or as part of a large-scale surveillance system.

● The RHS-44/74/84 radar systems for border protection can detect, identify, and track aerial and surface
border intruders including slow and small aircraft, vehicles, vessels, and pedestrians at tactical ranges. The
systems can operate either as a stand-alone, or as part of a large-scale surveillance system.

Among our customers and users of for radar systems are leading defense forces and industries worldwide, including the
Israeli MOD, IMI, Artis, Lockheed Martin, Boeing, DRS, SAZE, the U.S. Marine Corps and Navy, the U.S. Air Force,
Indian Security Forces, MBDA and additional air defense prime integrators and end-users. Some of our customers have
purchased a small number of radars for evaluation and integration in their air defense and/or other systems. These may
turn into larger production orders upon evaluation and if such systems begin full rate production.

Business Development, Sales and Marketing

Strategy

Our business development strategy is based on the following principles:

● Becoming a reliable and trusted supplier of sensors and sub-systems to defense system integrators and major
platforms manufacturers with global sales, such as Lockheed Martin, Boeing, IMI, IAI, Rafael, DRS,
Embraer, HAL and others.

● Establishing strategic joint venture companies in the primary target markets (i.e. U.S. for local presence,

direct market development, localization of the technology, production and customer support.

● Expanding our global business development efforts and potential customer base by engaging business
development consultants and service providers in the countries and territories in which our products may be
used, and actively managing this global network; and

● Establishing strategic partnerships with leading integrators in the prime target markets for tactical radars, i.e.
U.S. Europe, India; such partnerships may involve indigenization and localization of our technologies to
enable sales in significant quantities in these markets.

Strategic Relationships and Customers

As part of our strategy, we have established a number of strategic relationships with leading global defense contractors
and several air forces. We have focused our marketing and sales efforts to support these relationships.

Lockheed Martin. Lockheed Martin is the manufacturer of the F-16 aircraft, one of the most popular fighter aircraft in the
western world today. We are supplying the DVDR, HD-DVDR and GDS for new F-16 aircraft production and for F-16
upgrade programs led by Lockheed Martin. In 2015, Lockheed Martin ordered a single radar system for integration in
their internally funded high energy laser research and development program.

IMI Systems. IMI is a world leader in the field of APS for land platforms and is the developer and manufacturer of the
“Iron Fist” APS. We are teamed with IMI on the integration and production of our RPS-10 radars as part of their “Iron
Fist” APS solution for local and global customers. During 2016 there was a global increase in the interest of major forces
in APS; as a result, IMI were engaged along 2017 in extensive efforts to integrate, test and provide its APS to customers in
Europe and North America, along with our on-going support. We have sold dozens of CHR radars to IMI to support these
activities. We anticipate that these testing efforts will mature into acquisition programs.

Boeing Defense, Space and Security. Boeing, a provider of air defense and high-energy laser systems, acquired our MHR
in 2013 for evaluation of its use as part its directed energy tactical systems, and in 2017 has acquired our ieMHR to be
integrated into critical infrastructure surveillance solutions. We also provide Boeing with recorders and debriefing stations
for the T-45 VMTS, and have received follow-on orders from Boeing.

Leonardo DRS. DRS is a major player in the defense electronics market in North America, with a focus on tactical
systems and radars. In 2017, we signed a cooperation agreement with DRS to market and sell our tactical radars in the
North American market for counter-UAV, short-range air defense, and other solutions. DRS has acquired a few MHR
radars and is actively promoting it as part of their system solutions.

SAZE Technologies LLC. SAZE is the first customer and user of our MHR radars, and provided support and market access
to various radar programs and demonstrations that we were involved with. RADA and SAZE established a joint venture
company, or JV, in the U.S., RADA Technologies LLC,, that will seek special security agreements and will perform
market development, localization of the technology, customer support, production and maintenance. We are in the process
of recruiting personnel for the JV.

European Air Defense Integrators. Two major European air defense integrators have purchased radars for integration and
testing. We have signed a value-added representation agreement with one of the integrators for certain countries where it
has a dominant position in sales of air defense and other solutions.

Rafael Advanced Defense Systems Ltd. Rafael is a world leader in the development and supply of missiles, smart weapons
and pods of various types. Rafael has become a strategic customer of ours as a result of our development and production
of a few advanced built-to-specification products in recent years. Recently, Rafael selected the MHR as the radar for the
“Drone Dome” system that is designed to counter UAVs and drones, and is purchasing radars from us for test and
evaluation.

Military Forces. We are the sole providers of digital recorders and debriefing solutions to an air force in Latin America.
We are the primary provider of recorders and debriefing solutions to a major Asian air force. Our tactical radars for air
defense are under evaluation by a Far-East country’s army that has acquired f a few units, while two other Asian forces
have purchased radars for air surveillance and counter-mortar applications. Our tactical radars are used by the U.S. Navy
and Marines as part of their ground based air defense advanced technology development program. We believe that these
strategic relationships with military forces provide us with the potential for prolonged cooperation.

Israel Aerospace Industries. We actively supply avionics and test equipment to four different divisions of IAI, and in
particular to the LAHAV and MALAT divisions, who are major aircraft integrators and utilize our products and services
for repeated follow-on orders.

Hindustan Aeronautics Ltd. HAL is the major aerospace integrator in India. We are currently cooperating with four
divisions of HAL and supply DVDRs, HCVCs, GDS, support equipment and other services in growing numbers.

Embraer S.A. The Military Aircraft Division of the Brazilian aircraft manufacturer is a strategic customer. In addition to
supplying avionics such as DVDR, INS and HCVC to Embraer, we are participating to a greater degree in Embraer’s
programs through the development and supply of avionic units per their specifications and their training and support
activities.

Business Development and Marketing

Our Chief Executive Officer, Mr. Dov Sella, together with Mr. Gil Schwartz, our VP Business Development & Marketing,
lead our business development and marketing efforts. We currently employ twelve additional professionals (seven of
which are part-time consultants) in business development and the sales of our products. Our program managers, chief
technology officer and our engineering departments support our marketing and sales efforts with respect to proposal
preparations and products demonstrations. In addition, we have business development consultants in Europe, South
America and Asia who receive success fees for sales generated by them. Our U.S. JV is gradually taking over the business
development role in the North-American market, and works directly and in cooperation with DRS on the exploitation of
the large U.S. opportunities. Four of our seven part-time consultants are supporting this activity.

The Israeli Ministry of Defense has historically supported, and continues to support, our marketing efforts through its
defense export assistance branch and through various projects for the IDF and its related divisions. There is no guarantee
that this type of assistance will be available to us in the future.

We take part and present our tactical radars at the major land systems exhibitions on a regular basis, such as the (AUSA)
Annual Meetings, D.C., Eurosatory in Paris, DSEI in London, and in regional exhibitions such as Seoul Aerospace &
Defense, MSPO in Poland, DefExpo in India and others.

Fixed Price Contracts

The vast majority of our contracts are fixed-price contracts, under which the price is not subject to adjustment by reason of
the costs incurred in the performance of the contracts, as long as the costs incurred and work performed fall within
governmental guidelines. Under our fixed-price contracts, we assume the risk of increased or unexpected costs that may
reduce our profits or even generate losses. This risk can be particularly significant under fixed-price contracts for research
and development involving new technologies.

Our books and records may be subject to audits by the Israeli Ministry of Defense and other governmental agencies,
including the U.S. Department of Defense. These audits may result in adjustments to contract costs and profits.

Principal Customers

Generally, we complete a few major transactions each year, each in an amount comprising more than 10% of our revenues
for such year. As a result, each year a significant portion of our revenues is derived from a small number of customers.
The following table sets forth our principal customers in 2015, 2016 and 2017:

Israel Aerospace Industries
Ministry of Defense
RAFAEL
Embraer S.A.
Hindustan Aeronautics Ltd
Lockheed Martin Corporation
Leonardo DRS

Percentage of Revenues
2016

2017

2015

24%
9%
7%
10%
13%
8%
1%

20%
17%
16%
13%
11%
6%
1%

7%
9%
2%
3%
5%
13%
35%

Although we continually strive to increase the number of our customers, we anticipate that a significant portion of our
future revenues will continue to be derived from a small number of customers. Because of our dependency on a small
number of customers and on government contracts, we are subject to business risks, including changes in governmental
appropriations and changes in national defense policies and priorities. Although many of the programs in which we
participate as a contractor or subcontractor may extend for several years, our business is dependent upon annual
appropriations and funding of new and existing contracts. Most of the contracts are subject to termination for the
convenience of the customer, pursuant to which the customer pays only for reimbursement of costs incurred and the
applicable profit on work performed. The Israeli government or any other government may discontinue funding purchases
of our products over the long term.

Geographical Markets

We sell our products to various air forces and companies worldwide. The following table presents our revenues by
geographical markets for the periods indicated:

Israel
South and Latin America
Asia
North America
Europe
Australia

Competition

2015

2016

2017

43%
11%
20%
25%
1%
-

57%
10%
19%
13%
1%
-

24%
2%
17%
55%
1%
1%

The markets for our products are highly competitive. Our principal competitors on the avionics and recorders include Elbit
Systems Ltd., United Technologies Aerospace Systems, Honeywell International Inc., IAI, Northrop Grumman
Corporation, Sagem Avionics LLC., Thales Group and Zodiac Aerospace Group. Our principal competitors on tactical
radars are IAI (through its subsidiary, Elta), SRC Inc., SAAB, Thales and Leonardo Selex. We expect to continue to face
competition from these and other competitors. Currently, all of our competitors are larger and have substantially greater
resources than us, including financial, technological, marketing and distribution capabilities, and enjoy greater market
recognition than we do. These competitors may be able to achieve greater economies of scale and may be less vulnerable
to price competition than us. We may not be able to offer our products as part of integrated systems to the same extent as
our competitors or successfully develop or introduce new products that are more cost effective or offer better performance
than those of our competitors. Failure to do so could adversely affect our business, financial condition and results of
operations.

Government Regulations

Israel’s defense export policy regulates the sales of our systems and products. Current Israeli policy encourages export to
approved customers of defense systems and products, such as ours, as long as the export is consistent with Israeli
government policy.

A license is required to initiate marketing activities. We are also required to obtain a specific export license for any
hardware exported from Israel. We are regulated by an Israeli law regulating export of “dual use” items (items that are
typically sold in the commercial market, but that also may be used in the defense market) and the Defense Export Control
Law and its supplemental regulations. Those laws and regulations govern the enforcement of export control and defined
certain new areas of licensing, particularly with respect to transfer of technology. It is not certain that we will receive all
the required permits and licenses for which we may apply in the future. Our participation in governmental procurement
processes in Israel and other countries is subject to specific regulations governing the process of procuring defense
contracts. Furthermore, solicitations for procurements by governmental purchasing agencies in Israel and other countries
are governed by laws, regulations and procedures relating to procurement integrity, including avoiding conflicts of interest
and corruption in the procurement process.

In addition, antitrust laws and regulations in Israel and other countries often require governmental approvals for
transactions that are considered to limit competition. Such transactions may include cooperative agreements for specific
programs or areas, as well as mergers and acquisitions.

Proprietary Information

We generally do not consider patent protection significant to our current operations and rely upon a combination of
security devices, trade secret laws and contractual restrictions to protect our rights in our products. Our policy is to require
employees and consultants to execute confidentiality agreements upon the commencement of their relationships with us.
These measures may not be adequate to protect our technology from third-party infringement, and our competitors might
independently develop technologies that are substantially equivalent or superior to ours. Additionally, our products may be
sold in foreign countries that provide less protection for intellectual property rights than that provided under U.S. or Israeli
laws.

The Israeli government usually retains certain rights in technologies and inventions resulting from our performance as a
prime contractor or subcontractor under Israeli government contracts and may generally disclose such information to third
parties, including other defense contractors. When the Israeli government funds research and development, it may acquire
rights to proprietary data and title to inventions; we may retain a non-exclusive, royalty-free license for such inventions.
However, if the Israeli government purchases only the end product, we may retain the principal rights and the government
may use the data and take an irrevocable, non-exclusive, royalty-free license.

Manufacturing and Quality Management

Our production plant is located in Beit She’an, Israel. The plant is equipped to handle most of our manufacturing
processes and testing requirements. For a few specific processes we utilize outsourced resources. This structure allows us
flexibility and versatility. To support the growth in radar production, we are in the process of establishing a supply chain
of board assembly providers and chassis/casting providers, while final assembly, calibration and testing is kept internally.

We place great emphasis on quality control in our production processes. Commencing with customer requirements and
expectations, via raw material inspection through completion, specifications are repeatedly checked. We maintain a
quality assurance team that participates in every stage of the design and manufacturing of the products. Our quality
management system is certified by the Standards Institute of Israel, or SII, pursuant to ISO 9001:2015 for hardware design
and production and ISO 90003:2014 for software design. SII performs quality system audits twice a year and various
customers perform audits four to six times a year. Our environmental management system is certified by SII to ISO
14001:2004. Our quality management system is also certified according to AS-9100D, a quality management system for
aerospace requirements.

According to the standard warranty incorporated in most of our sales contracts, we warrant that our products will be free
from defects in design, materials or workmanship, and guarantee repair or replacement of defective parts typically for
periods between one to two years following delivery of a product to a customer. We also provide maintenance services to
customers who sign maintenance contracts.

Source and Availability of Raw Materials

We acquire most of the components for the manufacturing of our products from suppliers and subcontractors, most of
whom are located in Israel and the United States. Some of these suppliers are currently the sole source of one or more
components upon which we are dependent. Since many of our purchases require long lead-times, a delay in supply of an
item can significantly delay the delivery of a product. To date, we have not experienced any particular difficulties in
obtaining timely deliveries of necessary components. We depend on a limited number of suppliers of components for our
products and if we are unable to obtain these components when needed, we would experience delays in manufacturing our
products and our financial results could be adversely affected.

C. Organizational Structure

We own 80% interest in CACS, a company based in China that is engaged in aircraft repair services. In 2010, we and our
local partner in China, Tianzhu Forest Development Co., or Tianzhu, agreed that Tianzhu would divest its 20% interest
and CACS would become a wholly-owned subsidiary, but the necessary approvals for such sale have never been obtained.
In 2016, we resolved to pursue a sale of our interest in our CACS subsidiary. The results presented in this annual report
were adjusted to present CACS’ results in a separate line as “Discontinued Operations.”

D. Property, Plants and Equipment

We own a 30,000 square feet industrial building in Beit She’an, Israel. The building, which includes manufacturing
facilities and warehouse space, is situated on land leased from the Israel Land Authority for a period of 49 years ending in
2034. The plant has sufficient capacity to meet our current requirements.

Our executive offices and research and development facilities are located in a 17,782 square feet office facility in Netanya,
Israel. The lease for this facility expires in January 2022. The aggregate annual rent for our offices in Israel was
approximately $351,000 in 2017.

ITEM 4A. UNRESOLVED STAFF COMMENTS

Not applicable.

ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS

A. Operating Results

The following discussion of our results of operations should be read together with our consolidated financial statements
and the related notes, which appear elsewhere in this annual report. The following discussion contains forward-looking
statements that reflect our current plans, estimates and beliefs and involve risks and uncertainties. Our actual results may
differ materially from those discussed in the forward-looking statements. Factors that could cause or contribute to such
differences include those discussed below and elsewhere in this annual report.

Overview

We develop, manufacture and sell defense electronics including military avionics systems for manned and unmanned
aircraft, inertial navigation systems, or INS, and tactical land radars for force and border protection applications. We sell
and support our commercial aviation electronic products and services, mainly through CACS, our 80% owned Chinese
subsidiary. In 2016, we resolved to pursue a sale of our interest in our CACS subsidiary. The results presented in this
annual report were adjusted to present CACS’ results in a separate line as “Discontinued Operations.”

General

Our consolidated financial statements appearing in this annual report are prepared in dollars and in accordance with U.S.
GAAP. Transactions and balances originally denominated in dollars are presented at their original amounts. Transactions
and balances in other currencies are re-measured into dollars in accordance with the principles set forth in the Financial
Accounting Standards Board, or FASB, Accounting Standards Codification, or ASC 830. The majority of our sales are
made outside of Israel and a substantial part of them are in dollars. In addition, a substantial portion of our costs are
incurred in dollars. Since the dollar is the primary currency of the economic environment in which we operate, the dollar
is our functional and reporting currency and, accordingly, monetary accounts maintained in currencies other than the
dollar are re-measured using the foreign exchange rate at the balance sheet date. Operational accounts and non-monetary
balance sheet accounts are measured and recorded at the exchange rate in effect at the date of the transaction. All
monetary balance sheet accounts have been re-measured using the exchange rates in effect at the balance sheet date.
Statement of operations amounts have been re-measured using the average exchange rate for the period. The financial
statements of our foreign subsidiary, whose functional currency is not the dollar, have been translated into dollars. All
balance sheet amounts have been translated using the exchange rates in effect at balance sheet date. Statement of operation
amounts have been translated using the average exchange rate prevailing during the year. Such translation adjustments are
reported as a component of accumulated other comprehensive income (loss) in shareholders’ equity.

Discussion of Critical Accounting Policies and Estimations

Our critical accounting policies, including the assumptions and judgments underlying them, are disclosed in the notes to
our consolidated financial statements. These policies have been consistently applied in all material respects. While the
estimates and judgments associated with the application of these policies may be affected by different assumptions or
conditions, we believe the estimates and judgments associated with the reported amounts are appropriate under the
circumstances. We believe the following accounting policies are the most critical in fully understanding and evaluating
our financial condition and results of our operations under U.S. GAAP.

Revenue Recognition. Our revenues are mainly derived from sales of defense electronics (solid-state recorders, computers,
radars, etc.) and their supporting ground systems (automated testers, data debriefing stations). Product revenue is
recognized when there is persuasive evidence of an arrangement, the fee is fixed or determinable, delivery of the product
to the customer has occurred and the collection of the fee is probable. If the product requires specific customer acceptance,
revenue is deferred until customer acceptance occurs or the acceptance provisions lapse, unless we can objectively and
reliably demonstrate that the criteria specified in the acceptance provisions are satisfied.

Revenues from long-term fixed price contracts are recognized by the percentage-of-completion method in accordance with
the “input method.” We apply this method when the total of the costs and revenues of the contract can reasonably be
estimated. The percentage of completion is determined based on the ratio of actual costs incurred to total costs estimated
to be incurred over the duration of the contract. With regard to contracts for which a loss is anticipated, a provision is
made for the entire amount of the estimated loss at the time such loss becomes evident. Estimated gross profit or loss from
long-term contracts may change due to changes in estimates resulting from differences between actual performance and
original forecasts. Such changes in estimated gross profit or loss are recorded in results of operations when they are
reasonably determined by management, on a cumulative catch-up basis. Revenues under long-term fixed-price contracts
that involve both development and production are recorded using the cost-to-cost method (development phase) and units-
of-delivery method (production phase) as applicable to each phase of the contract, as the basis to measure progress toward
completion.

We also generate revenues from repair services using our automated test equipment, mainly through CACS (now
classified as a discontinued operation). Revenues from services are recognized when the service is performed.

Impairment of Long-Lived Assets. We are required to assess the impairment of long-lived assets whenever events or
changes in circumstances indicate that the carrying value may not be recoverable. We assess the impairment of our assets
based on a number of factors, including any significant changes in the manner of our use of the respective assets or the
strategy of our overall business and significant negative industry or economic trends. Upon determination that the carrying
value of a long-lived asset may not be recoverable, based upon a comparison of expected undiscounted future cash flows
to the carrying amount of the asset, an impairment charge is recorded in the amount of the carrying value of the asset
exceeds its fair value. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to
sell. As of December 31, 2017 and 2016, no impairment losses have been identified.

Accounting for income taxes. On January 1, 2007, we adopted FASB ASC 740-10 “Income Taxes,” which contains a two-
step approach to recognizing and measuring uncertain tax positions accounted for in accordance with ASC 740-10. The
first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of
available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position
will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to
measure the tax benefit as the largest amount that is more than 50% likely to be realized upon ultimate settlement ASC
740-10. We provided a valuation allowance in respect to the deferred tax assets resulting from operating loss
carryforwards and other temporary differences. Our management currently believes that since our company has a history
of losses, it is more likely than not that the deferred tax regarding the loss carryforwards and other temporary differences
will not be realized in the foreseeable future.

Inventory valuation. The majority of our inventory consists of work in progress, raw materials and components.
Inventories are valued at the lower of cost or market. Cost of finished goods is determined on the basis of direct
manufacturing costs plus allocable indirect costs representing allocable operating overhead expenses and manufacturing
costs. Raw material is valued using the “FIFO” method. We assess the valuation of our inventory on a quarterly basis and
periodically write down the value for different finished goods and raw material items based on their potential utilization. If
we consider specific inventory to be damaged, we write such inventory down to zero. Inventory write-offs are provided to
cover risks arising from slow-moving items, discontinued products, and excess inventories. The process for evaluating
these write-offs often requires us to make subjective judgments and estimates concerning the future utilization of the
inventory items. Inventory write-offs were $122,000, $144,000 and $153,000 for the years ended December 31, 2017,
2016 and 2015, respectively.

Allowance for doubtful accounts. Our trade receivables are derived from sales to customers all over the world. We
perform ongoing credit evaluations of our customers. In certain circumstances, we may require letters of credit or
prepayments. We maintain an allowance for doubtful accounts for estimated losses from the inability of our customers to
make required payments that we have determined to be doubtful of collection. We determine the adequacy of this
allowance by regularly reviewing our accounts receivable and evaluating individual customers’ receivables, considering
customers’ financial condition, credit history and other current economic conditions. If a customer’s financial condition
were to deteriorate which might impact its ability to make payment, then additional allowances may be required.
Provisions for doubtful accounts are recorded in general and administrative expenses. Our allowance for doubtful accounts
was $14,000, $14,000, $2,000 for the years ended December 31, 2017, 2016 and 2015, respectively.

Stock-based compensation. We account for stock-based compensation in accordance with the provisions of ASC 718,
“Compensation - Stock Compensation.” Under the fair value recognition provisions of ASC 718, stock-based
compensation cost is estimated at the grant date based on the fair value of the award and is recognized as expense ratably
over the requisite service period of the award. We estimate the fair value of stock options granted using the Black-
Scholes-Merton option-pricing model.

The fair value of an award is affected by our stock price on the date of grant and other assumptions, including the
estimated volatility of our stock price over the term of the awards and the estimated period of time that we expect
employees to hold their stock options.

Discontinued Operations. Under ASC 205, “Presentation of Financial Statements - Discontinued Operation” when a
component of an entity, as defined in ASC 205, has been disposed of or is classified as held for sale, the results of its
operations, including the gain or loss on its component are classified as discontinued operations and the assets and
liabilities of such component are classified as assets and liabilities attributed to discontinued operations; that is, provided
that the operations, assets and liabilities and cash flows of the component have been eliminated from the company’s
consolidated operations and the company will have no significant continuing involvement in the operations of the
component. Subsequent to our determination to sell our interest in CACS, CACS’ results are accounted as discontinued
operation and appear in this annual report in a separate line item as “Discontinued Operations.”

Explanation of Key Income Statement Items

Revenues. Our revenues are mainly derived from sales of defense electronics and their supporting ground systems.

Cost of Revenues. Cost of revenues consists primarily of salaries, raw materials, subcontractor expenses, related
depreciation costs, inventories write-downs and overhead allocated to cost of revenues activities.

Research and Development Expenses, net. Research and development expenses consist primarily of salaries for research
and development personnel, use of subcontractors and other costs incurred in the process of developing product
prototypes.

Marketing and Selling Expenses. Marketing and selling expenses consist primarily of salaries for marketing and business
development personnel, marketing activities, public relations, promotional materials, travel expenses, trade show exhibit
expenses, and success fees to business development consultants.

General and Administrative Expenses. General and administrative expenses consist primarily of salaries and related
expenses for executive, accounting, legal, administrative personnel, professional fees, provisions for doubtful accounts
and other general corporate expenses.

Financial Expenses, Net. Financial expenses consist of interest and bank expenses, interest on convertible note and loans,
amortization expenses of discount on convertible note, deferred charges and currency re-measurement losses. Financial
income consists of interest on cash and cash equivalent balances and currency re-measurement gains.

Results of Operations

The following table presents certain financial data expressed as a percentage of total revenues for the periods indicated:

Revenues
Cost of revenues
Gross profit
Research and development, net
Marketing and selling
General and administrative
Operating income (loss)
Financial expenses, net
Net income (loss) from continuing operations
Net income (loss) from discontinued operations
Net income (loss)
Net income (loss) attributable to non-controlling
interest
Net income (loss) attributable to RADA
Electronic Industries’ shareholders

Year Ended December 31,
2016

2017

2015

100%
82.9%
17.1%
4.9%
16.7%
14.9%
(19.5)%
(25.4)%
(44.9)%
(1.3)%
(46.2)%

(0.2)%

(45.9)%

100%
88.7%
11.3%
5.9%
17.7%
14.1%
(26.5)%
(11.9)%
(38.4)%
0.1%
(38.3)%

0.0%

(38.3)%

100%
68.4%
31.6%
6.0%
8.2%
9.8%
7.6%
0.6%
7.0%
1.9%
8.9%

0.3%

8.6%

Year Ended December 31, 2017 Compared with Year Ended December 31, 2016

Revenues. Our revenues increased by 104% to $26.2 million in 2017 from $12.8 million in 2016 mainly due to the
increase in our radars business revenues.

Cost of Revenues. Cost of revenues increased by 57% to $17.9 million in 2017 from $11.4 million in 2016. The increase in
our cost of revenues is attributable to the increase in revenues.

Gross Profit. Our gross profit increased by 473% to $8.3 million in 2017 from $1.4 million in 2016. Our gross profit
margin was approximately 31.6% in 2017 and 11.2% in 2016. The increase in our gross profit and gross profit margin in
2017 was mainly attributable to the increase in revenues and especially to the higher gross margin generated from the
radars business.

Research and Development Expenses, Net. Our research and development expenses increased by 107.8% to $1.6 million
in 2017 from $0.8 million in 2016. The increase in expenditures is a result of our strategy to achieve and maintain a
technological edge for our products in the market.

Marketing and Selling Expenses. Marketing and selling expenses decreased by 5.8% to approximately $2.1 million in
2017 from $2.3 million in 2016. We maintained a similar level of marketing and selling expenses primarily due to our
efforts to sell our radar products, mainly reflected in the costs incurred as part of our participation in field demonstrations
requested by our potential customers.

General and Administrative Expenses. General and administrative expenses increased by 41% to approximately $2.6
million in 2017 from $1.8 million in 2016. The increase is attributable mainly to the increase in the non-cash expense
associated with employee option compensation.

Financial Expenses, Net. Our financial expenses, net, decreased by 90% to $0.2 million in 2017 compared to $1.5 million
in 2016. The decrease is attributed mainly to the lower level of interest expenses related to the loans (including a
convertible loan) and bank credit, which were converted and repaid in full during 2017. Our non-cash financial expense
resulting from the amortization of the discount on a convertible loan and loans from shareholders was $0.103 million in
2017 compared to $1.1 million in 2016. Our interest expense, net, was $0.164 million in 2017 compared to $0.3 million in
2016.

Year Ended December 31, 2016 Compared with Year Ended December 31, 2015

Revenues. Our revenues decreased by 9% to $12.8 million in 2016 from $14.1 million in 2015 mainly due to delays in
securing expected contracts that were delayed to later dates.

Cost of Revenues. Cost of revenues decreased by 2% to $11.4 million in 2016 from $11.7 million in 2015. The decrease in
our cost of revenues is attributable to the reduction in sales.

Gross Profit. Our gross profit decreased by 40% to $1.4 million in 2016 from $2.4 million in 2015. Our gross profit
margin was approximately 11.2% in 2016 and 17% in 2015. The decrease in our gross profit and gross profit margin in
2016 was mainly attributable to the decrease in revenues and the relatively lower decrease in cost of revenues.

Research and Development Expenses, Net. Our research and development expenses increased by 9.4% to $758,000 in
2016 from $693,000 in 2015. The relatively low level of expenditures in both 2016 and 2015 reflects maturation of our
radar products.

Marketing and Selling Expenses. Marketing and selling expenses decreased by 4% to approximately $2.27 million in 2016
from $2.36 million in 2015. We maintained a similar level of marketing and selling expenses primarily due to our efforts
to sell our new radar products, mainly reflected in the costs incurred as part of our participation in field demonstrations
requested by our potential customers.

General and Administrative Expenses. General and administrative expenses decreased by 14% to approximately $1.8
million in 2016 from $2.1 million in 2015. Our general and administrative expenses in 2015 include a $0.6 million charge
due to goodwill impairment.

Financial Expenses, Net. Our financial expenses, net, decreased by 57% to $1.5 million in 2016 compared to $3.6 million
in 2015. Our non-cash financial expense resulting from the amortization of the discount on a convertible note and loans
from shareholders was $1,116,000 in 2016 compared to $2,684,000 in 2015. Our interest expense, net, was $270,000 in
2016 compared to $575,000 in 2015.

Our Location in Israel

We are incorporated under the laws of the State of Israel, and our principal executive offices and principal manufacture,
research and development facilities are located in Israel. See Item 3D “Key Information – Risk Factors – Risks Relating to
Our Location in Israel” for a description of governmental, economic, fiscal, monetary or political polices or factors that
have materially affected or could materially affect our operations.

Corporate Tax Rate

Israeli companies were generally subject to corporate tax at a rate of 24% in 2017. The corporate tax as of January 1, 2018
is 23%.

As of December 31, 2017, our net operating loss carry forward for Israeli tax purposes was approximately $73 million,
including capital loss carry forwards of approximately $3.8 million.

Trade Relations

Israel is a member of the United Nations, the International Monetary Fund, the International Bank for Reconstruction and
Development, and the International Finance Corporation. Israel is a member of the World Trade Organization and is a
signatory to the General Agreement on Tariffs and Trade. Israel is a member of the Organization for Economic Co-
operation and Development, or the OECD, an international organization whose members are governments of mostly
developed economies. The OECD’s main goal is to promote policies that will improve the economic and social well-being
of people around the world. In addition, Israel has been granted preferences under the Generalized System of Preferences
from the U.S., Australia, Canada and Japan. These preferences allow Israel to export the products covered by such
programs either duty-free or at reduced tariffs.

Israel and the E.U. concluded a Free Trade Agreement in July 1975 that confers some advantages with respect to Israeli
exports to most European countries and obligates Israel to lower its tariffs with respect to imports from these countries
over a number of years. In 1985, Israel and the U.S. entered into an agreement to establish a Free Trade Area. The Free
Trade Area has eliminated all tariff and some non-tariff barriers on most trade between the two countries. On January 1,
1993, an agreement between Israel and the European Free Trade Association, known as the “EFTA,” established a free-
trade zone between Israel and the EFTA nations. In November 1995, Israel entered into a new agreement with the E.U.,
which includes a redefinition of rules of origin and other improvements, such as allowing Israel to become a member of
the Research and Technology programs of the E.U.

Impact of Currency Fluctuation and of Inflation

A significant portion of the cost of our Israeli operations, primarily personnel and facility-related, is incurred in NIS.
Therefore, our NIS related costs, as expressed in dollars, are influenced by the exchange rate between the dollar and the
NIS. In addition, if the rate of inflation in Israel will exceed the rate of devaluation of the NIS in relation to the dollar, or if
the timing of such devaluations were to lag considerably behind inflation, our cost as expressed in dollars may increase.
NIS linked balance sheet items, may also create foreign exchange gains or losses, depending upon the relative dollar
values of the NIS at the beginning and end of the reporting period, affecting our net income and earnings per share.
Although we may use hedging techniques, we may not be able to eliminate the effects of currency fluctuations. Therefore,
exchange rate fluctuations could have a material adverse impact on our operating results and share price. The caption
“Financial expenses, net” in our consolidated financial statements includes the impact of these factors as well as
traditional interest income or expense.

The following table sets forth, for the periods indicated, (i) depreciation or appreciation of the NIS against the most
important currency for our business, the dollar, until December 31 each year and the year before, and (ii) inflation as
reflected in changes in the Israeli consumer price index.

2013

Year Ended December 31,
2015

2016

2014

2017

NIS vs. U.S. Dollar
Israeli Consumer Price Index

(7.0)%
1.8%

12%
(0.2)%

0%
(1.0)%

(1.0)%
(0.2)%

(9.8)%
1.5%

Since exchange rates between the NIS and the dollar fluctuate continuously, exchange rate fluctuations, particularly larger
periodic devaluations, may have an impact on our profitability and period-to-period comparisons of our results. We cannot
assure you that in the future our results of operations may not be materially adversely affected by currency fluctuations

Recently Issued Accounting Standards

ASU 2014-09- Revenue from Contracts with Customers (Topic 606)

In May 2014, the FASB issued new standard related to revenue recognition, ASU No. 2014-09, “Revenue from Contracts
with Customers (Topic 606)” and related subsequent updates (collectively, the “new revenue standard”). Under the new
revenue standard, revenue is recognized when a customer obtains control of promised goods or services and is recognized
in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services. In
addition, the new revenue standard requires disclosure of the nature, amount, timing, and uncertainty of revenue and cash
flows arising from contracts with customers. The new revenue standard permits two transition methods: retrospectively to
each prior reporting period presented (the “full retrospective method”), or retrospectively with the cumulative effect of
initially applying the new revenue standard recognized at the date of initial application (the “modified retrospective
method”). The Company will adopt the new revenue standard effective January 1, 2018 using the modified retrospective
method applied to those contracts which were not substantially completed as of January 1, 2018.

The Company did not have any material cumulative-effect adjustment as a result of the adoption. In addition, the adoption
of ASU 2014-09 and the overall Topic 606 will not have any material impact on our consolidated financial statement line
items in the year of adoption. The Company will make the additional required disclosures under Topic 606, starting with
the Company’s consolidated financial statements that include the initial adoption date.

ASU 2016-02 - Leases (Topic 842):

In February 2016, the FASB issued guidance on the recognition, measurement, presentation and disclosure of leases for
both parties to a contract (i.e., lessees and lessors). The new standard requires lessees to apply a dual approach, classifying
leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed
purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective
interest method or on a straight-line basis over the term of the lease, respectively. A lessee is also required to record a
right-of-use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification.
Leases with a term of 12 months or less will be accounted for in a manner similar to the accounting under existing
guidance for operating leases today. The new standard requires lessors to account for leases using an approach that is
substantially equivalent to existing guidance for sales-type leases, direct financing leases and operating leases. Topic 842
supersedes the previous leases standard, ASC 840, “Leases.” The guidance is effective for the interim and annual periods
beginning on or after December 15, 2018 (early adoption is permitted). The Company is currently evaluating the potential
effect of the guidance on its consolidated financial statements.

ASU 2016-18 - Statement of Cash Flows (Topic 230):

In November 2016, the FASB issued Accounting Standards Update No. 2016-18, Statement of Cash Flows (Topic 230):
Restricted Cash. The ASU requires that the Consolidated Statement of Cash Flows explain the change in total cash and
equivalents and amounts generally described as restricted cash or restricted cash equivalents when reconciling the
beginning-of-period and end-of-period total amounts. The ASU also requires a reconciliation between the total of cash and
equivalents and restricted cash presented on the Consolidated Statement of Cash Flows and the cash and equivalents
balance presented on the Consolidated Balance Sheet. ASU 2016-18 is effective retrospectively on January 1, 2018, with
early adoption permitted. The Company does not expect this guidance to have a material effect on its consolidated
financial statements at the time of adoption of this standard.

ASU 2017-09, “Compensation – Stock Compensation (Topic 718):

In May 2017, the FASB issued ASU 2017-09, “Compensation – Stock Compensation (Topic 718): Scope of Modification
Accounting.” ASU 2017-09 was issued to provide clarity and reduce both 1) diversity in practice and 2) cost and
complexity when applying the guidance in Topic 718 to a change in the terms or conditions of a share-based payment
award. ASU 2017-09 provides guidance about which changes to the terms or conditions of a share-based payment award
require an entity to apply modification accounting under Topic 718. The amendments in ASU 2017-09 are effective for
fiscal years, and interim periods within those years, beginning after December 15, 2017. Early adoption is permitted,
including adoption in any interim period. The amendments in ASU2017-09 should be applied prospectively to an award
modified on or after the adoption date. The adoption of this ASU will not have a material impact on our consolidated
financial statements.

ASU 2017-12, “Derivatives and Hedging:

In August 2017, the FASB issued ASU 2017-12, “Derivatives and Hedging - Targeted Improvements to Accounting for
Hedging Activities”, which is intended to simplify and amend the application of hedge accounting to more clearly portray
the economics of an entity’s risk management strategies in its financial statements. The ASU will make more financial and
nonfinancial hedging strategies eligible for hedge accounting, reduce complexity in fair value hedges of interest rate risk
and ease certain documentation and assessment requirements of hedge effectiveness. It also changes how companies
assess effectiveness and amends the presentation and disclosure requirements. ASU 2017-12 is effective for fiscal years
beginning after December 15, 2018. The Company is currently evaluating the impact of adopting the ASU on its
consolidated financial statements.

Recently Adopted Accounting Pronouncements:

ASU 2016-09- Compensation - Stock Compensation (Topic 718)

In March 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update 2016-09,
“Compensation - Stock Compensation (Topic 718)” (“ASU 2016-09”). ASU 2016-09 permits entities to make an
accounting policy election related to how forfeitures will impact the recognition of compensation cost for stock-based
compensation: to estimate the total number of awards for which the requisite service period will not be rendered or to
account for forfeitures as they occur. Upon adoption of ASU 2016-09, the Company elected to change its accounting
policy to account for forfeitures as they occur. The guidance was applied on a modified, retrospective basis in the first
quarter of fiscal 2017 and did not have a material impact on the Company’s consolidated financial results.

B. Liquidity and Capital Resources

We have historically met our financial requirements primarily through cash generated by operations, funds generated by
our public offerings, private placements of our ordinary shares and debt securities, loans from our principal shareholders,
short-term loans and credit facilities from banks (most recently Bank Leumi Le-Israel B.M. and the Israeli branch of State
Bank of India, or the Banks), research and development grants from the government of Israel and the Israel-U.S.
Binational Industrial Research and Development Foundation, investment grants for approved enterprise programs and
marketing grants from the government of Israel.

We had working capital of $25.6 million as of December 31, 2017 compared with working capital of $11.1 million at
December 31, 2016. Cash and cash equivalents were $12.4 million as of December 31, 2017 compared to $1.2 million as
of December 31, 2016. Short-term and long-term bank deposits and restricted bank deposits were $0.32 million as of
December 31, 2017 and December 31, 2016.

As of December 31, 2017, our Banks provided $0.4 million of guarantees on our behalf, mainly to our customers and
suppliers in the ordinary course of business. The guarantees are secured by a first priority floating charge on all of our
assets and by a fixed charge on our property in Beit She’an, unpaid share capital and insurance rights (rights to proceeds
on insured assets in the event of loss). Our agreements with the Banks prohibit us from: (i) selling or otherwise
transferring any assets except in the ordinary course of business; (ii) placing a lien on our assets without the Banks’
consent; or (iii) declaring dividends to our shareholders.

On July 30, 2015, we completed a public offering of 3,455,284 ordinary shares, offered at a price to the public of $2.46
per share. We received gross proceeds of $8.5 million before deducting underwriting discounts and commissions and other
offering expenses. Issuance costs amounted to approximately $1.07 million. As of December 31, 2015 the remaining
principal amount of the debt owed under the Standstill Agreement was $3.09 million.

On May 15, 2016, our shareholders approved the sale to DBSI of 8,510,638 of our ordinary shares in consideration for
approximately $4 million, reflecting a price per share of $0.47. In addition, we issued to DBSI warrants to purchase: (i) an
additional 4,255,319 ordinary shares at an exercise price per share of $0.47 (resulting in an aggregate exercise price of $2
million), exercisable for a period of 24 months following the date of the initial investment and (ii) warrants to purchase an
additional 3,636,363 shares at an exercise price per share of $0.55 (resulting in an aggregate exercise price of $2 million),
exercisable for a period of 48 months following the date of the initial investment.

DBSI also granted the company an option, exercisable by either us or DBSI, for us to obtain a three -year loan in the
principal amount of up to $3.175 million solely for the purpose of the repayment of the outstanding shareholders’ debt.
We exercised such option in June 2016 and used the funds to fully repay our outstanding shareholders’ debt.

During the term of the loan, which has a three-year term, DBSI had the right, but not the obligation, at its sole discretion,
to convert the then remaining convertible loan amount into ordinary shares at a price per share equal to the lower of: (i)
$2.40, or (ii) a five percent (5%) discount to the FMV (the average of the closing prices of our Ordinary Shares over the 5
consecutive trading days ending on the last trading day prior to the date of conversion), but in no event less than $0.47. In
August 2017, DBSI converted the entire principal of the loan and acquired 1,322,917 ordinary shares, reflecting a
conversion price of $2.40 per share.

DBSI’s exercise of warrants has resulted in proceeds to our company of $1.25 million in 2016 and $1.95 million in 2017
in the aggregate.

In connection with the DBSI transaction, we issued warrants to purchase 255,319 ordinary shares to each of Legos
Advisors Ltd. and Mr. Avi Geffen as commission and finder’s fees. All of these warrants were exercised in 2017 for total
consideration of $0.24 million.

On November 15, 2016, we completed a $2 million directed registered offering of 1,904,762 ordinary shares at a price per
share of $1.05 to The Phoenix Insurance Company Ltd. and its affiliate, Shotfut-Menayot-Israel-HaPhoenix Amitim Ltd.
At the same time, DBSI invested an additional $1 million in our company through the exercise of 2,127,660 warrants.

On August 20, 2017, we sold 4,604,500 of our ordinary shares to Israeli institutional investors, at a price of $2.15 per
share pursuant to our shelf registration statement.

We made capital expenditures of $1 million in the year ended December 31, 2017, primarily for machinery and
equipment. We currently do not have any significant capital spending or purchase commitments.

Cash Flows

The following table summarizes our cash flows for the periods presented:

2015

Year ended December 31,
2016
(U.S. dollars in thousands)

2017

Net cash provided by (used in) operating activities from
continuing operations
Net cash used in investing activities from continuing
operations
Net cash provided by financing activities from
continuing operations
Net cash provided by (used in) operating activities from
discontinued operations
Net cash used in investing activities from discontinued
operations
Effect of exchange rate changes on cash and cash
equivalents
Increase (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of the year
Cash and cash equivalents at end of the year
Less cash and cash equivalents of discontinued
operation at the end of the year

(3,018)

(370)

3,227

253

(8)

(116)
(32)
1,786
1,754

1,020
734

(4,919)

(44)

5,442

298

(34)

(133)
610
1,754
2,364

1,159
1,205

1,722

(1,811)

11,292

(644)

(101)

(138)
10,320
2,364
12,684

267
12,417

Continuing Operations:

Net cash provided by operating activities was $1,722,000 in 2017. This was primarily due to our net income of
$2,342,000, depreciation and amortization of $638,000, share based non-cash compensation to employees of $559,000 and
a decrease in costs and estimated earnings in excess of billings of $809,000. This was offset by an increase in trade
receivables of $2,280,000, and an increase in inventories of $890,000. Net cash used in operating activities was
$4,919,000 in 2016. This was primarily due to our loss in 2016 and increase in inventories of $1,503,000, an increase in
trade receivables of $1,360,000. This was offset by a decrease in costs and estimated earnings in excess of billings of
$403,000. Net cash used in operating activities was $3,018,000 in 2015. This was primarily due to our loss in 2015 and a
decrease in other accounts payables and accrued expenses of $1,437,000, an increase in trade receivables of $607,000, and
increase in inventories of $499,000. This was offset by a decrease in costs and estimated earnings in excess of billings of
$1,467,000, an increase in trade payables of $602,000 and a decrease in other accounts receivable and prepaid expenses of
$81,000.

Net cash used in investing activities was $1,811,000 in 2017, primarily due to the investment of $1,041,000 in property,
plant and equipment and construction-in-process of production infrastructure of $736,000. Net cash provided by investing
activities was approximately $44,000 in 2016, primarily due to change in restricted deposits, net of $356,000 which was
offset by the investment of $411,000 in property, plant and equipment. Net cash used in investing activities was
approximately $370,000 in 2015, primarily due to a change in restricted deposits of $6,000, which was offset by the
investment of $366,000 in property, plant and equipment.

Net cash provided by financing activities was $11,292,000 in 2017, due to issuance of ordinary shares and exercise of
warrants. This was offset by a decrease in short-term bank credit of $575,000. Net cash used in financing activities was
$5,442,000 in 2016, reflecting net proceeds of $7,096,000, mainly from our transactions with DBSI and The Phoenix
Insurance Company Ltd. and its affiliate, the net repayment of $2,988,000 of shareholders loans and a decrease in short-
term bank credit of $1,841,000. Net cash provided by financing activities was $3,227,000 in 2015, reflecting the issuance
of ordinary shares in a public offering that provided us with net proceeds of $7,430,000, the net repayment of $5,030,000
of shareholders loans and an increase in short-term bank credit of $827,000.

Discontinued Operations:

Net cash used in operating activities from discontinued operations was $644,000 in 2017. This was primarily due to an
increase in trade receivables of $956,000. This was offset by depreciation of $391,000. Net cash provided by operating
activities from discontinued operations was $298,000 in 2016. This was primarily due to a decrease in inventories of
$29,000 and decrease in trade receivables of $148,000. This was offset by an increase in trade payables of $44,000. Net
cash provided by operating activities from discontinued operations was $253,000 in 2015. This was primarily due to
depreciation of $101,000.

Net cash used in investing activities from discontinued operations was $101,000 in 2017, due to investment of $101,000 in
property, plant and equipment Net cash used in investing activities from discontinued operations was approximately
$34,000 in 2016, due to investment of $34,000 in property, plant and equipment. Net cash used in investing activities from
discontinued operations was approximately $8,000 in 2015, due to investment of $8,000 in property, plant and equipment.

As a result of the foregoing, at December 31, 2017, we had working capital of $25,641,000 and cash and cash equivalents
of $12,417,000 as compared to working capital of $11,106,000 and cash and cash equivalents of $1,205,000 at December
31, 2016.

We expect to fund our short-term liquidity needs in 2018, including our obligations under our credit facilities, other
contractual agreements and any other working capital requirements, from our cash and cash equivalents, operating cash
flow and our credit facilities. We project that our current cash and cash equivalents, credit facilities and our expected cash
flow from operations, will be sufficient to meet our cash requirements in 2018.

C. Research and Development, Patents and Licenses

Research and Development

Our research and development activities focus on improvements to our existing products, the development of
complementary products that would provide continued support for our current customers and would improve our
capability to market our products to new customers and keep a competitive edge over our main competitors. In 2017, 2016
and 2015 we incurred $1.6 million, $0.8 million and $0.7 million, respectively, of research and development expenses,
net. The vast majority of these expenses are attributable to the development of our radars. In 2018, we intend to continue
to invest in the research and development of new products. As of December 31, 2017, we employed 38 engineers
(including 2 sub-contractors) in research and development who concentrate mainly on research and development activities
generated through customer orders and to a lesser extent on internal research and development activities.

The Israel Innovation Authority, or the IIA, encourages research and development by providing grants to Israeli
companies, pursuant to the Law for the Encouragement of Industrial Research and Development, 1984, as amended. The
terms of such grants prohibit the manufacture of the developed products outside of Israel and the transfer of technologies
developed using the grants to any person without the prior written consent of the IIA. During 2011 and 2012 we developed
a new radar sensor for APS, partly financed by the IIA. In 2013 and 2012, we received royalty bearing grants of $15,000
and $142,000, respectively, from the IIA. Pursuant to applicable Israeli law, we are currently required to pay royalties at
the rate of 3.5% of sales of products developed with certain grants received from the IIA, up to 100% of the amount of
such grants, adjusted by the exchange rate with the dollar. As of December 31, 2017, our total obligation for royalty
payments, net of royalties paid or accrued was approximately $0.8 million.

D. Trend Information

In 2017, our revenues increased by approximately 104% compared to our revenues in 2016.

Our future revenues will, in great measure, be dependent upon the success of our sales and marketing strategy. We are
currently focusing our sales efforts on:

● Military avionics and inertial navigation systems; and

● Tactical radar systems for force and border protection solutions.

We cannot provide any assurances that we will be successful in meeting our targets in the future. As a result of the
unpredictable business environment in which we operate, we are unable to provide any specific guidance as to sales and
profitability trends. If we are unsuccessful in our sales efforts, it is unlikely that we will be able to achieve profitability in
the future and we will require additional capital.

E. Off-Balance Sheet Arrangements

We are not a party to any material off-balance sheet arrangements. In addition, we have no unconsolidated special purpose
financing or partnership entities that are likely to create material contingent obligations.

F. Tabular Disclosure of Contractual Obligations

The following table summarizes our minimum contractual obligations and commercial commitments, as of December 31,
2017 and the effect we expect them to have on our liquidity and cash flow in future periods.

Contractual Obligations

Payments due by Period

Long-term debt obligations
Operating lease obligations
Total

Total

21
2,408
2,429

Less than 1
year

-
752
752

1-3 Years

3-5 Years

More than 5
years

21
688
709

-
968
968

-
-
-

In addition, we have long-term liabilities for severance pay for certain employees that are calculated pursuant to Israeli
law generally based on the most recent salary of the employees multiplied by the number of years of employment, as of
the balance sheet date. Under Israeli law, employees are entitled to one month’s salary for each year of employment or a
portion thereof upon termination of employment in certain circumstances, including the retirement or death of an
employee or the termination of employment of an employee without due cause. As of December 31, 2017 our severance
pay liability was $0.8 million.

ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES

A. Directors and Senior Management

Set forth below are the name, age, principal position and a biographical description of each of our directors and executive
officers:

Name
Yossi Ben Shalom (2)
Nir Cohen
Dr. Alon Dumanis (1)(2)
Ben Zion Gruber
Israel Livnat(2)
Nurit Mor (1)
Elan Sigal (1)
Kineret Ya’ari
Guy Zur
Dov Sella
Avi Israel
Oleg Kiperman

Age
61
45
68
59
67
74
50
34
56
62
53
64

Position
Executive Chairman of the Board of Directors
Director
Director
Director
Director
External Director
External Director
Director
Director
Chief Executive Officer
Chief Financial Officer
Chief Technology Officer

(1) Member of the Audit and Compensation Committee
(2) Member of the Business Development Committee

Messrs. Yossi Ben Shalom, Nir Cohen, Israel Livnat, Ben Zion Gruber, and Alon Dumanis, Ms. Kineret Ya’ari and Mr.
Guy Zur will serve as directors until our 2018 annual general meeting of shareholders. Ms. Mor and Mr. Sigal serve as our
external directors and each currently holds office for three year terms until October 21, 2018 and August 30, 2019,
respectively. On February 20, 2018, Mr. Herzle Bodinger retired as a member of our Board of Directors for personal
reasons.

Yossi Ben Shalom was appointed as a director effective as of May 18, 2016 and has served as the Chairman of our Board
of Directors since June 14, 2016. Mr. Ben-Shalom was Executive Vice President and Chief Financial Officer of Koor
Industries Ltd. from 1998 through to 2000. Before that, Mr. Ben-Shalom served as Chief Financial Officer of Tadiran Ltd.
Mr. Ben-Shalom was an active director on numerous boards of directors, including: NICE Systems Ltd. (NASDAQ:
NICE) (computer telephony); Machteshim Agan (chemistry); and Investec Bank. He also participated in the creation of
TDA VC fund (a joint venture between Templeton and Tadiran) and was an active Chairman of Scopus – a technology
company with sales of over $30 million. Yossi is a co-founder of DBSI Investments Ltd. As such, he currently serves as
the Chairman of Pointer Telocation Ltd. (NASDAQ: PNTR) and Chairman of Shagrir Group Car Services Ltd. (TASE:
SHGR). Mr. Ben-Shalom also serves as a director of Taldor Computer Systems (1986) Ltd. (TASE: TALD) and several
other privately held companies. Mr. Ben-Shalom holds a B.A. degree in Economics and an M.A. degree in Business
Management from Tel Aviv University.

Nir Cohen has served as a director since May 18, 2016. Mr. Cohen serves as Chief Financial Officer of DBSI Investments
Ltd. and of its affiliate – Shiraz DS Investments Ltd. As the CFO of both DBSI and Shiraz, Mr. Cohen serves as a director
in several public companies: Taldor Computer Systems (1986) Ltd. (TASE: TALD); Pointer Telocation Ltd. (NASDAQ:
PNTR); Danel (Adir Joshua) Ltd.; and Shagrir Group Vehicle Services Ltd.(TASE: SHGR). Before joining DBSI, Mr.
Cohen served as partner and CFO of Argoquest Holdings, LLC, a privately held U.S.-based investment company
specializing in high-tech investments. Prior to joining Argoquest, Mr. Cohen served as a senior associate at Kesselman &
Kesselman, an Israeli affiliate of the global accounting firm PricewaterhouseCoopers (PwC). Before joining PwC, Mr.
Cohen worked as an auditor for the accounting firm KPMG in Israel. Mr. Cohen holds a B.A. degree in Accounting and
Business Management from the College of Management and is a Certified Public Accountant in Israel.

Dr. Alon Dumanis has served as a director of Rada since 2015. Until December 31, 2015, Dr. Dumanis acted as the Chief
Executive Officer of Crecor B.V, Docor International B.V, Docor Levi Lassen I BV, Docor Levi Lassen II BV and Docor
International Management Ltd., all Dutch investment companies, subsidiaries of the Van-Leer Group Foundation,. Dr.
Dumanis is currently a chairman of Aposense Ltd. (TASE: APOS) and a member of the board of directors of Nova
Measuring Instruments Ltd. (NASDAQ and TASE:NVMI). Dr. Dumanis is the Chairman of Dumanis Investments Ltd.,
Dumanis Holdings Ltd., Dumanis Ventures Ltd. and the CEO of ACS Air Cyber Solutions Ltd. and a managing partner of
Augmentum Ltd. Dr. Dumanis is a former member of the board of directors of Tadiran Communications (TASE:TDRN),
of El Al Israel Airlines (TASE:ELAL), of Protalix Biotherapeutics (NYSE:PLX), and a former member of the board of
directors of Inventec Investments Co. Ltd. (TASE:IVTC), Spectronix Ltd. (TASE: SPCT) and IceCure Medical Ltd.
(TASE:ICCM). Previously, Dr. Dumanis was the Head of the Material Command of the Israel Air Force holding the rank
of Brigadier General. Dr. Dumanis currently serves as chairman and member of several national steering committees and
is the author of many papers published in a number of subject areas, including technology and management. Dr. Dumanis
holds a Ph.D. in Aerospace Engineering from Purdue University, West Lafayette, Indiana.

Ben Zion Gruber has served as a director since June 2002. Mr. Gruber is a founder and manager of several real estate and
construction companies and an entrepreneur involved in several hi-tech companies. Mr. Gruber is a Br. General (Res.) of
the IDF serving today as deputy commander of an armored division. Mr. Gruber is a member of the Board of Employment
Service of the government of Israel. Mr. Gruber also serves on the board of R. Riskin or Tora intuitions and the board of
Har Etzyun yeshiva, board of Hertzog College, Association of Friends of Kefar Shaul Hospital. Mr. Gruber serves on the
Ethics Committees of the Eitanim and Kefar Shaul Hospitals as well as a director of several other charitable organizations.
Mr. Gruber holds a B.Sc. degree in Engineering of Microcomputers from JCT Jerusalem College of Technology. In
addition, Mr. Gruber is a graduate of a summer course in Business Administration at Harvard University, as well as
several other courses and training in management, finance and entrepreneurship.

Israel Livnat has served as a director since May 18, 2016. Mr. Livnat is the founder and Chairman of Anteo WW AG,
which developed a software platform for physical-security, cyber-security safety and other business continuity
applications. Mr. Livnat serves as a director on the board of Mobilicom Ltd., a provider of advanced communication
solutions. He serves also as Director at Urban Aeronautics Leader in developing a compact VTOL vehicle with no
exposed rotors that is tailored to meet FAA requirements for powered lift vehicles and is also capable of flying and
operating inside complex urban and natural environment. Mr. Livnat was the President of the Security Group at Nice
Systems Ltd. from May 2006 until August 2011. Prior to joining NICE and since 2001, he served as the President and
CEO of Elta Systems Ltd., the leading defense company in Israel for radar, signal intelligence and communication
systems. Prior to his position with Elta, Mr. Livnat headed the MLM division of Israeli Aircraft Industries, leading the
development of the Arrow weapons system, the Israeli Shavit satellite launcher and other airborne command and control
systems. Before that he was VP Engineering of the MLM division and director for hardware engineering at Daisy Systems
of Mountain View, California, a leading developer of hardware and software for large computer-embedded systems. Mr.
Livnat holds a B.Sc. degree and a M.Sc. degree in Electrical Engineering from the Technion-Israel Institute of
Technology, and an Executive MBA degree from Stanford University, California. He was awarded the prestigious Israeli
Industry Prize for 2004.

Nurit Mor has served as one of our external directors since August 2006. Ms. Mor has served as an external director of
two subsidiaries of Bank of Jerusalem from 2010 until 2012, Aspen Real Estate Ltd., an Israeli public company, from
September 2005 until 2009 and of I.B.I Investment House Ltd (TASE: IBI) from May 2004 until 2010. From 1973 to
2003, Ms. Mor served in senior positions at the Bank of Israel, including in the public complaints and banking supervision
department. Ms. Mor holds a B.A. degree in Economics and Statistics and a diploma in Business Administration from the
Hebrew University of Jerusalem, and an M.A. degree in Labor Studies from Tel Aviv University.

Elan Sigal has served as one of our external directors since August 2013. Between January 2013 and August 2017, Mr.
Sigal served as the Chief Financial Officer of Landa Corporation (Israel), an Israeli company that develops printing
systems with proprietary nanography technology for the commercial market. Between January 2008 and December 2012,
Mr. Sigal was the Chief Financial Officer of Objet Geometries Ltd., an Israeli company that is engaged in the design,
development and manufacture of 3D printers. Between 2004 and December 2007, Mr. Sigal served as the Chief Financial
Officer of our company. From May 2000 to December 2003, Mr. Sigal worked as a management consultant in the London
office of McKinsey & Co., a leading global management consulting firm. For ten years Mr. Sigal served as a fighter pilot
in the Israeli Air Force. Mr. Sigal holds a B.A. degree in Economics from Tel Aviv University.

Kineret Ya’ari has served as a director since May 18, 2016. Mrs. Ya’ari serves as an Analyst & Economist at DBSI
Investments Ltd. Mrs. Ya’ari also serves as a director of Taldor Computer Systems (1986) Ltd. (TASE: TALD) and
Shagrir Group Vehicle Services Ltd. (TASE: SHGR). Before joining DBSI Investments, Mrs. Ya’ari served as a senior
business analyst at Giza-Singer-Even, a financial advisory and investment banking firm in Israel. Mrs. Ya’ari holds a B.A.
degree in Economics and Management and an M.B.A. degree in Accounting and Finance from Tel Aviv University.

Guy Zur has served as a director since March 27, 2017. Mr. Zur joined the IDF in 1983 and served in the military until
2016 in a variety of positions retiring with the rank of Major General. Mr. Zur served as the commander of the Ground
Forces from 2013 until 2016. Between 2010 and 2013, Mr. Zur served as the Head of the IDF Planning Division.
Between 2007 and 2010, Mr. Zur served as the commander of the National Training Center for Ground Trainings (NTC).
Mr. Zur is currently the CEO of some Taavura Group subsidiaries, one of the largest logistics and transportation
conglomerates in Israel, as well as a technology entrepreneur. Mr. Zur holds an M.B.A. degree from Be’er Sheva
University, a Bc.S. degree in Mechanical Engineering from Tel Aviv University, and is an alumnus of the Royal College
of Defense Studies, London.

Dov Sella has served as our Chief Executive Officer since November 2016 and had previously, since July 2007, served as
our chief business development officer. Prior to that and from January 2003, Mr. Sella served as our chief operating
officer. Mr. Sella has over 20 years of senior management and product development experience. From 1982 until 1997,
Mr. Sella worked for Elbit Systems Ltd., a leading Israeli defense contractor. Among his positions at Elbit, he served as
director of programs, director of avionics engineering and director of business development. Between 1997 and 2000, Mr.
Sella served as executive vice president and vice president of business development and vice president of research and
development of UltraGuide Ltd., a medical devices start-up. During the three years prior to joining our company, Mr.
Sella was the president of NeuroVision Inc., a medical technology start-up. Mr. Sella has a B.Sc. degree (cum laude) in
Computer Engineering from the Technion - Israeli Institute of Technology. Mr. Sella served as a fighter aircraft navigator
in the IAF.

Avi Israel has served as our Chief Financial Officer since November 2017. Prior to that and since 2014, Mr. Israel has
served as the CEO of Logisticare Ltd., a leading Israeli private company providing third-party logistics and supply chain
services. Between 2010 and 2013, Mr. Israel served as the CEO of Brimag Communication Ltd., the Israeli importer and
distributor of mobile phones and other cellular products manufactured by LG Electronics. Prior to that and since 2004, Mr.
Israel served in several positions (including Deputy CEO and Finance Director) of Telit Communications PLC., an IoT
(Internet of Things) company listed on AIM in London. Between 1996 and 2004, Mr. Israel served in several positions in
the Formula Systems Group, as the VP M&A in charge of the international operations of Matrix Ltd. (TASE: MTRX), one
of Israel’s largest software solutions companies, as well as the CFO of New Applicom Ltd., an Israeli software company
that merged with Matrix. Prior to that and since 1992, Mr. Israel acted as the CFO of Burford International Application
Ltd in the United Kingdom. Between 1989 and 1992, Mr. Israel was a certified public accountant with Almagor & Co,
(today Deloitte Israel). Mr. Israel also served between the years 2011-2017 as an external director of Analyst Portfolio
Management Ltd. and between 2004 and 2010 as an external director of Semicom Industries Ltd. Currently, Mr. Israel is
also an external director of Or Shay Ltd., whose bonds are traded on theTASE. Mr. Israel has a B.A. degree in Economics
and Accounting and an M.B.A. degree, both from Bar-Ilan University in Israel. Mr. Israel is a CPA and a member of the
Israeli Accountants Council.

Oleg Kiperman has served as our chief technology officer since July 2007. Mr. Kiperman joined us in 1984 as project
manager of several embedded avionics development programs and in 2000 was named as our director of engineering.
From 1982 until 1984, Mr. Kiperman served as a hardware development team leader at Tadiran Ltd. developing digital
communication systems. From 1977 until 1982, Mr. Kiperman served as a senior engineer in the IAF Weapons Control
Branch. Mr. Kiperman holds a B.Sc. degree in Electrical Engineering from the Technion - Israeli Institute of Technology.

B. Compensation

For so long as we qualify as a foreign private issuer, we are not required to comply with the proxy rules applicable to U.S.
domestic companies, including the requirement to disclose information concerning the amount and type of compensation
paid to its Chief Executive Officer, Chief Financial Officer and the three other most highly compensated executive
officers, rather than on an aggregate basis. Nevertheless, regulations promulgated under the Israeli Companies Law
requires us to disclose the annual compensation of our five most highly compensated officers (or all the named executive
officers if there are fewer than five) on an individual basis, rather than on an aggregate basis, as was previously permitted
for Israeli public companies listed overseas. Under the Companies Law regulations, this disclosure is required to be
included in the notice of our annual meeting of shareholders each year or in a public document that accompanies such
notice, which we furnish to the SEC under cover of a Report of Foreign Private Issuer on Form 6-K. The Companies Law
regulations permit us to refer to a report filed pursuant to the laws of the country in which our shares are listed for trading
that includes the required information in lieu of its inclusion in the notice of annual meeting. Because of that disclosure
requirement under Israeli law, we are including such information in this annual report.

The following table includes information for the year ended December 31, 2017 concerning the five (5) most highly
compensated executive officers of our company, (the figures below reflect the applicable cost of employment on an annual
basis):

Dov Sella1

Oleg
Kiperman

Ronen
Ofek4

Shiri
Lazarovich3

Gil
Schwartz

Annual salary cost and other benefits
($)2
Total ($)

553,724
553,724

313,472
313,472

222,004
222,004

246,641
246,641

218,835
218,835

(1) In January 2017, our shareholders approved a new employment agreement with our Chief Executive Officer, Mr.
Dov Sella, who had previously served as our Chief Business Development Officer. Mr. Sella is entitled to a
monthly gross base salary of NIS 75,000. In addition to the options to purchase 131,250 ordinary shares that were
granted to Mr. Sella on June 14, 2016, our shareholders approved the grant of additional options to Mr. Sella as
follows: (i) options to purchase 68,750 ordinary shares at an exercise price of $1.16 per ordinary share that will
vest ratably over a period of four (4) years and (ii) options to purchase 150,000 ordinary shares at an exercise
price of $1.16 per ordinary share that will vest immediately instead of 99 vacation days that were accrued and
redeemable for the benefit of Mr. Sella. In November 2017, our shareholders approved the grant of additional
options to Mr. Sella as follows: options to purchase 500,000 ordinary shares at an exercise price of $2.96 per
shares that will vest ratably over a period of four (4) years.

(2) Includes the gross salary of the five (5) most highly compensated executive officers plus payments of (i) salary
bonus; (ii) social benefits such as payments for savings funds, education funds, pension, severance, insurances,
social security; (iii) general benefits such as car (including maintenance and gas) and cell phone; and (iv) option
compensation and other benefits pursuant to our company’s policy; including tax gross-up in respect therewith.

(3) Amount reflects Mrs. Lazarovich’s compensation up until November 30, 2017. Mr. Avi Israel joined RADA on

November 12, 2017 replacing Mrs. Lazarovich.

(4) Mr. Ronen Ofek has been our VP Programs since January 2017.

Mr. Yossi Ben Shalom has served as the Executive Chairman of our Board of Directors since May 18, 2016. In January
2017, our shareholders approved that in addition to the directors’ fees to be paid to all of our directors commencing as of
January 1, 2017, we will pay DBSI an additional monthly payment of NIS 17,500 (approximately $4,600) for time
devoted by Mr. Ben Shalom to such position. As of 2017, the first calendar year in which our consolidated audited
financial statements reflect net income (before taxes), the additional monthly payment was increased to NIS 35,000
(approximately $10,000).

Mr. Israel Livnat has served as a member of our Board of Directors since May 18, 2016. In January 2017, our shareholders
approved a new engagement letter with Mr. Livnat, according to which he will be entitled to receive a commission of
2.5% of the net revenues received by our company with respect to specific transactions introduced to us by Mr. Livnat,
subject to a detailed agreement to be entered into by Mr. Livnat and the company and the prior approval of any such
transaction by the Audit Committee. To date, no such transactions were introduced.

During the year ended December 31, 2017, the aggregate compensation paid to all of our executive officers and directors
as a group was approximately $1,546,675. As of December 31, 2017, the aggregate amount set aside or accrued for
pension, retirement, recreation payments and vacation or similar benefits for our directors and executive officers was
approximately $370,819.

During the year ended December 31, 2017, we paid each of our external directors a per-meeting attendance fee of
NIS 1,836 (approximately $500) and an annual fee of NIS 28,863 (approximately $8,300).

Pursuant to the Israeli Companies Law, we have adopted a compensation policy and are required to follow certain
approval requirements with respect to the compensation of our directors and executive officers. See below “Board of
Directors – Compensation Committee” and Item 10. Additional Information – Office Holders.

We follow Israeli law and practice instead of the requirements of the NASDAQ Stock Market Rules regarding the
compensation of our Chief Executive Officer and other executive officers. See Item 16G. “Corporate Governance.”

C. Board Practices

Introduction
According to the Israeli Companies Law and our articles of association, the management of our business is vested in our
board of directors. The board of directors may exercise all powers and may take all actions that are not specifically granted
to our shareholders. Our executive officers are responsible for our day-to-day management. The executive officers have
individual responsibilities established by our Chief Executive Officer and board of directors. Executive officers are
appointed by and serve at the discretion of the board of directors, subject to any applicable agreements.

Election of Directors

Our Articles of Association provide for a board of directors consisting no less than four (4) and no more than twelve (12)
members, or such other number as may be determined from time to time at a general meeting of shareholders. All the
directors in the company must be qualified to serve as a director and the time required for such position, taking into
consideration the type and size of the company and the scope and complexity of its operation. The directors must provide
the electing general meeting with a detailed declaration as to the compliance with the above-listed requirements. Our
board of directors is currently composed of ten (10) directors.

Pursuant to our Articles of Association, our directors, except for the External Directors, are elected at the Annual General
Meeting by the vote of the holders of a majority of the voting power represented at such meeting in person or by proxy
and voting on the election of directors, and each director generally serves until the Annual General Meeting next following
the Annual General Meeting at which such director was appointed, or his earlier vacation of office or removal. Except
with respect to the removal of External Directors, the shareholders are entitled to remove any director(s) from office, by a
simple majority of the voting power of the company represented at the meeting in person or by proxy and voting thereon.
All the members of our board of directors (except the external directors as detailed below) may be reelected upon
completion of their term of office. The majority of directors may appoint additional directors to fill any vacancies in the
board of directors until the next annual general meeting; provided, however that the total number of directors will not
exceed the maximum number, if any, fixed by or in accordance with our Articles of Association. We do not follow the
requirements of the NASDAQ Marketplace Rules with regard to the nomination process of directors and instead follow
Israeli law and practice. See Item 16G. “Corporate Governance.”

External and Independent Directors

External Directors. The Israeli Companies Law requires publicly held Israeli companies to appoint at least two external
directors. The Israeli Companies Law provides that a person may not be appointed as an external director if the person, or
the person’s relative, partner, employer or an entity under that person’s control, has or had during the two years preceding
the date of appointment any affiliation with the company, or any entity controlling, controlled by or under common
control with the company. The term “relative” means a spouse, sibling, parent, grandparent, child or child of spouse or
spouse of any of the above as well as a sibling, brother, sister or parent of the foregoing relatives. In general, the term
“affiliation” includes an employment relationship, a business or professional relationship maintained on a regular basis,
control and service as an office holder. Furthermore, if the company does not have a controlling shareholder or a
shareholder holding at least 25% of the voting rights “affiliation” also includes a relationship, at the time of the
appointment, with the chairman of the board, the Chief Executive Officer, a substantial shareholder or the most senior
financial officer of such company. Regulations promulgated under the Israeli Companies Law include certain additional
relationships that would not be deemed an “affiliation” with a company, for the purpose of service as an external director.
In addition, no person may serve as an external director if the person’s position or other activities create, or may create, a
conflict of interest with the person’s responsibilities as director or may otherwise interfere with the person’s ability to
serve as director. If, at the time an external director is appointed, all current members of the board of directors are of the
same gender, then that external director must be of the other gender. A director of one company may not be appointed as
an external director of another company if a director of the other company is acting as an external director of the first
company at such time.

At least one of the elected external directors must have “accounting and financial expertise” and any other external
director must have “accounting and financial expertise” or “professional qualification,” as such terms are defined by
regulations promulgated under the Israeli Companies Law. However, Israeli companies listed on certain stock exchanges
outside Israel, including the NASDAQ Capital Market, such as our company, are not required to appoint an external
director with “accounting and financial expertise” if a director with accounting and financial expertise who qualifies as an
independent director for purposes of audit committee membership under the laws of the foreign exchange serves on its
board of directors. All of the external directors of such a company must have “professional qualification.”

The external directors are elected by shareholders at a general meeting. The shareholders voting in favor of their election
must include at least a simple majority of the shares voted by shareholders other than controlling shareholders or
shareholders who have a personal interest in the election of the external director (unless such personal interest is not
related to such person’s relationship with the controlling shareholder). This majority requirement will not be required if
the total number of shares of such non-controlling shareholders and disinterested shareholders who vote against the
election of the external director represent 2% or less of the voting rights in the company.

In general, under the Israeli Companies Law, external directors serve for a three-year term and may be reelected to two
additional three-year terms, at the nomination of either the board of directors or any shareholder(s) holding at least 1% of
the voting rights in the company. If the board of directors proposed the nominee, the reelection must be approved by the
shareholders in the same manner required to appoint external directors for an initial term, as described above. If such
reelection is proposed by shareholders, such reelection requires the approval of the majority of the shareholders voting on
the matter, excluding the votes of any controlling shareholder and other shareholders having a personal interest in the
matter as a result of their relationship with the controlling shareholder(s), provided that, the aggregate votes cast by
shareholders who are not controlling shareholders and do not have a personal interest in the matter as a result of their
relationship with the controlling shareholder(s) who voted in favor of the nominee constitute more than 2% of the voting
rights in the company and provided further that, at the time of the appointment, such reelected external director is not (i) a
related or competitor shareholder, or (ii) a relative of such related or competitor shareholder or otherwise affiliated with a
related or competitor shareholder either at the time of appointment or at any time during the two years period prior to such
appointment. A related or competitor shareholder is defined by the Israeli Companies Law as the shareholder that
proposed the reelection or a holder of 5% or more of the outstanding share capital of the company, provided that at the
time of appointment (i) such shareholders, their controlling shareholder or any entity controlled by either of them has
business relations with company, or (ii) such shareholders, their controlling shareholder or any entity controlled by either
of them are competitors of the company. External directors can be removed from office only by the same special
percentage of shareholders that can elect them, or by a court order, and then only if the external directors cease to meet the
statutory qualifications with respect to their appointment or if they violate their fiduciary duty to the company.

Each committee of the board of directors that is authorized to exercise powers vested in the board of directors must
include at least one external director and the audit committee and the Compensation Committee must include all the
external directors. An external director is entitled to compensation as provided in regulations adopted under the Israeli
Companies Law and is otherwise prohibited from receiving any other compensation, directly or indirectly, in connection
with such service.

Independent Directors. In general, NASDAQ Stock Market Rules require that the board of directors of a NASDAQ-listed
company have a majority of independent directors and its audit committee must have at least three members and be
comprised only of independent directors, each of whom satisfies the respective “independence” requirements of NASDAQ
and the SEC. However, foreign private issuers, such as our company, may follow certain home country corporate
governance practices instead of certain requirements of the NASDAQ Stock Market Rules. We do not follow the
requirement of the NASDAQ Stock Market Rules to maintain a majority of independent directors on our board and
instead follow Israeli law and practice (see Item 16G. “Corporate Governance”). However, we have the mandated three
independent directors on our audit committee, in accordance with the rules of the SEC and NASDAQ Stock Market.

Pursuant to the Israeli Companies Law, a director may be qualified as an independent director if such director is either (i)
an external director; or (ii) a director that serves as a board member for less than nine years and the audit committee has
approved that he or she meets the independence requirements of an external director. A majority of the members serving
on the audit committee and the compensation committee must be independent under the Israeli Companies Law.

Our board of directors has determined that Ms. Mor, Mr. Sigal, Mr. Dumanis and Mr. Zur qualify as independent directors
under the SEC and NASDAQ requirements and that Ms. Mor, Mr. Sigal and Mr. Dumanis qualify as independent
directors under the Israeli Companies Law requirements.

We do not follow the requirements of the NASDAQ Stock Market Rules with regard to regularly scheduled meetings of
independent directors. Under Israeli law, external directors are not required to hold executive sessions. See Item 16G.
“Corporate Governance.”

Committees of the Board of Directors

Audit Committee. Under the Israeli Companies Law, the board of directors of any public company must establish an audit
committee. The audit committee must be comprised of at least three directors, the majority of which must be independent
directors. Such independent directors must meet all of the standards required of an external director and may not serve as a
director for more than consecutive nine years (a cessation of service as a director for up to two years during any nine years
period will not be deemed to interrupt the nine years period). The audit committee may not include the chairman of the
board of directors; any director employed by the company or providing services to the company on an ongoing basis; a
controlling shareholder or any of the controlling shareholder’s relatives; and any director who rendered services to the
controlling shareholder or an entity controlled by the controlling shareholder. Any person who is not permitted to be a
member of the audit committee may not be present in the meetings of the audit committee unless the chairman of the audit
committee determines that such person’s presence is necessary in order to present a specific matter. However, an
employee who is not a controlling shareholder or relative of a controlling shareholder may participate in the audit
committee’s discussions but not in any vote, and at the request of the audit committee, the secretary of the company and
its legal counsel may be present during the meeting. The chairman of the audit committee must be an external director.

Under Israeli law, an audit committee may not approve an action or a transaction with a controlling shareholder, or with
an office holder, unless at the time of approval two external directors are serving as members of the audit committee and
at least one of the external directors was present at the meeting in which an approval was granted.

The role of the audit committee, pursuant to the Israeli Companies Law, includes:

● monitoring deficiencies in the management of the company, including in consultation with the independent
auditors or the internal auditor, and to advise the board of directors on how to correct such deficiencies. If the
audit committee finds a material deficiency, it will hold at least one meeting regarding such material
deficiency, with the presence of the internal auditor or the independent auditors but without the presence of
the senior management of the company. However, a member of the company’s senior management can
participate in the meeting in order to present an issue which is under his or her responsibility;

● determining, on the basis of detailed arguments, whether to classify certain engagements or transactions as
material or extraordinary, as applicable, and therefore as requiring special approval under the Israeli
Companies Law. The audit committee may make such determination according to principles and guidelines
predetermined on an annual basis;

● determining if transactions (excluding extraordinary transactions) with a controlling shareholder, or in which
a controlling shareholder has a personal interest, are required to be rendered pursuant to a competitive
procedure;

● deciding whether to approve engagements or transactions that require the audit committee approval under the

Israeli Companies Law;

● determining the approval procedure of non-extraordinary transactions, following classification as such by the
audit committee, including whether such specific non-extraordinary transactions require the approval of the
audit committee;

● examining and approving the annual and periodical working plan of the internal auditor;

● overseeing the company’s internal auditing and the performance of the internal auditor; confirm that the
internal auditor has sufficient tools and resources at his disposal, taking into account, among other, the
special requirements of the company and its size;

● examining the scope of work of the independent auditor and its pay, and bringing such recommendations on
these issue before the Board; determining the procedure of addressing complaints of employees regarding
shortcomings in the management of the company and ensure the protection of employees who have filed
such complaints;

● determining with respect to transactions with the controlling shareholder or in which such controlling
shareholder has personal interest, whether such transactions are extraordinary or not, an obligation to
conduct competitive process under supervisions of the audit committee or determination that prior to
entering into such transactions the company shall conduct other process as the audit committee may deem fit,
all taking into account the type of the company. The audit committee my set such qualifications for one year
in advance; and

● determining the manner of approval of transactions with the controlling shareholder or in which it has
personal interest which (i) are not negligible transactions (pursuant to the committee’s determination) and (ii)
are not qualified by the committee as extraordinary transactions.

In addition, the NASDAQ Stock Market Rules require us to establish an audit committee comprised of at least three
members, all of whom must be financially literate, satisfy the respective “independence” requirements of the SEC and
NASDAQ and one of whom must have an accounting or related financial management expertise at senior levels within a
company.

Pursuant to recent amendment to the Israeli companies Law, effective as of February 2016, an audit committee that
complies with the requirements of the Israeli Companies Law may act also as compensation committee. Our board of
directors has determined that our audit committee complies with such requirements and therefore, commencing as of May
2016, it shall serve also as compensation committee.

The current members of our audit and compensation committee are Ms. Nurit Mor, Mr. Elan Sigal and Dr. Alon Dumanis,
each of whom satisfies the “independence” requirements of both the SEC and NASDAQ. We also comply with Israeli law
requirements for audit committee members. The audit committee meets at least once each quarter.

Compensation Committee. Our Board of Directors is required to appoint a compensation committee, whose role is to: (i)
recommend to the board on a compensation policy for office holders and to recommend to the board, once every three
years, on the approval of the continued validity of the compensation policy that was determined for a period exceeding
three years; (ii) recommend an update the compensation policy from time to time and to examine its implementation; (iii)
determine whether to approve the Terms of Service and Employment of Office Holders that require the committee’s
approval; and (iv) exempt a transaction from the requirement for shareholders’ approval. The compensation committee
also has oversight authority over the actual terms of employment of directors and officers and may make
recommendations to the board of directors and the shareholders (where applicable) with respect to deviation from the
compensation policy that was adopted by the company. Under Israeli law, our compensation committee must consist of no
less than three members, including all of our external directors (who must constitute a majority of its members of the
committee), and the remainder of the members of the compensation committee must be directors whose terms of service
and employment were determined pursuant to the applicable regulations. The same restrictions on the actions and
membership in the audit committee apply to the compensation committee with respect to, among other things, the
requirement that an external director serve as the chairman of the committee and the list of persons who may not serve on
the committee. Our board of directors established a compensation committee composed of Ms. Nurit Mor, Mr. Elan Sigal
and Dr. Alon Dumanis. In August 2016, our shareholders approved an updated compensation policy for an additional
period of three years.

Business Development Committee. In November 2016, our Board of Directors established a Business Development
Committee whose role is to review and make recommendations to the Board of Directors with respect to business
development strategies, plans and targets. The Business Development Committee is composed of Messrs. Yossi Ben
Shalom, Israel Livnat and Dr. Alon Dumanis.

Internal Audit

The Israeli Companies Law also requires the board of directors of a publicly held company to appoint an internal auditor
nominated by the audit committee. An internal audit must satisfy the Israeli Companies Law’s independence requirements.
The role of the internal auditor is to examine, among other things, the compliance of the company’s conduct with
applicable law and orderly business practice. Under the Companies Law, the internal auditor may not be an interested
party or an office holder, or a relative of any of the foregoing, nor may the internal auditor be the company’s independent
accountant or its representative. Our internal auditor complies with the requirements of the Israeli Companies Law.

Directors’ Service Contracts

We do not have any service contracts with our directors. However, all of our directors receive director’s fees that are equal
to those paid to our External Directors. There are no arrangements or understandings between us and any of our
subsidiaries, on the one hand, and any of our directors, on the other hand, providing for benefits upon termination of their
employment or service as directors of our company or any of our subsidiaries.

Approval of Related Party Transactions under Israeli Law

Fiduciary Duties of Office Holders

The Israeli Companies Law codifies the fiduciary duties that “office holders,” including directors and executive officers,
owe to a company. An “office holder” is defined in the Israeli Companies Law as a director, general manager, chief
business manager, deputy general manager, vice general manager, other manager directly subordinated to the general
manager or any other person assuming the responsibilities of any of the foregoing positions without regard to such
person’s title. An office holder’s fiduciary duties consist of a duty of care and a fiduciary duty. The duty of care requires
an office holder to act at a level of care that a reasonable office holder in the same position would employ under the same
circumstances. This includes the duty to utilize reasonable means to obtain (i) information regarding the appropriateness
of a given action brought for his approval or performed by him by virtue of his position and (ii) all other information of
importance pertaining to the foregoing actions. The fiduciary duty includes (i) avoiding any conflict of interest between
the office holder’s position in the company and any other position he holds or his personal affairs, (ii) avoiding any
competition with the company’s business, (iii) avoiding exploiting any business opportunity of the company in order to
receive personal gain for the office holder or others, and (iv) disclosing to the company any information or documents
relating to the company’s affairs that the office holder has received due to his position as an office holder.

Disclosure of Personal Interests of an Office Holder; Approval of Transactions with Office Holders

The Israeli Companies Law requires that an office holder promptly and no later than the first board meeting at which such
transaction is considered, disclose any personal interest that he or she may have and all related material information
known to him or her and any documents in their position, in connection with any existing or proposed transaction by us. In
addition, if the transaction is an extraordinary transaction, that is, a transaction other than in the ordinary course of
business, other than on market terms, or likely to have a material impact on the company’s profitability, assets or
liabilities, the office holder must also disclose any personal interest held by the office holder’s spouse, siblings, parents,
grandparents, descendants, spouse’s descendants and the spouses of any of the foregoing, or by any corporation in which
the office holder or a relative is a 5% or greater shareholder, director or general manager or in which he or she has the
right to appoint at least one director or the general manager.

Some transactions, actions and arrangements involving an office holder (or a third party in which an office holder has an
interest) must be approved by the board of directors or as otherwise provided for in a company’s articles of association,
however, a transaction that is adverse to the company’s interest may not be approved. In some cases, such a transaction
must be approved by the audit committee and by the board of directors itself, and under certain circumstances shareholder
approval may also be required. A director who has a personal interest in a transaction that is considered at a meeting of the
board of directors or the audit committee may not be present during the board of directors or audit committee discussions
and may not vote on the transaction, unless the transaction is not an extraordinary transaction or the majority of the
members of the board or the audit committee have a personal interest, as the case may be. In the event the majority of the
members of the board of directors or the audit committee have a personal interest, then the approval of the general meeting
of shareholders is also required.

Approval of a Compensation Policy for Office Holders

The Israeli Companies Law and the regulations adopted thereunder require the compensation committee to adopt a policy
for director and office holders.

The compensation policy needs to be re-approved every three years by the board of directors, following the
recommendation of the compensation committee, and by the company’s shareholders, by a Special Majority (as defined
below). In the event that the compensation policy is not so approved by the shareholders, the board of directors may
nonetheless approve it, provided that the compensation committee and the board of directors, following further discussion
of the matter and for specified reasons, determine that the approval of the compensation policy is in the best interests of
the company.

Special Majority means: (a) a majority of the shareholders who are not controlling shareholders of the Company and do
not have a “Personal Interest” in the approval of the respective resolution who participate in the vote, in person, by proxy
or by a voting instrument vote to approve it (abstentions will not be taken into account) or (b) the total number of votes of
the shareholders referred to in (a) above that are voted against the proposed resolution does not exceed two percent (2%)
of the company’s total voting rights.

The compensation policy serves as the basis for decisions concerning the financial terms of employment or engagement of
officer holders, including exculpation, insurance, indemnification or any monetary payment or obligation of payment in
respect of employment or engagement.

In addition, compensation of the directors and the Chief Executive Officer is also subject to the approval of the
compensation /audit committee, the board of directors and the shareholders at a general meeting. The approval of the
compensation of the Chief Executive Officer is subject to the Special Majority requirements

Any deviations from the compensation policy in respect of the compensation of the office holders require the approval of
the compensation/audit committee, the board of directors and the shareholders by Special Majority.

Under the Israeli Companies Law, all arrangements as to compensation of office holders who are not directors require the
approval of the compensation/audit committee prior and in addition to the approval of the board of directors. However, if
the company duly adopts a compensation plan for its office holders, the approval of the board of directors is not required if
the new arrangement only modifies an existing arrangement and the compensation committee determines that such
modification is not material.

Disclosure of Personal Interests of a Controlling Shareholder; Approval of Transactions with Controlling Shareholders

Pursuant to the Israeli Companies Law, the disclosure requirements regarding personal interests that apply to directors and
executive officers also apply to a controlling shareholder of a public company. A controlling shareholder is a shareholder
who has the ability to direct the activities of a company, but excludes a shareholder whose power derives solely from its
position on the board of directors or any other position at the company. A person is presumed to be a “controlling
shareholder” if it holds or controls, by itself or together with others, one half or more of any one of the “Means of Control”
of the company. “Means of Control” is defined as any one of the following: (i) the right to vote at a General Meeting of
the company, or (ii) the right to appoint directors of the company or its Chief Executive Officer. For the purpose of related
party translations, under the Israeli Companies Law, a controlling shareholder is also a shareholder who holds 25% or
more of the voting rights if no other shareholder who holds more than 50% of the voting rights. For this purpose, the
holdings of all shareholders who have a personal interest in the same transaction will be aggregated. As of Admission, the
company does not have a controlling shareholder.

Certain shareholders also have a duty of fairness toward the company. These shareholders include any controlling
shareholder, together with any shareholder who knows that it has the power to determine the outcome of a shareholder
vote and any shareholder who has the power to appoint or to prevent the appointment of an office holder of the company
or exercise any other rights available to it under the company’s articles of association with respect to the company. The
Israeli Companies Law does not define the substance of this duty of fairness, except to state that the remedies generally
available upon a breach of contract will also apply in the event of a breach of the duty of fairness.

An extraordinary transaction between a public company and a controlling shareholder, or in which a controlling
shareholder has a personal interest, including a private placement in which the controlling shareholder has a personal
interest, and the terms of engagement of the company, directly or indirectly, with a controlling shareholder or a controlling
shareholder’s relative (including through a corporation controlled by a controlling shareholder), regarding the company’s
receipt of services from the controlling shareholder, and if such controlling shareholder is also an office holder of the
company, regarding his or her terms of employment, require the approval of a company’s audit committee (or
compensation committee with respect to compensation arrangements), board of directors and shareholders, in that order.
Such transaction must be elected by a majority vote of the Ordinary Shares present and voting at a shareholders’ meeting,
provided that either: (i) such majority includes at least a majority of votes held by all shareholders who do not have a
personal interest in such transaction, present and voting at such meeting (excluding abstentions); or (ii) the total number of
votes of shareholders who do not have a personal interest in such transaction voting against the approval of the
transaction, does not exceed 2% of the aggregate voting rights in the company.

Pursuant to the Israeli Companies Law, the audit committee of the company should determine in connection with such
transaction if it requires rendering pursuant to a competitive procedure or pursuant to other proceedings. See “Audit
Committee” above.

To the extent that any such transaction with a controlling shareholder or his relative is for a period extending beyond three
years, shareholder approval is required once every three years, unless, in respect to certain transactions, the audit
committee determines that the longer duration of the transaction is reasonable under the circumstances.

Pursuant to regulations promulgated pursuant to the Israeli Companies Law, a transaction with a controlling shareholder
that would otherwise require approval of the shareholders is exempt from shareholders’ approval if each of the audit
committee and the board of directors determine that the transaction meets certain criteria that are set out in specific
regulations promulgated under the Israeli Companies Law. Under these regulations, a shareholder holding at least 1% of
the issued share capital of the company may require, within 14 days of the publication of such determination, that despite
such determination by the audit committee and the board of directors, such transaction will require shareholder approval
under the same majority requirements that otherwise apply to such transactions.

The Israeli Companies Law provides that an acquisition of shares in a public company must be made by means of a tender
offer if as a result of the acquisition the purchaser would become a 25% or greater shareholder of the company. This rule
does not apply if there is already another 25% or greater shareholder of the company. Similarly, the Israeli Companies
Law provides that an acquisition of shares in a public company must be made by means of a tender offer if as a result of
the acquisition the purchaser would hold greater than a 45% interest in the company, unless there is another shareholder
holding more than a 45% interest in the company. These requirements do not apply if, in general, (i) the acquisition was
made in a private placement that received shareholder approval, (ii) was from a 25% or greater shareholder of the
company which resulted in the acquirer becoming a 25% or greater shareholder of the company, if there is not already a
25% or greater shareholder of the company, or (iii) was from a shareholder holding a 45% interest in the company which
resulted in the acquirer becoming a holder of a 45% interest in the company if there is not already a 45% or greater
shareholder of the company.

If, as a result of an acquisition of shares, the acquirer will hold more than 90% of a public company’s outstanding shares
or a class of shares, the acquisition must be made by means of a tender offer for all of the outstanding shares or a class of
shares. If less than 5% of the outstanding shares are not tendered in the tender offer, all the shares that the acquirer offered
to purchase will be transferred to the acquirer. If more than 5% of the outstanding shares are not tendered in the tender
offer, then the acquirer may not acquire shares in the tender offer that will cause his shareholding to exceed 90% of the
outstanding shares. The Israeli Companies Law provides for appraisal rights if any shareholder files a request in court
within six months following the consummation of a full tender offer. However, in the event of a full tender offer, the
offeror may determine that any shareholder who accepts the offer will not be entitled to appraisal rights. Such
determination will be effective only if the offeror or the company has timely published all the information that is required
to be published in connection with such full tender offer pursuant to all applicable laws.

Exculpation, Indemnification and Insurance of Directors and Officers

Exculpation of Office Holders

The Israeli Companies Law provides that an Israeli company cannot exculpate an office holder from liability with respect
to a breach of his or her duty of loyalty. If permitted by its articles of association, a company may exculpate in advance an
office holder from his or her liability to the company, in whole or in part, with respect to a breach of his or her duty of
care. However, a company may not exculpate in advance a director from his or her liability to the company with respect to
a breach of his duty of care in the event of distributions.

Insurance of Office Holders

The Israeli Companies Law provides that a company may, if permitted by its articles of association, enter into a contract to
insure office holders in respect of liabilities incurred by the office holder with a respect to an act performed in his or her
capacity as an office holder, as a result of:

● a breach of the office holder’s duty of care to the company or to another person;

● a breach of the office holder’s duty of loyalty to the company, provided that the office holder acted in good
faith and had reasonable cause to assume that his or her act would not prejudice the company’s interests; or

● a financial liability imposed upon the office holder in favor of another person.

Indemnification of Office Holders

The Israeli Companies Law provides that a company may, if permitted by its articles of association, indemnify an office
holder for acts or omissions performed by the office holder in such capacity for:

● a monetary liability imposed on the office holder in favor of another person by any judgment, including a

settlement or an arbitrator’s award approved by a court;

● reasonable litigation expenses, including attorney’s fees, actually incurred by the office holder as a result of
an investigation or proceeding instituted against him or her by a competent authority, provided that such
investigation or proceeding concluded without the filing of an indictment against the office holder or the
imposition of any monetary liability in lieu of criminal proceedings, or concluded without the filing of an
indictment against the office holder and a monetary liability was imposed on the officer holder in lieu of
criminal proceedings with respect to a criminal offense that does not require proof of criminal intent; and

● reasonable litigation expenses, including attorneys’ fees, incurred by the office holder or which were
imposed on him or her by a court, in an action instituted by the company or on the company’s behalf or by
another person, against the office holder, or in a criminal charge from which he was acquitted, or in a
criminal proceeding in which the office holder was convicted of a criminal offense which does not require
proof of criminal intent.

In accordance with the Israeli Companies Law, a company’s articles of association may permit the company to:

● prospectively undertake to indemnify an office holder, except that with respect to a monetary liability
imposed on the office holder by any judgment, settlement or court-approved arbitration award, the
undertaking must be limited to types of events which the company’s board of directors deems foreseeable
considering the company’s actual operations at the time of the undertaking, and to an amount or standard that
the board of directors has determined as reasonable under the circumstances.

● retroactively indemnify an office holder of the company.

Limitations on Exculpation, Insurance and Indemnification

The Israeli Companies Law provides that neither a provision of the articles of association permitting the company to enter
into a contract to insure the liability of an office holder, nor a provision in the articles of association or a resolution of the
board of directors permitting the indemnification of an office holder, nor a provision in the articles of association
exculpating an office holder from duty to the company shall be valid, where such insurance, indemnification or
exculpation relates to any of the following:

● a breach by the office holder of his duty of loyalty unless, with respect to insurance coverage or
indemnification, the office holder acted in good faith and had a reasonable basis to believe that the act would
not prejudice the company;

● a breach by the office holder of his duty of care if such breach was committed intentionally or recklessly,

unless the breach was committed only negligently;

● any act or omission done with the intent to unlawfully yield a personal benefit; or

● any fine or forfeiture imposed on the office holder.

Pursuant to the Israeli Companies Law, exculpation of, procurement of insurance coverage for, and an undertaking to
indemnify or indemnification of, our office holders must be approved by our audit committee and our board of directors
and, if the office holder is a director, also by our shareholders.

Our Articles of Association allow us to insure, indemnify and exempt our office holders to the fullest extent permitted by
law, subject to the provisions of the Israeli Companies Law. Up until August 2017 we maintained directors and officers
liability insurance policy with per claim and aggregate coverage limit of $7.5 million. On August 2017, our Compensation
Committee and Board of Directors approved an increase in the per claim coverage and aggregate coverage of up to $10
million under its directors and officers liability insurance policy. Pursuant to resolutions adopted by our shareholders on
May 15, 2016, we have also entered into agreements with our directors and officeholders providing for their
indemnification and exemption from the duty of care.

D. Employees

As of December 31, 2017, we employed 112 persons, of whom 38 persons were employed in research, development and
engineering, 60 persons in manufacturing and logistics, 5 persons in sales and marketing, and 9 persons in administration,
management and finance. All of our employees are located in Israel. In addition, CACS, our 80% owned subsidiary,
employed 17 persons in China as of such date.

As of December 31, 2016, we employed 93 persons, of whom 35 persons were employed in research, development and
engineering, 48 persons in manufacturing and logistics, 3 persons in sales and marketing, and 7 persons in administration,
management and finance. All of our employees are located in Israel. In addition, CACS, our 80% owned subsidiary,
employed 16 persons in China as of such date.

As of December 31, 2015, we employed 105 persons, of whom 45 persons were employed in research, development and
engineering, 51 persons in manufacturing and logistics, 2 persons in sales and marketing, and 7 persons in administration,
management and finance. All of our employees are located in Israel. In addition, CACS, our 80% owned subsidiary,
employed 16 persons in China as of such date.

Our technical employees have signed nondisclosure agreements covering all proprietary information that they might
possess or to which they might have access. Employees are not organized in any union, although they are employed
according to provisions established by the Israeli Ministry of Economy and Industry. Certain provisions of the collective
bargaining agreements between the General Federation of Labor in Israel (Histadrut) and the Coordination Bureau of
Economic Organizations (including the Industrialists Association) are applicable to our Israeli employees by order of the
Israeli Ministry of Economy and Industry. These provisions primarily concern the length of the workday, minimum daily
wages for professional workers, contributions to a pension fund, insurance for work-related accidents, procedures for
dismissing employees, determination of severance pay and other conditions of employment. We generally provide our
employees with benefits and working conditions beyond the required minimums.

Israeli law generally requires severance pay upon the retirement or death of an employee or termination of employment
without due cause. Further, Israeli employees and employers are required to pay predetermined sums to the National
Insurance Institute; such amounts also include payments for national health insurance. Most of our ongoing severance
obligations for our Israeli employees are provided for by monthly payments made by us for insurance policies to cover
these obligations.

E. Beneficial Ownership of Executive Officers and Directors

The following table sets forth certain information as of March 28, 2018 regarding the beneficial ownership by each of our
directors and executive officers:

Number of Ordinary
Shares or Options
Beneficially Owned
(1)

9,001,634
-
-
-
-
-
-
-
-
850,000
200,000
202,000

Percentage of
Ownership (2)

27.37%

-
-
-
-
-
-
-
-
*
*
*

Name
Yossi Ben Shalom (3)
Nir Cohen
Alon Dumanis
Ben Zion Gruber
Israel Livnat
Nurit Mor
Elan Sigal
Kineret Ya’ari
Guy Zur
Dov Sella
Avi Israel
Oleg Kiperman

All directors and executive officers as a group (12 persons)

* Less than 1%

Except as otherwise indicated, the business address of all directors and executive officers is c/o RADA Electronic
Industries Ltd., 7 Giborei Israel Street, Netanya, 4250407, Israel.

(1)

(2)

(3)

Beneficial ownership is determined in accordance with the rules of the SEC and generally includes voting or
investment power with respect to securities. Ordinary shares relating to options and warrants currently
exercisable or exercisable within 60 days of the date of this table are deemed outstanding for computing the
percentage of the person holding such securities but are not deemed outstanding for computing the percentage of
any other person. Except as indicated by footnote, and subject to community property laws where applicable, the
persons named in the table above have sole voting and investment power with respect to all shares shown as
beneficially owned by them.

The percentages shown are based on 32,882,914 ordinary shares issued and outstanding as of March 28, 2018.

Mr. Yossi Ben Shalom and Mr. Barak Dotan, by virtue of their relationship with and indirect interests in DBSI
may be deemed to control DBSI and consequently share the beneficial ownership of the 9,001,634 Ordinary
Shares of the company beneficially owned by DBSI, including the right to jointly direct the voting of, and
disposition of, such shares. Mr. Barak Dotan holds his shares of DBSI through his control of B.R.Y.N.
Investments Ltd., or BRYN. Mr. Barak Dotan controls BRYN pursuant to the terms of a power of attorney
granted to him by Mr. Boaz Dotan and Mrs. Varda Dotan (collectively referred to as the Dotans). Pursuant to the
power of attorney, Barak Dotan is entitled to take all actions to which the Dotans would be entitled by virtue of
their shareholdings in BRYN, with the exception of the disposition of such shares. According to the terms of the
power of attorney, the Dotans are required to give notice of not less than 90 days to (i) revoke the power of
attorney, thereby acquiring the ability to vote the shares of BRYN; and (ii) dispose of the shares of BRYN. Mr.
Yossi Ben Shalom holds his shares of DBSI through his control of White Condor Holdings Ltd. and Pulpit Rock
Investments Ltd. The address of DBSI is 85 Medinat Hayehudim Street, Herzliya 4676670, Israel.

ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS

A. Major Shareholders

The following table sets forth certain information as of March 28, 2018, regarding the beneficial ownership by all
shareholders known to us to own beneficially 5% or more of our ordinary shares:

Name

DBSI Investments Ltd. (3) (4)
Howard P.L. Yeung (5)
Yelin Lapidot Holdings Management Ltd. (7)

Number of
Ordinary Shares
Beneficially Owned
(1)

9,001,634
1,786,009
1,663,942

Percentage of
Ownership (2)

27.37%
5.40%
5.55%

(1)

Beneficial ownership is determined in accordance with the rules of the SEC and generally includes voting or
investment power with respect to securities. Ordinary shares relating to options and notes currently exercisable or
convertible or exercisable or convertible within 60 days of the date of this table are deemed outstanding for
computing the percentage of the person holding such securities but are not deemed outstanding for computing the
percentage of any other person. Except as indicated by footnote, and subject to community property laws where
applicable, the persons named in the table above have sole voting and investment power with respect to all shares
shown as beneficially owned by them.

(2)

The percentages shown are based on 32,882,914 ordinary shares issued and outstanding as of March 28, 2018.

(3)

(4)

(5)

(6)

As reported by DBSI in its latest Schedule 13D/A, dated January 22, 2018, it is currently the beneficial owner of
9,001,634 ordinary shares, constituting 27.37% of our issued and outstanding ordinary shares.

Mr. Yossi Ben Shalom and Mr. Barak Dotan, by virtue of their relationship with and indirect interests in DBSI
may be deemed to control DBSI and consequently share the beneficial ownership of the 9,001,364 Ordinary
Shares of the company beneficially owned by DBSI, including the right to jointly direct the voting of, and
disposition of, such shares. Mr. Barak Dotan holds his shares of DBSI through his control of B.R.Y.N.
Investments Ltd., or BRYN. Mr. Barak Dotan controls BRYN pursuant to the terms of a power of attorney
granted to him by Mr. Boaz Dotan and Mrs. Varda Dotan (collectively referred to as the Dotans). Pursuant to the
power of attorney, Barak Dotan is entitled to take all actions to which the Dotans would be entitled by virtue of
their shareholdings in BRYN, with the exception of the disposition of such shares. According to the terms of the
power of attorney, the Dotans are required to give notice of not less than 90 days to (i) revoke the power of
attorney, thereby acquiring the ability to vote the shares of BRYN; and (ii) dispose of the shares of BRYN. Mr.
Yossi Ben Shalom holds his shares of DBSI through his control of White Condor Holdings Ltd. and Pulpit Rock
Investments Ltd. The address of DBSI is 85 Medinat Hayehudim Street, Herzliya 4676670, Israel.

Based on a Schedule 13D/A filed by Howard P.L. Yeung on August 8, 2016. Includes 1,560,995 outstanding
ordinary shares. In addition, as an admission of beneficial ownership by Mr. Howard P.L. Yeung, we are
including 225,015 ordinary shares held by Horsham Enterprises Ltd., a British Virgin Islands corporation jointly
owned by Messrs. Howard P.L. Yeung and his brother Kenneth Yeung. The address of Messrs. Howard P.L.
Yeung and Kenneth Yeung is 2202 Kodak House II, 39 Healthy Street, North Point, Hong Kong.

Based on the Schedule 13G/A filed by Yelin Lapidot Holdings Management Ltd. jointly with Yelin Lapidot
Mutual Funds Management Ltd. and Messrs. Dov Yelin, Yair Lapidot with the SEC on January 31, 2018. The
address of Yelin Lapidot is 50 Dizengoff St., Dizengoff Center, Gate 3, Top Tower, 13th floor, Tel Aviv 64332,
Israel.

Significant Changes in the Ownership of Major Shareholders

On June 2, 2016, DBSI first reported beneficial ownership of more than five percent (5%) of our issued and outstanding
ordinary shares. DBSI purchased 8,510,638 newly issued ordinary shares as well as warrants to purchase up to 4,255,319
shares, at an exercise price of $0.47 per share, exercisable within 24 months following the closing on May 18, 2016, and
warrants to purchase up to 3,636,363 shares, at an exercise price of $0.55 per share exercisable within 48 months
following the closing, as well as the right to acquire up to a maximum of 6,755,319 additional ordinary shares pursuant to
the conversion by DBSI of a convertible loan in the amount of $3,175,000. These holdings amounted to a 67.4%
ownership of our company. On June 15, 2016, DBSI funded the full loan amount ($3,175,000) at the request of a special,
independent committee of our board of directors. DBSI has since regularly reported on Form 13D/A sales of our ordinary
shares and of exercises of warrants. On January 25, 2017, DBSI reported that it had sold an aggregate of
1,402,389 additional ordinary shares and that it had exercised warrants to purchase an additional 531,915 ordinary shares.
The aggregate impact of these transactions reduced DBSI’s beneficial ownership from 61.3% to 56.0%. Further
transactions reduced DBSI’s ownership in our company to the current level of 27.37%.

On February 8, 2017, Yelin Lapidot Holdings Management Ltd., jointly with Messrs. Dov Yelin and Yair Lapidot, filed a
Schedule 13G/A with the SEC reflecting ownership of 1,790,284, or 4.04%, of our ordinary shares as of December 31,
2016. On February 3, 2015, Yelin Lapidot Holdings Management Ltd., jointly with Messrs. Dov Yelin and Yair Lapidot,
filed a Schedule 13G/A with the SEC reflecting ownership of 2,400,005, or 5.41%, of our ordinary shares as of December
31, 2015. On October 12, 2015, Yelin Lapidot Holdings Management Ltd., jointly with Messrs. Dov Yelin and Yair
Lapidot filed a Schedule 13G/A with the SEC reflecting ownership of 1,663,942, or 5.55%, of our ordinary shares.

On January 19, 2017, Sphera Capital Ltd., an investment management company for Sphera Small Cap Fund Ltd., and the
portfolio manager of Sphera Capital, Mr. Ron Senator, reported that they purchased 1,260,504 ordinary shares of our
company for a total beneficial ownership of 6.78% of our company. On February 13, 2018, they reported on Schedule
13/G that they own 973,032, or 3.25%, of our ordinary shares.

On November 10, 2016, the Phoenix Insurance Company Ltd. and its affiliate, Shotfut-Menayot-Israel-HaPhoenix Amitim
Ltd., purchased 1,904,762 ordinary shares from us in a registered offering. On August 29, 2017, the Phoenix Insurance
Company reported that it held 2,601,418, or 11.20%, of our ordinary shares. On December 27, 2017, it reported that it
held 1,455,870, or 4.86%, of our ordinary shares.

On April 7, 2015, Howard Yeung reported on a Schedule 13D/A that he owned directly 1,560,995 ordinary shares,
representing 34.73% of our outstanding ordinary shares. On August 28, 2015, Mr. Yeung reported on a Schedule 13D/A
that he owned 1,560,995 ordinary shares, representing 19.63% of our outstanding ordinary shares. This dilution was the
result of our public offering conducted in July 2015. On August 8, 2016, Mr. Yeung reported that the secured convertible
notes in the amount of $3,000,000 issued to Mr. Yeung on December 10, 2007 were fully repaid on June 16, 2016, which
reduced Mr. Yeung’s holdings on a beneficial basis, taking into account the termination of the conversion feature of the
note. In addition, the issuance of 8,510,638 ordinary shares to DBSI Investments Ltd. in a transaction which closed on
May 18, 2016, significantly diluted Mr. Yeung’s holdings to 10.85% based on 16,460,120 ordinary shares issued and
outstanding as of June 14, 2016.

Shareholders Voting Rights

Our major shareholders do not have different voting rights.

Record Holders

Based on a review of the information provided to us by American Stock Transfer & Trust Company, our transfer agent, as
of March 26, 2018, there were 74 holders of record of our ordinary shares, of which 62 record holders holding
approximately 72% of our ordinary shares had registered addresses in the United States, including banks, brokers and
nominees. These numbers are not representative of the number of beneficial holders of our shares nor are they
representative of where such beneficial holders reside, since many of these ordinary shares were held of record by banks,
brokers or other nominees.

B. Related Party Transactions

On July 30, 2015, we completed a public offering of 3,455,285 ordinary shares, offered at a price to the public of $2.46
per share. We received gross proceeds of $8,500,000 before deducting underwriting discounts and commissions and other
offering expenses. Issuance costs amounted to approximately $1,070,000. As of December 31, 2015, the remaining
principal amount of the debt owed under the standstill agreement was $3,090,000.

On May 18, 2016, we completed the sale to DBSI of 8,510,638 of our ordinary shares in consideration for approximately
$4,000,000, reflecting a price per share of $0.47. In addition, we issued to DBSI warrants to purchase 4,255,319 ordinary
shares at an exercise price per share of $0.47 (resulting in an aggregate exercise price of $2,000,000), exercisable for a
period of 24 months following the date of the initial investment and warrants to purchase an additional 3,636,363 shares at
an exercise price per share of $0.55 (resulting in an aggregate exercise price of $2,000,000), exercisable for a period of 48
months following the date of the initial investment.

DBSI also granted our company an option, exercisable either by either us or DBSI, for us to obtain a convertible loan in
the principal amount of up to $3,175,000 solely for the purpose of the repayment of the outstanding shareholders’ debt.
We exercised such option in June 2016. In August 2017, DBSI converted the entire principal loan into 1,322,917 ordinary
shares reflecting a conversion price of $2.40 per share.

Form F-3 Registration Statements

Pursuant to the registration rights agreements we entered into with DBSI in 2016 and 2017, we filed several registration
statements on Form F-3 relating to the resale of the ordinary shares held by DBSI.

Form S-8 Registration Statements and Reoffer Prospectus

On August 24, 2016, we filed a registration statement on Form S-8 which included a “reoffer prospectus” in connection
with reoffers and resales of “control securities” by certain of our officers. We registered 168,750 ordinary shares on behalf
of Zvi Alon, our former Chief Executive Officer, 131,250 ordinary shares on behalf of Shiri Lazarovich, our former Chief
Financial Officer and 131,250 ordinary shares for each of Dov Sella and Oleg Kiperman.

C. Interests of Experts and Counsel

Not applicable.

ITEM 8. FINANCIAL INFORMATION

A. Consolidated Statements and Other Financial Information

Export Sales

Export sales constitute a significant portion of our sales. In 2017, we had approximately $19,819 million of export sales,
constituting approximately 76% of our total sales. For further information regarding the allocation of our revenues by
geographic region see Item 4 – “Information on the Company-Markets.”

Legal Proceedings

Currently, we are not a party to any legal proceedings; however, from time to time we are involved in legal proceedings
arising from the operation of our business. Based on the advice of our legal counsel, management believes such current
proceedings, if any, will not have a material adverse effect on our financial position or results of operations.

Dividend Distribution Policy

We have never paid cash dividends to our shareholders. We intend to retain future earnings for use in our business and do
not anticipate paying cash dividends on our ordinary shares in the foreseeable future. Any future dividend policy will be
determined by the board of directors and will be based upon conditions then existing, including our results of operations,
financial condition, current and anticipated cash needs, contractual restrictions and other conditions as the board of
directors may deem relevant.

According to the Israeli Companies Law, a company may distribute dividends out of its profits, so long as the company
reasonably believes that such dividend distribution will not prevent the company from paying all its current and future
debts. Profits, for purposes of the Israeli Companies Law, means the greater of retained earnings or earnings accumulated
during the preceding two years. In the event cash dividends are declared, such dividends will be paid in NIS.

B. Significant Changes

Except as otherwise disclosed in this annual report, no significant change has occurred since December 31, 2017.

ITEM 9. THE OFFER AND LISTING

A. Offer and Listing Details

Annual Stock Information

All of the share price information provided below has been adjusted to give effect to a 1 share for 2 shares reverse share
split effected on September 14, 2016.

The following table sets forth for each of the years indicated, the range of high ask and low bid prices of our ordinary
shares on the NASDAQ Capital Market:

Year
2013
2014
2015
2016
2017

Quarterly Stock Information

High

Low

$
$
$
$
$

4.20
11.94
5.80
1.50
3.67

$
$
$
$
$

2.10
2.60
0.70
0.56
1.04

The following table sets forth for each of the full financial quarters in the years indicated, the range of high ask and low
bid prices of our ordinary shares on the NASDAQ Capital Market:

2016
First Quarter
Second Quarter
Third Quarter .
Fourth Quarter

2017
First Quarter
Second Quarter
Third Quarter
Fourth Quarter

2018
First Quarter (through March 26)

Monthly Stock Information

High

Low

$
$
$
$

0.92
1.40
1.50
1.28

$
$
$
$

High

Low

1.35
1.94
3.58
3.67

3.09

High

Low

0.56
0.72
0.93
1.00

1.12
1.04
1.83
2.86

1.93

The following table sets forth, for the most recent six months, the range of high ask and low bid prices of our ordinary
shares on the NASDAQ Capital Market:

September 2017
October 2017
November 2017
December 2017
January 2018
February 2018
March 2018 (through March 26)

High

Low

$
$
$
$
$
$
$

3.58
3.67
3.44
3.59
3.09
2.14
2.49

$
$
$
$
$
$
$

2.75
3.11
2.86
3.08
2.31
1.93
2.08

B. Plan of Distribution

Not applicable.

C. Markets

Our ordinary shares traded on the NASDAQ Global Market under the symbol “RADIF” from 1985 until June 10, 2002,
when the listing of our ordinary shares was transferred to the NASDAQ Capital Market. On December 13, 2005, we
changed our symbol to “RADI,” and on March 15, 2007, we changed our symbol to “RADA.”

D. Selling Shareholders

Not applicable.

E. Dilution

Not applicable.

F. Expense of the Issue

Not applicable.

ITEM 10. ADDITIONAL INFORMATION

A. Share Capital

Not applicable.

B. Memorandum and Articles of Association

Purposes and Objectives of the Company

We are registered with the Israeli Companies Registry and have been assigned company number 52-003532-0. Section 2
of our memorandum of association provides that we were established for the purpose of engaging in the business of
providing services of planning, development, consultation and instruction in the electronics field. In addition, the purpose
of our company is to perform various corporate activities permissible under Israeli law.

On February 1, 2000, the Israeli Companies Law came into effect and superseded most of the provisions of the Israeli
Companies Ordinance (New Version), 5743-1983, except for certain provisions which relate to liens, bankruptcy,
dissolution and liquidation of companies. Under the Israeli Companies Law, as recently amended, various provisions,
some of which are detailed below, overrule the current provisions of our articles of association.

The Powers of the Directors

Under the provisions of the Israeli Companies Law, and our articles of association, a director cannot participate in a
meeting nor vote on a proposal, arrangement or contract in which he or she is materially interested. In addition, our
directors cannot vote compensation to themselves or any members of their body without the approval of our audit
committee and our shareholders at a general meeting. The authority of our directors to enter into borrowing arrangements
on our behalf is not limited, except in the same manner as any other transaction by us.

Under our articles of association, retirement of directors from office is not subject to any age limitation and our directors
are not required to own shares in our company in order to qualify to serve as directors.

Rights Attached to Shares

Our authorized share capital consists of 37,500,000 ordinary shares of a nominal value of NIS 0.03 each. All outstanding
ordinary shares are validly issued, fully paid and non-assessable. The rights attached to the ordinary shares are as follows:

The rights attached to the ordinary shares are as follows:

Dividend rights. Holders of our ordinary shares are entitled to the full amount of any cash or share dividend subsequently
declared. The board of directors may declare interim dividends and propose the final dividend with respect to any fiscal
year only out of the retained earnings, in accordance with the provisions of the Israeli Companies Law. Our articles of
association provide that the declaration of a dividend requires approval of the board of directors. See Item 8A. “Financial
Information – Consolidated and Other Financial Information – Dividend Distribution Policy.” If after one year a dividend
has been declared and it is still unclaimed, the board of directors is entitled to invest or utilize the unclaimed amount of
dividend in any manner to our benefit until it is claimed. We are not obligated to pay interest or linkage differentials on an
unclaimed dividend.

Voting rights. Holders of ordinary shares have one vote for each ordinary share held on all matters submitted to a vote of
shareholders. Such voting rights may be affected by the grant of any special voting rights to the holders of a class of shares
with preferential rights that may be authorized in the future.

Except as otherwise required by the Israeli Companies Law, a resolution of the Shareholders shall be deemed adopted if
approved by the holders of a simple majority of the voting power represented at the General Meeting in person or by
proxy and voting thereon, as one class, and disregarding abstentions from the count of the voting power present and
voting.

Pursuant to our Articles of Association, our directors, except for the external directors, shall be elected at the Annual
General Meeting by the vote of the holders of a majority of the voting power represented at such meeting in person or by
proxy and voting on the election of directors, and each director shall generally serve until the Annual General Meeting
next following the Annual General Meeting at which such director was appointed, or his earlier vacation of office or
removal pursuant to the Articles of Association. Except with respect to the removal of external directors, the shareholders
shall be entitled to remove any director(s) from office, by a simple majority of the voting power represented at the meeting
in person or by proxy and voting thereon. All the members of our Board of Directors (except the external directors) may
be reelected upon completion of their term of office. For information regarding the election of external directors, see Item
6C “Directors, Senior Management and Employees - Board Practices -Election of Directors.”

Rights to share in the company’s profits. Our shareholders have the right, in accordance with the Board of Directors
resolution, to share in our profits distributed as a dividend and any other permitted distribution. See this Item 10B.
“Additional Information – Memorandum and Articles of Association – Rights Attached to Shares – Dividend Rights.”

Rights to share in surplus in the event of liquidation. In the event of our liquidation, after satisfaction of liabilities to
creditors, our assets will be distributed to the holders of ordinary shares in proportion to the nominal value of their
holdings. This right may be affected by the grant of preferential dividend or distribution rights to the holders of a class of
shares with preferential rights that may be authorized in the future.

Liability to capital calls by the company. Under our memorandum of association and the Israeli Companies Law, the
liability of our shareholders is limited to the par value of the shares held by them.

Limitations on any existing or prospective major shareholder.

See Item 6C. “Directors, Senior Management and Employees - Board Practices – Approval of Related Party Transactions
under Israeli Law.”

Changing Rights Attached to Shares

According to the Articles of Association, in order to change the rights attached to any class of shares, unless otherwise
provided by the terms of the class, such change must be adopted by a general meeting of the shareholders with a simple
majority of the class of shares so effected, and a simple majority vote of all classes of shares voting together as a single
class at a General Meeting.

Annual and Extraordinary General Meetings

The board of directors must convene an annual meeting of shareholders at least once every calendar year, within 15
months of the last annual meeting. Depending on the matter to be voted upon, notice of at least 21 days or 35 days prior to
the date of the meeting is required. Our board of directors may, in its discretion, convene additional meetings as
“Extraordinary General Meetings.” In addition, the board of directors must convene an Extraordinary General Meeting
upon the demand of two of the directors, 25% of the nominated directors, one or more shareholders having at least 5% of
the outstanding share capital and at least 1% of the voting power in the company, or one or more shareholders having at
least 5% of the voting power in the company.

The quorum required for a General Meeting of shareholders consists of at least two shareholders present in person or
represented by proxy who hold or represent, in the aggregate, at least 25% of the voting rights of the issued share capital.
A meeting adjourned for lack of a quorum is adjourned to the same day in the following week at the same time and place
or any time and place as the directors designate in a notice to the shareholders or to such day and at such time and place as
the Chairman of the General Meeting shall determine. At the reconvened meeting, if the original meeting was convened
upon the demand of one or more shareholders having at least 5% of the outstanding share capital and at least 1% of the
voting power in the company, or one or more shareholders having at least 5% of the voting power in the company, the
quorum will be one or more Shareholders, present in person or by proxy, and holding the number of shares required for
making such requisition. In any other case the required quorum consists of any two members present in person or by
proxy.

Limitations on the Rights to Own Securities in Our Company

Neither our memorandum of association or our articles of association nor the laws of the State of Israel restrict in any way
the ownership or voting of shares by non-residents, except with respect to subjects of countries which are in a state of war
with Israel.

Provisions Restricting Change in Control of Our Company

The Israeli Companies Law requires that mergers between Israeli companies be approved by the board of directors and
general meeting of shareholders of both parties to the transaction. The approval of the board of directors of both
companies is subject to such board’s confirmation that there is no reasonable doubt that after the merger the surviving
company will be able to fulfill its obligations towards its creditors. Each company must notify its creditors about the
contemplated merger. Generally, under the Israeli Companies Law, our articles of association are deemed to include a
requirement that such merger be approved by a special resolution of the shareholders, as explained above. The approval of
the merger by the general meetings of shareholders of the companies is also subject to additional approval requirements as
specified in the Israeli Companies Law and regulations promulgated thereunder. For purposes of the shareholders’
approval, the merger shall not be deemed as granted, unless the court determines otherwise, if it is not supported by the
majority of the shares represented at the general meeting, other than those shares that are held by the other party to the
merger or by any shareholder holding 25% or more of the outstanding share capital of the company or the right to appoint
25% or more of the members of the board of directors. The Israeli Companies Law also provides that an acquisition of
shares of a public company must be made by means of a special tender offer if as a result of the acquisition the purchaser
would become a 25% or greater shareholder of the company and there is no existing 25% or greater shareholder in the
company. An acquisition of shares of a public company must also be made by means of a tender offer if as a result of the
acquisition the purchaser would become a 45% or greater shareholder of the company and there is no existing 45% or
greater shareholder in the company. These requirements do not apply if the acquisition (i) was made through a private
placement that received shareholder approval, (ii) was from a 25% shareholder of the company and resulted in the acquirer
becoming a 25% shareholder of the company or (iii) was from a 45% shareholder of the company and resulted in the
acquirer becoming a 45% shareholder of the company. The special tender offer must be extended to all shareholders but,
the offer may include explicit limitations allowing the offeror not to purchase shares representing more than 5% of the
voting power attached to the company’s outstanding shares, regardless of how many shares are tendered by shareholders.
The special tender offer may be effected only if (i) at least 5% of the voting power attached to the company’s outstanding
shares will be acquired by the offeror and (ii) the number of shares tendered in the offer exceeds the number of shares
whose holders objected to the offer.

If, as a result of an acquisition of shares, the acquirer will hold more than 90% of the outstanding shares, the acquisition
must be made by means of a tender offer for the entire outstanding shares. In such event, if less than 5% of the outstanding
shares are not tendered in the tender offer, all the shares of the company will be deemed as tendered and sold. However, if
more than 5% of the outstanding shares are not tendered in the tender offer, then the acquirer may not acquire any shares
at all. The law provides for appraisal allowing any shareholder to file a motion to the court within six months following
the consummation of a full tender offer. However, in the event of a full tender offer, the offeror may determine that any
shareholder who accepts the offer will not be entitled to appraisal rights. Such determination will be effective only if the
offeror or the company has timely published all the information that is required to be published in connection with such
full tender offer pursuant to all applicable laws.

In addition, the purchase of 25% or more of the outstanding share capital of a company or the purchase of substantial
assets of a company requires, under certain conditions the approval of the Restrictive Practices Authority. Furthermore, if
the target company has received tax incentives of grants from the Innovation Authority, changes in ownership may require
also the approval of the tax authorities or the Innovation Authority, as applicable.

Disclosure of Shareholders Ownership

The Israeli Securities Law and regulations promulgated thereunder do not require a company whose shares are publicly
traded solely in a stock exchange outside of Israel, as in the case of our company, to disclose its share ownership.

Changes in Our Capital

Changes in our capital are subject to the approval of the shareholders at a general meeting by a simple majority of the
votes of shareholders participating and voting in the general meeting.

C Material Contracts

We do not deem any individual contract to be a material contract which is not already discussed and filed as an exhibit or
in the ordinary course of our business.

D Exchange Controls

Israeli law and regulations do not impose any material foreign exchange restrictions on non-Israeli holders of our ordinary
shares.

Non-residents of Israel who purchase our ordinary shares will be able to convert dividends, if any, thereon, and any
amounts payable upon our dissolution, liquidation or winding up, as well as the proceeds of any sale in Israel of our
ordinary shares to an Israeli resident, into freely repairable dollars, at the exchange rate prevailing at the time of
conversion, provided that the Israeli income tax has been withheld (or paid) with respect to such amounts or an exemption
has been obtained.

E Taxation

The following is a discussion of Israeli and United States tax consequences material to us and our shareholders. To the
extent that the discussion is based on new tax legislation which has not been subject to judicial or administrative
interpretation, the views expressed in the discussion might not be accepted by the tax authorities in question. The
discussion is not intended, and should not be construed, as legal or professional tax advice and does not exhaust all
possible tax considerations.

Holders of our ordinary shares should consult their own tax advisors as to the United States, Israeli or other tax
consequences of the purchase, ownership and disposition of ordinary shares, including, in particular, the effect of any
foreign, state or local taxes.

Israeli Tax Considerations

The following is a summary of the current tax structure applicable to companies in Israel, with special reference to its
effect on us. The following also contains a discussion of the material Israeli tax consequences to purchasers of our
ordinary shares and Israeli government programs benefiting us. This summary does not discuss all the aspects of Israeli
tax law that may be relevant to a particular investor in light of his or her personal investment circumstances or to some
types of investors subject to special treatment under Israeli law. Examples of this kind of investor include residents of
Israel or traders in securities who are subject to special tax regimes not covered in this discussion. Since some parts of this
discussion are based on new tax legislation that has not yet been subject to judicial or administrative interpretation, we
cannot assure you that the appropriate tax authorities or the courts will accept the views expressed in this discussion.

General Corporate Tax Rate

Generally, Israeli companies were subject to corporate tax on taxable income and capital gains at the rate of 24%, 25%
and 26.5% for the tax years 2017, 2016 and 2015, respectively.

Law for the Encouragement of Industry (Taxes), 1969

We qualify as an “Industrial Company” under the Law for the Encouragement of Industry (Taxes), 1969 (the “Industrial
Encouragement Law”). The Industrial Encouragement Law defines an “Industrial Company” as a company that is resident
in Israel and that derives at least 90% of its income in any tax year, other than income from defense loans, capital gains,
interest and dividends, from an enterprise whose major activity in a given tax year is industrial production.

The principal benefit from the above law is the deduction of expenses in connection with a public offering. Also, under the
industrial Encouragement Law an “Industrial Company” is entitled to special rates of depreciation for industrial equipment
and in addition to amortization of the cost of purchased know-how and patents over an eight years period for tax purposes
and an accelerated depreciation rate on equipment.

Eligibility for the benefits under the Industry Encouragement Law is not subject to receipt of prior approval from any
governmental authority.

Capital Gains Tax on Sales of Our Ordinary Shares

Capital gains tax is imposed on the disposal of capital assets by an Israeli resident and on the disposal of such assets by a
non-Israeli resident if those assets are either (i) located in Israel; (ii) shares or rights to shares in an Israeli resident
company, or (iii) represent, directly or indirectly, rights to assets located in Israel. The Israeli Income Tax Ordinance
distinguishes between “Real Capital Gain” and “Inflationary Surplus.” The Real Capital Gain on the disposition of a
capital asset is the amount of total capital gain in excess of Inflationary Surplus. Inflationary Surplus is computed,
generally, on the basis of the increase in the Israeli Consumer Price Index between the date of purchase and the date of
disposal of the capital asset.

Under income tax regulations shareholders that are not Israeli residents are generally exempt from Israeli capital gains tax
on any gains derived from the sale, exchange or disposition of our ordinary shares, provided that: (1) the securities were
purchased upon or after the registration of the securities on a stock exchange (this requirement generally does not apply to
shares purchased on or after January 1, 2009); (2) the seller of the securities does not have a permanent establishment in
Israel to which the generated capital gain is attributed; and (3) such gains did not derive from a permanent establishment
or business activity of such shareholders in Israel. However, non-Israeli corporations will not be entitled to the foregoing
exemptions if an Israeli resident (i) has a controlling interest of 25% or more in such non-Israeli corporation, or (ii) is the
beneficiary of or is entitled to 25% or more of the revenues or profits of such non-Israeli corporation, whether directly or
indirectly.

Under the U.S.-Israel Tax Treaty, the sale, exchange or disposition of our ordinary shares by a shareholder who is a U.S.
resident (for purposes of the U.S.-Israel Tax Treaty) holding the ordinary shares as a capital asset is exempt from Israeli
capital gains tax unless either (i) the shareholder holds, directly or indirectly, shares representing 10% or more of our
voting capital during any part of the 12-month period preceding such sale, exchange or disposition, (ii) ) or the seller, if an
individual, has been present in Israel for more than 183 days (in the aggregate) during the taxable year, or (iii) the capital
gains arising from such sale are attributable to a permanent establishment of the shareholder located in Israel. However,
under the U.S.-Israel Tax Treaty, U.S. Residents would be permitted to claim a credit for such taxes against the U.S.
federal income tax imposed with respect to such sale, exchange or disposition, subject to limitations in U.S. laws
applicable to foreign tax credits. The treaty does not relate to U.S. state or local taxes.

Individual and corporate shareholders dealing in securities in Israel are taxed at the tax rates applicable to business income
(a tax rate of 24% for a corporation in 2011, 25% in 2012 and 2013 and 26.5% in 2014 and 2015 and 25% in 2016 and
thereafter) and a marginal tax rate of up to 45% for an individual in 2011, 48% in 2012 and thereafter. In 2014, an
additional tax liability of 3% was added to the applicable tax rate on the annual taxable income of individuals (whether
any such individual is an Israeli resident or non-Israeli resident) exceeding NIS 640,000.

Taxation of Foreign Resident Holders of Shares

Non-residents of Israel are generally subject to Israeli income tax on the receipt of dividends paid on our ordinary shares
at the rate of 25%, which tax will be withheld at source, unless a different rate is provided in a treaty between Israel and
the shareholder’s country of residence. With respect to a substantial shareholder, the applicable tax rate is at 30% Under
the U.S.-Israel Tax Treaty, the maximum rate of tax withheld in Israel on dividends paid to a holder of our ordinary shares
who is a U.S. resident (for purposes of the U.S.-Israel Tax Treaty) is 25%. However, generally, the maximum rate of
withholding tax on dividends, not generated by our Approved Enterprise, that are paid to a U.S. corporation holding 10%
or more of our outstanding voting capital throughout the tax year in which the dividend is distributed as well as the
previous tax year, is 12.5%.

A non-resident of Israel who receives dividends from which tax was withheld is generally exempt from the duty to file
returns in Israel in respect of such income; provided such income was not derived from a business conducted in Israel by
the taxpayer, and the taxpayer has no other taxable sources of income in Israel.

Foreign Exchange Regulations

Dividends (if any) paid to the holders of our ordinary shares, and any amounts payable with respect to our ordinary shares
upon dissolution, liquidation or winding up, as well as the proceeds of any sale in Israel of the ordinary shares to an Israeli
resident, may be paid in non-Israeli currency or, if paid in Israeli currency, may be converted into freely reparable U.S.
dollars at the rate of exchange prevailing at the time of conversion, however, Israeli income tax is required to have been
paid or withheld on these amounts.

Controlled Foreign Corporation

In general, and subject to the provisions of all relevant legislation, an Israeli resident who holds, directly or indirectly,
10% or more of the rights in a foreign corporation whose shares are not publicly traded, in which more than 50% of the
rights are held directly or indirectly by Israeli residents, and a majority of whose income in a tax year is considered
passive income (generally referred to as a Controlled Foreign Corporation, or CFC), is liable for tax on the portion of his
income attributed to holdings in such corporation, as if such income was distributed to him as a dividend.

Share Allocations to controlling shareholders

Controlling shareholders will be taxable under section 3(i) to the Tax Ordinance, according to which, the grantee pays
income tax rate (according to the marginal tax rate of the grantee- up to 48% in 2012) on the profit upon the sale of the
underlying shares. As of January 1, 2013, the marginal tax rate (48%) of an individual will increase in 3% in case his
taxable income in a tax year exceed the amount of NIS 640,000 (including capital gains from marketable securities,
dividends and interest income).

United States Federal Income Taxation

The following is a general discussion of the material U.S. federal income tax consequences of the acquisition, ownership
and disposition of our ordinary shares. This description addresses only the U.S. federal income tax considerations that may
be relevant to U.S. Holders (as defined below) who hold our ordinary shares as capital assets. This summary is based on
the U.S. Internal Revenue Code of 1986, as amended, (the “Code”) Treasury regulations promulgated thereunder, judicial
and administrative interpretations thereof and the U.S.-Israel Tax Treaty (the “Treaty”), all as in effect on the date hereof
and all of which are subject to change either prospectively or retroactively or to differing interpretations. There can be no
assurance that the U.S. Internal Revenue Service (“IRS”) will not take a different position concerning the tax
consequences of the acquisition, ownership or disposition of our ordinary shares or that such a position would not be
sustained. This discussion does not address all tax considerations that may be relevant to a U.S. Holder of ordinary shares.
In addition, this description does not account for the specific circumstances of any particular investor, such as:

● broker-dealers;

● financial institutions or financial services entities;

● certain insurance companies;

● investors liable for alternative minimum tax;

● regulated investment companies, real estate investment trusts, or grantor trusts;

● dealers or traders in securities, commodities or currencies;

● tax-exempt organizations;

● retirement plans;

● S corporations:

● pension funds;

● certain former citizens or long-term residents of the United States;

● non-resident aliens of the United States or taxpayers whose functional currency is not the U.S. dollar;

● persons who hold ordinary shares through partnerships or other pass-through entities;

● persons who acquire their ordinary shares through the exercise or cancellation of employee stock options or

otherwise as compensation for services;

● direct, indirect or constructive owners of investors that actually or constructively own at least 10% of the

total combined voting power of our shares or at least 10% of our shares by value; or

● investors holding ordinary shares as part of a straddle, appreciated financial position, a hedging transaction

or conversion transaction.

If a partnership or an entity treated as a partnership for U.S. federal income tax purposes owns our ordinary shares, the
U.S. federal income tax treatment of a partner in such a partnership will generally depend upon the status of the partner
and the activities of the partnership. A partnership that owns our ordinary shares and the partners in such partnership
should consult their tax advisors about the U.S. federal income tax consequences of holding and disposing of ordinary
shares.

This summary does not address the effect of any U.S. federal taxation (such as estate and gift tax) other than U.S. federal
income taxation. In addition, this summary does not include any discussion of state, local or non-U.S. taxation.

For purposes of this summary the term “U.S. Holder” means a person that is eligible for the benefits of the Treaty and is a
beneficial owner of ordinary shares who is, for U.S. federal income tax purposes:

● an individual who is a citizen or a resident of the United States;

● a corporation or other entity taxable as a corporation for United States federal income tax purposes, created or

organized in or under the laws of the United States or any political subdivision thereof;

● an estate the income of which is subject to U.S. federal income taxation regardless of its source; or

● a trust if the trust has validly elected to be treated as a U.S. person for U.S. federal income tax purposes or if (1) a
court within the United States is able to exercise primary supervision over the trust’s administration and (2) one
or more U.S. persons have the authority to control all of the substantial decisions of the trust.

Unless otherwise indicated, it is assumed for the purposes of this discussion that the Company is not, and will not become,
a “passive foreign investment company” (“PFIC”) for U.S. federal income tax purposes. See “—Passive Foreign
Investment Companies” below.

Taxation of Distributions

Subject to the discussion below under the heading “—Passive Foreign Investment Companies,” the gross amount of any
distributions received with respect to our ordinary shares, including the amount of any Israeli taxes withheld therefrom,
will constitute dividends for U.S. federal income tax purposes when such distribution is actually or constructively
received, to the extent such distribution is paid out of our current and accumulated earnings and profits, as determined for
U.S. federal income tax purposes. Because we do not expect to maintain calculations of our earnings and profits under
U.S. federal income tax principles, it is expected that the entire amount of any distribution will generally be reported as
dividend income to you. Dividends are included in gross income at ordinary income rates, unless such dividends constitute
“qualified dividend income,” as set forth in more detail below. Distributions in excess of our current and accumulated
earnings and profits would be treated as a non-taxable return of capital to the extent of your adjusted tax basis in our
ordinary shares and any amount in excess of your tax basis would be treated as gain from the sale of ordinary shares. See
“—Sale, Exchange or Other Disposition of Ordinary Shares” below for a discussion of the taxation of capital gains. Our
dividends would not qualify for the dividends-received deduction generally available to corporations under section 243 of
the Code.

Dividends that we pay in NIS, including the amount of any Israeli taxes withheld therefrom, will be included in your
income in a U.S. dollar amount calculated by reference to the exchange rate in effect on the day such dividends are
received, regardless of whether the payment is in fact converted into U.S. dollars. A U.S. Holder who receives payment in
NIS and converts NIS into U.S. dollars at an exchange rate other than the rate in effect on such day may have a foreign
currency exchange gain or loss that would generally be treated as U.S.-source ordinary income or loss. U.S. Holders
should consult their own tax advisors concerning the U.S. tax consequences of acquiring, holding and disposing of NIS.

Subject to complex limitations, some of which vary depending upon the U.S. Holder’s circumstances, any Israeli
withholding tax imposed on dividends paid with respect to our ordinary shares, may be a foreign income tax eligible for
credit against a U.S. Holder’s U.S. federal income tax liability (or, alternatively, for deduction against income in
determining such tax liability). Israeli taxes withheld in excess of the applicable rate allowed by the Treaty (if any) will
not be eligible for credit against a U.S. Holder’s federal income tax liability. The limitation on foreign income taxes
eligible for credit is calculated separately with respect to specific classes of income. Dividends paid with respect to our
common stock generally will be treated as foreign-source passive category income or, in the case of certain U.S. Holders,
general category income for U.S. foreign tax credit purposes. Further, there are special rules for computing the foreign tax
credit limitation of a taxpayer who receives dividends subject to a reduced tax rate. A U.S. Holder may be denied a foreign
tax credit with respect to Israeli income tax withheld from dividends received on our ordinary shares if such U.S. Holder
fails to satisfy certain minimum holding period requirements or to the extent such U.S. Holder’s position in ordinary
shares is hedged. An election to deduct foreign taxes instead of claiming a foreign tax credit applies to all foreign taxes
paid or accrued in the taxable year. The rules relating to the determination of the foreign tax credit are complex. You
should consult with your own tax advisors to determine whether and to what extent you would be entitled to this credit.

Subject to certain limitations (including the PFIC rules discussed below), “qualified dividend income” received by a non-
corporate U.S. Holder may be subject to tax at the lower long-term capital gain rates (currently, a maximum rate of 20%).
Distributions taxable as dividends paid on our ordinary shares should qualify for a reduced rate if we are a “qualified
foreign corporation,” as defined in Code section 1(h)(11)(C). We will be a qualified foreign corporation if either: (i) we
are entitled to benefits under the Treaty or (ii) our ordinary shares are readily tradable on an established securities market
in the United States and certain other requirements are met. We believe that we are entitled to benefits under the Treaty
and that our ordinary shares currently are readily tradable on an established securities market in the United States.
However, no assurance can be given that our ordinary shares will remain readily tradable. The rate reduction does not
apply unless certain holding period requirements are satisfied, nor does it apply to dividends received from a PFIC (see
discussion below), in respect of certain risk-reduction transactions, or in certain other situations. U.S. Holders of our
ordinary shares should consult their own tax advisors regarding the effect of these rules in their particular circumstances.

Sale, Exchange or Other Disposition of Ordinary Shares

Subject to the discussion of the PFIC rules below, if you sell or otherwise dispose of our ordinary shares (other than with
respect to certain non-recognition transactions), you will generally recognize gain or loss for U.S. federal income tax
purposes in an amount equal to the difference between the amount realized on the sale or other disposition and your
adjusted tax basis in our ordinary shares, in each case determined in U.S. dollars. Such gain or loss will generally be
capital gain or loss and will be long-term capital gain or loss if you have held the ordinary shares for more than one year at
the time of the sale or other disposition. Long-term capital gain realized by a non-corporate U.S. Holder is generally
eligible for a preferential tax rate (currently at a maximum of 20%). In general, any gain that you recognize on the sale or
other disposition of ordinary shares will be U.S.-source for purposes of the foreign tax credit limitation; losses will
generally be allocated against U.S. source income. Deduction of capital losses is subject to certain limitations under the
Code.

In the case of a cash basis U.S. Holder who receives NIS in connection with the sale or disposition of our ordinary shares,
the amount realized will be based on the U.S. dollar value of the NIS received with respect to the ordinary shares as
determined on the settlement date of such exchange. A cash basis U.S. Holder who receives payment in NIS and converts
NIS into U.S. dollars at a conversion rate other than the rate in effect on the settlement date may have a foreign currency
exchange gain or loss, based on any appreciation or depreciation in the value of NIS against the U.S. dollar, which would
be treated as ordinary income or loss.

An accrual basis U.S. Holder may elect the same treatment of currency exchange gain or loss required of cash basis
taxpayers with respect to a sale or disposition of our ordinary shares that are traded on an established securities market,
provided that the election is applied consistently from year to year. Such election may not be changed without the consent
of the IRS. In the event that an accrual basis U.S. Holder does not elect to be treated as a cash basis taxpayer (pursuant to
the Treasury regulations applicable to foreign currency transactions), such U.S. Holder is required to calculate the value of
the proceeds as of the “trade date” and may have a foreign currency gain or loss for U.S. federal income tax purposes in
the event of any difference between the U.S. dollar value of NIS prevailing on the trade date and on the settlement date.
Any such currency gain or loss generally would be treated as U.S.- source ordinary income or loss and would be subject to
tax in addition to the gain or loss, if any, recognized by such U.S. Holder on the sale or disposition of such ordinary
shares.

Passive Foreign Investment Companies

We may have been a PFIC for U.S. federal income tax purposes for the 2017 taxable year. If we were a PFIC for any
taxable year during which a U.S. Holder owned ordinary shares, certain adverse consequences could apply to the U.S.
Holder. Specifically, unless a U.S. Holder makes one of the elections mentioned below, gain recognized by the U.S.
Holder on a sale or other disposition of ordinary shares would be allocated ratably over the U.S. Holder’s holding period
for the ordinary shares. The amounts allocated to the taxable year of the sale or other disposition and to any year before we
became a PFIC would be taxed as ordinary income. The amount allocated to each other taxable year would be subject to
tax at the highest rate in effect for individuals or corporations, as appropriate, for that taxable year, and an interest charge
would be imposed on the resulting tax liability. Further, any distribution in excess of 125% of the average of the annual
distributions received by the U.S. Holder on our ordinary shares during the preceding three years or the U.S. Holder’s
holding period, whichever is shorter, would be subject to taxation as described immediately above. Certain elections (such
as a mark-to-market election or a QEF election) may be available to U.S. Holders and may result in alternative tax
treatment. U.S. Holders should consult their tax advisors as to the availability and consequences of a mark-to-market
election or a QEF election with respect to their ordinary shares.

In addition, if we were a PFIC for a taxable year in which we pay a dividend or the prior taxable year, the favorable
dividend rates discussed above with respect to dividends paid to certain non-corporate U.S. Holders would not apply. If
we were a PFIC for any taxable year in which a U.S. Holder owned our shares, the U.S. Holder would generally be
required to file annual returns with the IRS on IRS Form 8621.

Additional Tax on Investment Income

In addition to the income taxes described above, U.S. Holders that are individuals, estates or trusts and whose income
exceeds certain thresholds may be subject to a 3.8% Medicare contribution tax on net investment income, which includes
dividends and capital gains from the sale or exchange of our ordinary shares.

Backup Withholding and Information Reporting

Payments in respect of our ordinary shares may be subject to information reporting to the IRS and to U.S. backup
withholding tax at the rate (currently) of 24%. Backup withholding will not apply, however, if you (i) fall within certain
exempt categories and demonstrate the fact when required or (ii) furnish a correct taxpayer identification number and
make any other required certification.

Backup withholding is not an additional tax. Amounts withheld under the backup withholding rules may be credited
against a U.S. Holder’s U.S. tax liability. A U.S. Holder may obtain a refund of any excess amounts withheld under the
backup withholding rules by filing the appropriate claim for refund with the IRS.

U.S. citizens and individuals taxable as resident aliens of the United States that (i) own “specified foreign financial
assets” (as defined in Section 6038D of the Code and the regulations thereunder) with an aggregate value in a taxable year
in excess of certain thresholds (as determined under rules in Treasury regulations) and (ii) are required to file U.S. federal
income tax returns generally will be required to file an information report with respect to those assets with their tax
returns. IRS Form 8938 has been issued for that purpose. “Specified foreign financial assets” include any financial
accounts maintained by foreign financial institutions, foreign stocks held directly, and interests in foreign estates, foreign
pension plans or foreign deferred compensation plans. Under those rules, our ordinary shares, whether owned directly or
through a financial institution, estate or pension or deferred compensation plan, would be “specified foreign financial
assets.” Under Treasury regulations, the reporting obligation applies to certain U.S. entities that hold, directly or
indirectly, specified foreign financial assets. Penalties can apply if there is a failure to satisfy this reporting obligation. In
addition, in the event a U.S. Holder that is required to file IRS Form 8938 does not file such form, the statute of limitations
on the assessment and collection of U.S. federal income taxes of such U.S. Holder for the related tax year may not close
until three years after the date that the required information is filed. A U.S. Holder is urged to consult the U.S. Holder’s
tax advisor regarding the reporting obligation.

Any U.S. Holder who acquires more than $100,000 of our ordinary shares or holds 10% or more of our ordinary shares by
vote or value may be subject to certain additional U.S. information reporting requirements.

The above description is not intended to constitute a complete analysis of all tax consequences relating to
acquisition, ownership and disposition of our ordinary shares. You should consult your tax advisor concerning the
tax consequences of your particular situation.

F. Dividend and Paying Agents

Not applicable.

G. Statement by Experts

Not applicable.

H. Documents on Display

We are subject to certain of the reporting requirements of the Exchange Act, as applicable to “foreign private issuers” as
defined in Rule 3b-4 under the Exchange Act. As a foreign private issuer, we are exempt from certain provisions of the
Exchange Act. Accordingly, our proxy solicitations are not subject to the disclosure and procedural requirements of
Regulation 14A under the Exchange Act, and transactions in our equity securities by our officers and directors are exempt
from reporting and the “short-swing” profit recovery provisions contained in Section 16 of the Exchange Act. In addition,
we are not required under the Exchange Act to file periodic reports and financial statements as frequently or as promptly
as U.S. companies whose securities are registered under the Exchange Act. However, we file with the SEC an annual
report on Form 20-F containing financial statements audited by an independent accounting firm. We also submit to the
SEC reports on Form 6-K containing (among other things) press releases and unaudited financial information. We post our
annual report on Form 20-F on our website (www.rada.com) promptly following the filing of our annual report with the
SEC. The information on our website is not incorporated by reference into this annual report.

This annual report and the exhibits thereto and any other document we file pursuant to the Exchange Act may be inspected
without charge and copied at prescribed rates at the SEC public reference room at 100 F Street, N.E., Room 1580,
Washington, D.C. 20549. You may obtain information on the operation of the SEC’s public reference room in
Washington, D.C. by calling the SEC at 1-800-SEC-0330. The Exchange Act file number for our SEC filings is 000-
15375.

The SEC maintains a website at www.sec.gov that contains reports, proxy and information statements, and other
information regarding registrants that make electronic filings with the SEC using its EDGAR (Electronic Data Gathering,
Analysis, and Retrieval) system.

The documents concerning our company that are referred to in this annual report may also be inspected at our offices
located at 7 Giborei Israel Street, Netanya 4250407, P.O. Box 8606, Israel.

I. Subsidiary Information

Not applicable.

ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISKS

Interest Rate Risk

We currently do not invest in or otherwise hold, for trading or other purposes, any financial instruments subject to market
risks. Generally, we pay interest on our credit facilities, convertible notes and short-term loans based on Libor, for dollar-
denominated loans, and Israeli prime or adjustment differences to the Israeli consumer price index, for some of our NIS-
denominated loans. As a result, changes in the general level of interest rates may affect the amount of interest payable by
us under these facilities.

Foreign Currency Exchange Risk

The depreciation of the NIS against the dollar has the effect of reducing the dollar amount of any of our expenses or
liabilities which are payable in NIS (unless such expenses or payables are linked to the dollar). As of December 31, 2017,
we had liabilities payable in NIS which are not linked to the dollar in the amount of $5.9 million and cash and receivables
in the amount of $2.9 million denominated in NIS. Accordingly, 1% appreciation of the NIS against the dollar would
increase our financing expenses by approximately $87,400. A 1% depreciation of the NIS against the dollar would
decrease our financing expenses by the same amount. However, the amount of liabilities payable and/or cash and
receivables in NIS is likely to change from time to time.

Because exchange rates between the NIS and the dollar fluctuate continuously, exchange rate fluctuations and especially
larger periodic devaluations will have an impact on our profitability and period-to-period comparisons of our results. The
effects of foreign currency re-measurements are reported in our consolidated financial statements in continuing operations.

ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES

Not applicable.

ITEM 13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES

PART II

None.

ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF

PROCEEDS

None.

ITEM 15. CONTROLS AND PROCEDURES

Disclosure Controls and Procedures

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in its
Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the SEC’s
rules and forms, and that such information is accumulated and communicated to our Chief Executive Officer and Chief
Financial Officer to allow timely decisions regarding required disclosure. Our management, including our Chief Executive
Officer and Chief Financial Officer, conducted an evaluation of our disclosure controls and procedures, as defined under
Exchange Act Rule 13a-15(e), as of the end of the period covered by this Annual Report on Form 20-F. Based upon that
evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as of such date, our disclosure
controls and procedures were effective.

Management’s Annual Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over our financial reporting.
Internal control over financial reporting is defined in Rule 13a-15(f) or 15d-15(f) promulgated under the Securities
Exchange Act of 1934 as a process designed by, or under the supervision of, the company’s principal executive and
principal financial officers and effected by the company’s board of directors, management and other personnel, to provide
reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting principles and includes those policies and procedures that:

● pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the

transaction and dispositions of the assets of the company;

● provide reasonable assurance that transactions are recorded as necessary to permit preparation of
financial statements in accordance with generally accepted accounting principles, and that receipts and
expenditures of the company are being made only in accordance with authorizations of management and
directors of the company; and

● provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use
or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements.
Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate
because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Our management assessed the effectiveness of our internal control over financial reporting as of December 31, 2017. In
making this assessment, our management used the criteria set forth by the Committee of Sponsoring Organizations of the
Treadway Commission (COSO) in Internal Control-Integrated Framework. Based on that assessment, our management
concluded that as of December 31, 2017, our internal control over financial reporting is effective.

Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting that occurred during the period covered by this annual
report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

ITEM 16. RESERVED.

ITEM 16A. AUDIT COMMITTEE FINANCIAL EXPERT

Our board of directors has determined that Mr. Elan Sigal, one of our external directors, within the meaning of the Israeli
Companies Law, and an independent director, as defined by the SEC and NASDAQ, meets the definition of an audit
committee financial expert, as defined by rules of the SEC. For a brief listing of Mr. Sigal’s relevant experience, see Item
6.A. “Directors, Senior Management and Employees — Directors and Senior Management.”

ITEM 16B. CODE OF ETHICS

We have adopted a code of ethics that applies to our Chief Executive Officer and all senior financial officers of our
company, including the Chief Financial Officer, Chief Accounting Officer or controller, or persons performing similar
functions. Written copies of our code of ethics are available upon request. If we make any substantive amendment to the
code of ethics or grant any waivers, including any implicit waiver, from a provision of the codes of ethics, we will disclose
the nature of such amendment or waiver on our website.

ITEM 16C. PRINCIPAL ACCOUNTANT FEES AND SERVICES

Independent Registered Public Accounting Firm Fees

The following table sets forth, for each of the years indicated, the fees billed by our principal independent registered
public accounting firm, Kost Forer Gabbay & Kasierer, a Member of Ernst & Young Global (“EY Israel”). All of such
fees were pre-approved by our Audit Committee.

Services Rendered:
Audit (1)
Audit-related (2)
Tax (3)
Total (2)

Year Ended December 31
2017
2016

$
$
$
$

83,000
17,000
5,000
105,000

$
$
$
$

97,300
12,000
5,000
114,300

(1) Audit fees are the aggregate fees for the audit of our consolidated annual financial statements. It also
includes fees billed for accounting consultations regarding the accounting treatment of matters that occur in
the regular course of business, implications of new accounting pronouncements and other accounting issues
that occur from time to time.

(2) Audit-related fees relate to assurance and associated services that traditionally are performed by the
independence auditor including SEC filings, comfort letters, consents and comment letters in connection
with regulatory filings.

(3) Tax fees are the aggregate fees billed for professional services rendered for tax compliance and tax advice,
other than in connection with the audit. Tax compliance involves preparation of original and amended tax
returns, tax planning and tax advice.

EY Israel and other EY affiliates did not bill the company for services other than the fees described above for
fiscal year 2017 or fiscal year 2016.

Pre-Approval Policies and Procedures

Our Audit Committee has adopted a policy and procedures for the pre-approval of audit and non-audit services rendered
by our independent registered public accounting firm, Kost Forer Gabbay & Kasierer, a Member of Ernst & Young Global
(“EY Israel”). Pre-approval of an audit or non-audit service may be given as a general pre-approval, as part of the audit
committee’s approval of the scope of the engagement of our independent auditor, or on an individual basis. The policy
prohibits retention of the independent public accountants to perform the prohibited non-audit functions defined in Section
201 of the Sarbanes-Oxley Act or the rules of the Securities and Exchange Committee, and also requires the Audit
Committee to consider whether proposed services are compatible with the independence of the public accountants.

ITEM 16D. EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES

Not applicable.

ITEM 16E. PURCHASE OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS

Issuer Purchase of Equity Securities

Neither we, nor any “affiliated purchaser” of our company, has purchased any of our securities during 2017.

ITEM 16F. CHANGES IN REGISTRANT’S CERTIFYING ACCOUNTANT

None.

ITEM 16G.CORPORATE GOVERNANCE

Under NASDAQ Stock Market Rule 5615(a) (3), foreign private issuers, such as our company, are permitted to follow
certain home country corporate governance practices instead of certain provisions of the NASDAQ Stock Market Rules. A
foreign private issuer that elects to follow a home country practice instead of any of such NASDAQ rules must submit to
NASDAQ, in advance, a written statement from an independent counsel in such issuer’s home country certifying that the
issuer’s practices are not prohibited by the home country’s laws.

We have notified NASDAQ pursuant to Rule 5615(a) (3), that we do not comply with the following Rules and instead
follow Israeli law and practice in respect of such Rules:

● The Rule requiring maintaining a majority of independent directors, as defined under the NASDAQ
Marketplace Rules. Instead, under Israeli law and practice, we are required to appoint at least two external
directors, within the meaning of the Israeli Companies Law, to our board of directors. In addition, in
accordance with the rules of the SEC and NASDAQ, we have the mandated three independent directors, as
defined by the rules of the SEC and NASDAQ, on our audit committee. See above in Item 6C. “Directors,
Senior Management and Employees - Board Practices Outside and Independent Directors.”

● The Rule requiring that our independent directors have regularly scheduled meetings at which only
independent directors are present: instead, we follow Israeli law according to which independent directors
are not required to hold executive sessions.

● The Rule regarding independent director oversight of director nominations process for directors. Instead, we
follow Israeli law and practice according to which our board of directors recommends directors for election
by our shareholders. See above Item 6C. “Directors, Senior Management and Employees - Board Practices -
Election of Directors.”

● The requirements regarding the directors’ nominations process. Instead, we follow Israeli law and practice in
accordance with which our directors are recommended by our board of directors for election by our
shareholders. See Item 6C “Directors, Senior Management and Employees - Board Practices - Election of
Directors.”

● The requirement to obtain shareholder approval for the establishment or amendment of certain equity based
compensation plans, an issuance that will result in a change of control of the company, certain transactions
other than a public offering involving issuances of a 20% or more interest in the company and certain
acquisitions of the stock or assets of another company. Under Israeli law and practice, the approval of the
board of directors is required for the establishment or amendment of equity based compensation plans and
private placements. Under Israeli regulations, Israeli companies whose shares have been publicly offered
only outside of Israel or are listed for trade only on an exchange outside of Israel, such as our company, are
exempt from the Israeli law requirement to obtain shareholder approval for private placements of a 20% or
more interest in the company. For the approvals and procedures required under Israeli law and practice for an
issuance that will result in a change of control of the company and acquisitions of the stock or assets of
another company, see Item 6C “Directors, Senior Management and Employee - Board Practices - Approval
of Related Party Transactions Under Israeli Law - Disclosure of Personal Interests of a Controlling
Shareholder; Approval of Transactions with Controlling Shareholders” and Item 10B “Additional
Information - Memorandum and Articles of Association - Provisions Restricting Change in Control of Our
Company.”

● Shareholder Approval. We seek shareholder approval for all corporate action requiring such approval in
accordance with the requirements of the Israeli Companies Law rather than under the requirements of the
NASDAQ Listing Rules, including (but not limited to) the appointment or termination of auditors,
appointment and dismissal of directors, approval of interested party acts and transactions requiring general
meeting approval as discussed above and a merger.

● Shareholder Approval. We seek shareholder approval for all corporate action requiring such approval in
accordance with the requirements of the Israeli Companies Law rather than under the requirements of the
NASDAQ Listing Rules, including (but not limited to) the appointment or termination of auditors,
appointment and dismissal of directors, approval of interested party acts, adoption of Stock Option Plans and
any amendment thereto, and transactions requiring general meeting approval as discussed above and a
merger.

ITEM 16H. MINE SAFETY DISCLOSURE

Not applicable.

PART III

ITEM 17. FINANCIAL STATEMENTS

Not applicable.

ITEM 18. FINANCIAL STATEMENTS

Consolidated Financial Statements

Index to Financial Statements
Report of Independent Registered Public Accounting Firm
Consolidated Balance Sheets
Consolidated Statements of Operations
Consolidated Statements of Other Comprehensive Income (loss)
Consolidated Statements of Changes in Shareholders’ Equity
Consolidated Statements of Cash Flows
Notes to Consolidated Financial Statements

ITEM 19. EXHIBITS

Index to Exhibits

Exhibit Description

F-1
F-2
F-3
F-5
F-6
F-7
F-8
F-10

1.1

1.2

2.1

4.1

4.2

4.3

4.4

4.5

4.6

4.7

4.8

4.9

Memorandum of Association of the Registrant (1)

Articles of Association of the Registrant(2)

Specimen of Share Certificate(3)

Compensation Policy of Office Holders (August 31, 2016) (4)

Purchase Agreement between the Registrant and DBSI Investments Ltd., dated April 14, 2016 (5)

Registration Rights Agreement between the Registrant and DBSI Investments Ltd., dated April 14, 2016 (6)

Convertible Loan Agreement between the Registrant and DBSI Investments Ltd., dated April 14, 2016 (7)

First Amendment to Convertible Loan Agreement between the Registrant and DBSI, dated May 15, 2016 (8)

Warrant to Purchase Ordinary Shares of the Registrant granted to DBSI, dated April 14, 2016 (up to
20,105,282 ordinary shares) (9)

Warrant to Purchase Ordinary Shares of the Registrant granted to DBSI, dated April 14, 2016 (up to
7,272,727 ordinary shares) (10)

Warrant to Purchase Ordinary Shares of the Registrant granted to Legos Advisors Ltd and Avi Gefen dated
April 14, 2016 (11)

Share Purchase Agreement between RADA and The Phoenix Insurance Company dated November 9, 2016
(12)

4.10

Form of Indemnification Agreement of the Registrant with its officers and directors (13)

4.11

Ordinary Shares Purchase Form (August 2017) (14)

4.12

2015 Share Option Plan (15)

8.1

List of Subsidiaries of the Registrant

12.1

12.2

Certification of the Chief Executive Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act,
as amended

Certification of the Chief Financial Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act, as
amended

13.1

13.2

Certification of the Chief Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002

Certification of the Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002

15.1

Consent of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global

101.INS

XBRL Instance Document

101.SCH

XBRL Taxonomy Extension Schema Document.

101.CAL

XBRL Taxonomy Calculation Linkbase Document.

101.LAB

XBRL Taxonomy Label Linkbase Document.

101.PRE

XBRL Taxonomy Presentation Linkbase Document.

101.DEF

XBRL Taxonomy Extension Definition Linkbase Document.

(1)

(2)

(3)

(4)

(5)

(6)

(7)

(8)

(9)

Filed as an exhibit to our Annual Report on Form 20-F for the year ended December 31, 2000 and incorporated
herein by reference.

Filed as Annex A to our Proxy Statement on Form 6-K furnished on April 4, 2016 and incorporated herein by
reference.

Filed as Exhibit 2.1 to our Annual Report on Form 20-F for the year ended December 31, 2016 and incorporated
herein by reference.

Filed as Exhibit A to Exhibit 99.1 to our Proxy Statement on Form 6-K furnished on July 27, 2016 and
incorporated herein by reference.

Filed as Exhibit 4.4 to our Annual Report on Form 20-F for the year ended December 31, 2015 and incorporated
herein by reference.

Filed as Exhibit 4.5 to our Annual Report on Form 20-F for the year ended December 31, 2015 and incorporated
herein by reference.

Filed as Exhibit 4.6 to our Annual Report on Form 20-F for the year ended December 31, 2015 and incorporated
herein by reference.

Filed as Exhibit 4.7 to our Annual Report on Form 20-F for the year ended December 31, 2015 and incorporated
herein by reference.

Filed as Exhibit 4.8 to our Annual Report on Form 20-F for the year ended December 31, 2015 and incorporated
herein by reference.

(10)

Filed as Exhibit 4.8 to our report on Form 6-K furnished on June 9, 2016 and incorporated herein by reference.

(11)

(12)

(13)

(14)

(15)

Filed as Exhibit 4.8 to our Annual Report on Form 20-F for the year ended December 31, 2016 and incorporated
herein by reference.

Filed as Exhibit 10.1 to our Report on Form 6-K furnished on November 10, 2016 and incorporated herein by
reference.

Filed as an Annex B to our Proxy Statement on Form 6-K furnished on April 4, 2016 and incorporated herein by
reference.

Filed as Exhibit 99.1 to our Report on Form 6-K furnished on August 21, 2017 and incorporated herein by
reference.

Filed as Exhibit 4.3 to Registration Statement on Form S-8 filed on August 24, 2016 and incorporated herein by
reference.

RADA ELECTRONIC INDUSTRIES LTD. AND ITS SUBSIDIARIES

CONSOLIDATED FINANCIAL STATEMENTS

AS OF DECEMBER 31, 2017

U.S. DOLLARS IN THOUSANDS

INDEX

Report of Independent Registered Public Accounting Firm

Consolidated Balance Sheets

Consolidated Statements of Operations

Consolidated Statements of Comprehensive Income (Loss)

Consolidated Statements of Changes in Equity

Consolidated Statements of Cash Flows

Notes to Consolidated Financial Statements

- - - - - - - - - - - - - - -

F-1

Page

F-2

F-3 – F-4

F-5

F-6

F-7

F-8 – F-9

F-10 – F-37

Kost Forer Gabbay & Kasierer
144 Menachem Begin Road,
Building A
Tel-Aviv 6492102, Israel

Tel: +972-3-6232525
Fax: +972-3-5622555
ey.com

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Shareholders and Board of Directors of RADA ELECTRONIC INDUSTRIES LTD.

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of RADA Electronic Industries Ltd. and
subsidiaries (the “Company”) as of December 31, 2017 and 2016 and the related consolidated statements of operations,
comprehensive income (loss), changes in equity and cash flows for each of the three years in the period ended December
31, 2017, and the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the
consolidated financial statements present fairly, in all material respects, the financial position of the Company at
December 31, 2017 and 2016, and the results of its operations and its cash flows for each of the three years in the period
ended December 31, 2017, in conformity with U.S. generally accepted accounting principles.

Basis for Opinion

These financial statements are the responsibility of the Company’s management. Our responsibility is to express
an opinion on the Company’s consolidated financial statements based on our audits. We are a public accounting firm
registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be
independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and
regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan
and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of
material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to
perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an
understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the
effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the financial
statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included
examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also
included evaluating the accounting principles used and significant estimates made by management, as well as evaluating
the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

/s/ Kost Forer Gabbay and Kasierer,
A Member of Ernst & Young Global

We have served as the Company’s auditor since 2003.

Tel-Aviv, Israel
March 28, 2018

F-2

CONSOLIDATED BALANCE SHEETS
U.S. dollars in thousands

ASSETS

CURRENT ASSETS:

RADA ELECTRONIC INDUSTRIES LTD.
AND ITS SUBSIDIARIES

December 31,

2017

2016

Cash and cash equivalents
Restricted deposits
Trade receivables (net of allowance for doubtful accounts of $14 at December 31,
2017 and 2016)
Costs and estimated earnings in excess of billings on uncompleted contracts (Note 3)
Other accounts receivable and prepaid expenses (Note 4)
Inventories, net (Note 5)
Current assets related to discontinued operations

12,417
322

7,286
995
330
7,910
2,468

1,205
317

5,006
1,096
349
7,102
2,254

Total current assets

31,728

17,329

LONG-TERM ASSETS:
Long-term receivables and other deposits (Note 6)

Property, plant and equipment, net (Note 7)

Long-term assets related to discontinued operations

Total long-term assets

Total assets

3,915

319

4,302

742

2,650

266

3,658

36,030

20,987

The accompanying notes are an integral part of the consolidated financial statements.

F-3

CONSOLIDATED BALANCE SHEETS
U.S. dollars in thousands, except share and per share data

RADA ELECTRONIC INDUSTRIES LTD.
AND ITS SUBSIDIARIES

LIABILITIES AND EQUITY

CURRENT LIABILITIES:
Bank credit (Note 8)
Trade payables
Other accounts payable and accrued expenses (Note 9)
Advances from customers, net
Current liabilities related to discontinued operations

Total current liabilities

LONG-TERM LIABILITIES:

Convertible loan from shareholders, net (Note 8)
Accrued severance pay and other long term liability

Total long-term liabilities

COMMITMENTS AND CONTINGENT LIABILITIES (Note 10)

EQUITY:

Share capital (Note 11) -

Ordinary shares of NIS 0.03 par value - Authorized: 37,500,000 at December 31,
2017 and at December 31, 2016; Issued and outstanding: 31,392,040 and
21,246,502 at December 31, 2017 and at December 31, 2016 respectively.

Additional paid-in capital
Accumulated other comprehensive income
Accumulated deficit

Total RADA Electronic Industries shareholders’ equity
Non-controlling interest

Total equity

Total liabilities and equity

The accompanying notes are an integral part of the consolidated financial statements.

F-4

December 31,

2017

2016

-
2,904
2,814
41
328

6,087

-
758

758

575
2,557
1,987
839
265

6,223

3,072
663

3,735

335
104,923
392
(77,124)

28,526
659

250
89,407
222
(79,363)

10,516
513

29,185

11,029

36,030

20,987

CONSOLIDATED STATEMENTS OF OPERATIONS
U.S. dollars in thousands, except share and per share data

Revenues:
Products
Services

Cost of revenues:

Products
Services

Gross profit
Operating costs and expenses:

Research and development, net
Marketing and selling
General and administrative
Goodwill impairment

Total operating costs and expenses

Operating income (loss)

Financial expenses, net (Note 13)

Net income (loss) from continuing operations

Net income (loss) from discontinued operations

Net income (loss)
Net income (loss) attributable to non-controlling interest
Net income (loss) attributable to RADA Electronic Industries’
shareholders

Basic net income (loss) from continuing operations per Ordinary share
Diluted net income (loss) from continuing operations per Ordinary
share
Basic and diluted net income from discontinued operations per
Ordinary share
Basic net income(loss) per Ordinary share
Diluted net income (loss) per Ordinary share
Weighted average number of Ordinary shares used for computing
basic net income (loss) per share
Weighted average number of Ordinary shares used for computing
diluted net income (loss) per share

RADA ELECTRONIC INDUSTRIES LTD.
AND ITS SUBSIDIARIES

Year ended December 31,
2016

2015

2017

$
$
$

25,010
1,172
26,182

17,807
112
17,919
8,263

1,575
2,137
2,568
-

6,280

1,983

156

1,827

515

2,342
103

2,239

0.07

0.06

0.02
0.09
0.08

$
$
$

11,663
1,158
12,821

10,594
785
11,379
1,442

758
2,269
1,814
-

4,841

12,375
1,699
14,074

11,139
526
11,665
2,409

693
2,357
1,513
587

5,150

(3,399)

(2,741)

1,521

3,577

(4,920)

(6,318)

(4,907)
3

(4,910)

(0.35)

0.00
(0.35)
(0.35)

$
$
$

(179)

(6,497)
(36)

(6,461)

(0.53)

(0.00)
(0.53)
(0.53)

24,956,915

14,029,346

11,904,088

28,126,509

14,029,346

11,904,088

The accompanying notes are an integral part of the consolidated financial statements.

F-5

RADA ELECTRONIC INDUSTRIES LTD.
AND ITS SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
U.S. dollars in thousands

Year ended December 31,
2016

2015

2017

Net income (loss)

2,342

(4,907)

(6,497)

Other Comprehensive Income (loss):
Change in foreign currency translation adjustment

Total comprehensive income (loss)
Less: comprehensive income (loss) attributable to non-controlling
interest
Comprehensive income (loss) attributable to RADA Electronic
Industries’ shareholders

213

2,555

146

(207)

(186)

(5,114)

(6,683)

(39)

(73)

2,409

(5,075)

(6,610)

The accompanying notes are an integral part of the consolidated financial statements.

F-6

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY
U.S. dollars in thousands, except share data

RADA ELECTRONIC INDUSTRIES LTD.
AND ITS SUBSIDIARIES

Number of
Ordinary Share
shares (*) capital
4,494,160 $ 119 $

Additional
paid-in
capital

70,884 $

Accumulated
other

Non

comprehensive Accumulated controlling Total
equity
625 $ 4,172

(67,992) $

interest

income

deficit

536 $

3,455,284

7,403

7,430

-
-

4,140
-

-
-
(149)

-
(6,461)
-

-
(36)
(37)

4,140
(6,497)
(186)

Balance at January 1, 2015

Issuance of Ordinary shares,
net of issuance costs of
$1,070
Beneficial conversion feature
related to convertible loans
from shareholders (Note 8)
Net loss
Other comprehensive loss

Balance at December 31, 2015

7,949,444 $ 146 $

82,427 $

387 $

(74,453) $

552 $ 9,059

Beneficial conversion feature
related to convertible loans
from shareholders (Note 8)
Extinguishment of
convertible loan
Share-based compensation to
employees
Issuance of shares and
warrants, net of issuance
costs of $204
Exercise of warrants and
conversion of convertible
loan to Ordinary shares
Net income (loss)
Other comprehensive loss

123

(359)

111

10,415,400

5,714

123

(359)

111

5,796

2,881,658
-
-

22
-
-

1,391
-
-

-
-
(165)

-
(4,910)
-

-
3
(42)

1,413
(4,907)
(207)

Balance at December 31, 2016

21,246,502

250

89,407

222

(79,363)

513

11,029

Share-based compensation to
employees
Exercise of warrants
Conversion of convertible
loan to Ordinary shares
Issuance of shares, net of
issuance costs of $174
Net income
Other comprehensive income
Balance at December 31, 2017

-
4,218,121

1,322,917

4,604,500
-
-

-
36

38
-
-

559
2,105

3,164

9,688
-
-

31,392,040 $ 335 $ 104,923 $

(*) See Note 11a.

-
-

-
-
170
392 $

-
2,239
-

(77,124) $

-
-

559
2,141

3,175

9,726
-
2,342
103
213
43
659 $29,185

The accompanying notes are an integral part of the consolidated financial statements.

F-7

CONSOLIDATED STATEMENTS OF CASH FLOWS
U.S. dollars in thousands

Cash flows from operating activities:

Net income (loss)
Adjustments required to reconcile net income (loss) to net cash
provided by (used in) operating activities:
Share based compensation to employees
Depreciation and amortization
Impairment of goodwill
Extinguishment and amortization expenses related to beneficial
conversion feature and discount of convertible loans
Severance pay, net
Increase in trade receivables, net
Decrease (increase) in other accounts receivable and prepaid
expenses
Decrease in costs and estimated earnings in excess of billings
Increase in inventories
Increase in trade payables
Increase (decrease) in other accounts payable, accrued expenses
and advances from customers, net

RADA ELECTRONIC INDUSTRIES LTD.
AND ITS SUBSIDIARIES

Year ended December 31,
2016

2015

2017

2,342

(4,907)

(6,497)

559
638
-

103
93
(2,280)

14
809
(890)
303

111
554
-

1,116
37
(1,360)

(135)
403
(1,503)
592

-
548
587

2,684
53
(607)

81
1,467
(499)
602

173

(1,437)

Net cash provided by (used in) operating activities from continuing
operations

1,722

(4,919)

(3,018)

Cash flows from investing activities:

Purchase of property, plant and equipment
Construction-in-process
Decrease (increase) in deposits, net
Change in restricted deposits, net

(1,041)
(736)
(29)
(5)

(411)
-
11
356

(366)
-
(10)
6

Net cash provided by (used in) investing activities from continuing
operations

(1,811)

(44)

(370)

F-8

CONSOLIDATED STATEMENTS OF CASH FLOWS
U.S. dollars in thousands

Cash flows from financing activities:

Issuance of Ordinary shares, net
Exercise of warrants
Proceeds from (repayment of) short-term bank credit, net
Proceeds from (repayment of) loans from shareholders, net

RADA ELECTRONIC INDUSTRIES LTD.
AND ITS SUBSIDIARIES

Year ended December 31,
2016

2015

2017

9,726
2,141
(575)
-

5,796
1,300
(1,841)
187

7,430
-
827
(5,030)

Net cash provided by financing activities from continuing operations

11,292

5,442

3,227

Net cash provided by (used in) operating activities from discontinued
operations
Net cash used in investing activities from discontinued operations

(644)
(101)

298
(34)

Effect of exchange rate changes of discontinued operation on cash and
cash equivalents

(138)

(133)

Increase (decrease) in cash and cash equivalents
Cash and cash equivalents at the beginning of the year

Cash and cash equivalents at the end of the year
Less cash and cash equivalents of discontinued operation at the end of
the year

10,320
2,364

12,684

267

610
1,754

2,364

1,159

253
(8)

(116)

(32)
1,786

1,754

1,020

(b)

Supplemental disclosures of cash flow activities:

Net cash paid during the year for:

Income taxes

Interest

Conversion of convertible loan including unpaid interest
Transfer of inventory to property, plant and equipment
Purchase of property, plant and equipment in credit

12,417

1,205

734

Year ended December 31,
2016

2015

2017

$
$
$

173

3,175
82
44

$
$
$

658

113
92
14

$
$
$

2,106

-
573
62

The accompanying notes are an integral part of the consolidated financial statements.

F-9

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 1:- GENERAL

RADA ELECTRONIC INDUSTRIES LTD.
AND ITS SUBSIDIARIES

RADA Electronic Industries Ltd. (the “Company”) is an Israeli based defense electronics contractor
that specialize in the development, manufacture and sale of data recording and management systems
(such as digital video and data recorders, ground debriefing stations, head-up display cameras),
inertial navigation systems for air and land applications, avionics solutions (such as aircraft upgrades,
avionics for unmanned aircraft vehicles (“UAVs”), store management systems and interface
computers) and land radar for defense forces and border protection applications (active protective
systems for armored fighting vehicles, hostile fire detection and perimeter surveillance). The
Company also provides test and repair services using its CATS testers and test program sets for
commercial aviation electronic systems mainly through its Chinese subsidiary.

The Company operates a test and repair shop using its Automated Test Equipment (“ATE”) products
in Beijing, China, through its 80% owned Chinese subsidiary, Beijing Huari Aircraft Components
Maintenance and Services Co. Ltd. (“CACS” or the “subsidiary”). CACS was established with a
Chinese third party, which owns the remaining 20% equity interest (see Note 1b).

The Company is organized and operates as one operating segment.

Discontinued operations

In December 2016, the Company committed to a plan to sell its test and repair services activity
(provided through the Company’s 80% owned subsidiary, CACS) in order to focus in its core
business. As of December 2017, the Company’s management believes that the selling transaction
will be completed by June 30, 2018.

The results of the discontinued operations including prior periods’ comparable results, assets and
liabilities which have been retroactively included in discontinued operations as separate line items in
the statements of operations and balance sheets, are presented below:

Year ended
December 31,
2016

2015

2017

1,729
(909)
(310)
510
5

515

909
(698)
(197)
14
(1)

790
(626)
(347)
(183)
4

(179)

Revenues
Cost of sales
Operating expenses
Operating income (loss)
Finance income (expenses), net

Net income (loss)

F-10

RADA ELECTRONIC INDUSTRIES LTD.
AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 1:- GENERAL (Cont.)

The major classes of assets and liabilities that were classified as discontinued operations were:

Year ended December 31,

2017

2016

Cash and cash equivalents
Trade receivables
Other accounts receivable and prepaid expenses
Inventories
Property, plant and equipment, net

Total assets of discontinued operations

Trade payables
Accrued expenses and other liabilities

267
1,200
61
940
319

2,787

4
324

Total liabilities of discontinued operations

328

Liquidity and Capital Resources:

1,159
244
6
845
266

2,520

54
211

265

On May 15, 2016, the Company’s shareholders approved an investment transaction with a new
investor (the “Investor”) after which the Investor became the controlling shareholder of the
Company. The Company issued 8,510,638 Ordinary shares in consideration for approximately
$4,000, or a price per share of $0.47 (the “Initial Investment”). The Company also issued to the
Investor, warrants to purchase: (i) 4,255,319 Ordinary shares at an exercise price per Ordinary share
of $0.47 (having an aggregate exercise price of $2,000) exercisable for a period of 24 months
following the date of the Initial Investment and (ii) 3,636,363 Ordinary shares at an exercise price
per Ordinary share of $0.55 (having an aggregate exercise price of $2,000) exercisable for a period
of 48 months following the date of the Initial Investment (collectively: the “Warrants”).

In addition, as part of the investment transaction, the Investor agreed to grant the Company an
option, exercisable in the discretion of either the Investor or the Company, to obtain a convertible
loan from the Investor in the principal amount of up to $3,175, which may be used solely for the
purpose of the repayment of the outstanding convertible loan and accrued interest to its former
controlling shareholder due on August 31, 2016.

On June 16, 2016, the Company obtained a $3,175 convertible loan from the Investor (convertible
into Ordinary Shares at a price per share of $2.40) and repaid the outstanding loan balance owed to
its former controlling shareholder in the amount of $2,988, including accrued interest of $247.

F-11

RADA ELECTRONIC INDUSTRIES LTD.
AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 1:- GENERAL (Cont.)

During the years ended December 31, 2016 and 2015, the Company had recurring losses and
negative cash flow from operating activity. Since incorporation, the Company incurred an
accumulated deficit of $77,124. As of December 31, 2017, the Company’s cash position (cash and
cash equivalents) totaled approximately $12,417 (excluding cash and cash equivalents attributable to
the discontinued operations). In addition, for the year ended December 31, 2017 the company had
positive cash flow from operating activity. Management believes that its cash and cash equivalents
are sufficient for the Company to meet its obligations as they come due at least for a period of twelve
months from the date of issuance of the consolidated financial statements.

NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES

The consolidated financial statements have been prepared in accordance with accounting principles
generally accepted in the United States (“US GAAP”). The significant accounting policies followed in the
preparation of the financial statements, applied on a consistent basis, are as follows:

Use of estimates:

The preparation of financial statements in conformity with (“US GAAP”) requires management to
make estimates and assumptions that affect the amounts reported in the financial statements and
accompanying notes. Actual results could differ from those estimates.

The Company’s management believes that the estimates, judgment and assumptions used are
reasonable based upon information available at the time they were made.

Financial statements in U.S. dollars:

The majority of the revenues of the Company are generated in U.S. dollars. In addition, Financing
activities are made in U.S. dollars.

The Company’s management believes that the dollar is the currency of the primary economic
environment in which the Company operates. Thus, its functional and reporting currency is the
dollar.

Accordingly, monetary accounts maintained in currencies other than the dollar are re-measured into
U.S. dollars in accordance with ASC 830, “Foreign Currency Matters”. All transaction gains and
losses of the re-measured monetary balance sheet items are reflected in the statement of operations as
financial income or expenses, as appropriate, in the period in which the currency exchange rate
changes.

F-12

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES (Cont.)

RADA ELECTRONIC INDUSTRIES LTD.
AND ITS SUBSIDIARIES

The financial statements of the Company’s foreign subsidiary, whose functional currency is not the
U.S. dollar, have been translated into dollars. All balance sheet amounts have been translated using
the exchange rates in effect at balance sheet date. Statement of operation amounts have been
translated using the average exchange rate prevailing during the year. Such translation adjustments
are reported as a separate component of accumulated other comprehensive income (loss) in equity.

Basis of consolidation:

The consolidated financial statements include the accounts of the Company and its subsidiary. Inter-
company transactions and balances have been eliminated upon consolidation.

Cash equivalents:

All highly liquid investments that are readily convertible to cash and are not restricted as to
withdrawal or use and the period to maturity of which did not exceed three months at time of deposit,
are considered cash equivalents.

Restricted deposit:

Restricted cash is invested in short-term bank deposits (less than twelve months), which are mainly
used as security for the Company’s guarantees to customers and lines of credits with banks. The
deposits are in U.S. dollars and bear a variable interest of up to 1.32%.

Inventories:

Inventories are stated at the lower of cost or market value. Inventory write-offs are provided to cover
risks arising from slow-moving items, excess inventories and for market prices lower than cost (see
also Note 5).

Cost is determined as follows:

Raw materials and components - using the FIFO cost method.

Work in progress and finished goods - represents the cost of manufacturing with the addition of
allocable indirect manufacturing costs.

Costs incurred on long-term contracts in progress include direct labor, material, subcontractors, other
direct costs and an allocation of overhead, which represent recoverable costs incurred for production.

F-13

RADA ELECTRONIC INDUSTRIES LTD.
AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES (Cont.)

Property, plant and equipment:

Property plant and equipment are stated at cost, net of accumulated depreciation. Depreciation is
calculated by the straight-line method over the estimated useful lives of the assets. Annual rates of
depreciation are as follows:

Factory and other buildings
Machinery and equipment
Office furniture and equipment

4
7 - 33
6 - 15

Leasehold improvements are depreciated over the shorter of the estimated useful life or the lease
period.

Assets, in respect of which investment grants have been received, are presented at cost less the
related grant amount. Depreciation is based on net cost.

Impairment of long-lived assets:

The Company’s long-lived assets are reviewed for impairment in accordance with ASC 360,
“Property, plant and equipment”, whenever events or changes in circumstances indicate that the
carrying amount of the assets may not be recoverable.

Recoverability of assets to be held and used is measured by a comparison of the carrying amount of
the assets to the future undiscounted cash flows expected to be generated by the assets. If such assets
are considered to be impaired, the impairment to be recognized is measured by the amount by which
the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are
reported at the lower of the carrying amount or fair value less costs to sell. As of December 31, 2017,
2016 and 2015, no impairment losses have been identified.

As required by ASC 820, “Fair Value Measurement”, the Company applies assumptions that market
place participations would consider in determines the fair value of long-lived assets (or asset group).

Research and development costs:

Research and development costs, net of participation grants, include costs incurred for research and
development, are charged to the statement of operations as incurred.

The Company received royalty-bearing grants, from the Israeli Innovation Authority (“IIA”) for the
purpose of partially funding research and development projects. The grants are recognized as a
deduction from research and development costs incurred (see also Note 10b).

F-14

RADA ELECTRONIC INDUSTRIES LTD.
AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES (Cont.)

Income taxes:

The Company accounts for income taxes in accordance with ASC 740, “Income taxes”. This
statement prescribes the use of the liability method whereby deferred tax assets and liability account
balances are determined based on differences between financial reporting and tax based assets and
liabilities and are measured using the enacted tax rates and laws that will be in effect when the
differences are expected to reverse.

The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to their
estimated realizable value.

The Company implements a two-step approach to recognizing and measuring uncertain tax positions
accounted for in accordance with ASC 740. The first step is to evaluate the tax position taken or
expected to be taken in a tax return by determining if the weight of available evidence indicates that
it is more likely than not that, on an evaluation of the technical merits, the tax position will be
sustained on audit, including resolution of any related appeals or litigation processes. The second
step is to measure the tax benefit as the largest amount that is more than 50% likely to be realized
upon ultimate settlement. The adoption of ASC 740-10 did not result in a change in the Company’s
accumulated deficit. The Company did not record any provision in connection with ASC 740-10 as
of December 31, 2017 and 2016.

Severance pay:

The Company’s agreements with most of its employees are in accordance with section 14 of the
Severance Pay Law - 1963, under which the Company’s contributions for severance pay shall be
instead of severance compensation. Upon release of the policy to the employee, no additional
liability exists between the parties regarding the matter of severance pay and no additional payments
will be made by the Company to the employee.

The Company’s liability for severance pay for the employees that are not covered in section 14 is
calculated pursuant to Israel’s Severance Pay Law - 1963, based on the most recent salary of the
employees as of the balance sheet date less monthly deposits for insurance policies and/or pension
funds. Employees are entitled to one month’s salary for each year of employment or a portion
thereof.

The carrying value of deposited funds includes profits (losses) accumulated up to the balance sheet
date. The deposited funds may be withdrawn only upon the fulfillment of the obligations pursuant to
Israeli severance pay law or labor agreements.

Severance expense recorded in the statement of operations is net of interest and other income
accumulated in the deposits. Severance expense for the years ended December 31, 2017, 2016 and
2015 amounted to $434, $251 and $553, respectively.

F-15

RADA ELECTRONIC INDUSTRIES LTD.
AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES (Cont.)

Accounting for share-based compensation:

The Company accounts for share-based payment in accordance with ASC 718, “Compensation -
Stock Compensation”, which requires the measurement and recognition of compensation expense
based on estimated fair values for all share-based payment awards made to employees on the date of
grant using an option-pricing model. The value of the portion of the award that is ultimately expected
to vest is recognized as an expense over the requisite service periods in the Company’s statement of
operations. The Company recognizes compensation expenses for the value of its awards granted
based on the straight-line method over the requisite service period of each of the awards.

The fair value for the Company’s stock options granted to employees and directors was estimated
using a Black-Scholes option-pricing model with the following weighted-average assumptions:

Dividend yield
Risk-free interest rate
Expected term (in years)
Volatility

December 31,

2017

2016

0%
1.78%
4.18

79%

0%
1.19%
4.5
80%

The dividend yield assumption is based on the Company’s historical experience and expectation of
future dividend payouts and may be subject to changes in the future.

The computation of expected volatility is based on realized historical share price volatility of the
Company’s Ordinary shares.

The risk-free interest rate assumption is the implied yield currently available on the U.S treasury
yield zero-coupon issues with a remaining term equal to the expected life term of the Company’s
options.

The expected term of the options represents the period of time that the options are expected to be
outstanding and is based on the simplified method, as allowed under Staff Accounting Bulletin No.
110, which is the mid-point between the vesting date and the end of the contractual of the option.

Fair value of financial instruments:

The Company measures its financial instruments at fair value. Fair value is an exit price,
representing the amount that would be received to sell an asset or paid to transfer a liability in an
orderly transaction between market participants. As such, fair value is a market-based measurement
that should be determined based on assumptions that market participants would use in pricing an
asset or a liability.

F-16

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES (Cont.)

RADA ELECTRONIC INDUSTRIES LTD.
AND ITS SUBSIDIARIES

A three-tier fair value hierarchy is established as a basis for considering such assumptions and for
inputs used in the valuation methodologies in measuring fair value:

Level 1 -

Valuations based on quoted prices in active markets for identical assets that the
Company has the ability to access. Valuation adjustments and block discounts are not
applied to Level 1 instruments. Since valuations are based on quoted prices that are
readily and regularly available in an active market, valuation of these products does not
entail a significant degree of judgment.

Level 2 -

Valuations based on one or more quoted prices in markets that are not active or for
which all significant inputs are observable, either directly or indirectly.

Level 3 -

Valuations based on inputs that are unobservable and significant to the overall fair
value measurement.

The availability of observable inputs can vary from investment to investment and is affected by a
wide variety of factors, including, for example, the type of investment, the liquidity of markets and
other characteristics particular to the transaction. To the extent that valuation is based on models or
inputs that are less observable or unobservable in the market, the determination of fair value requires
more judgment and the investments are categorized as Level 3.

The carrying amount of cash and cash equivalents, restricted deposits, trade receivables, other
accounts receivable, bank credit, trade payables and other accounts payable approximate their fair
value due to the short-term maturity of these instruments.

Foreign currency derivative contracts are classified within Level 2 as the valuation inputs are based
on quoted prices and market observable data of similar instruments. As of December 31, 2017 and
2016 the fair value of foreign currencies derivatives asset (liability) were 19 and (8), respectively.

Concentrations of credit risk:

Financial instruments that potentially subject the Company to concentrations of credit risk consist
principally of cash and cash equivalents, restricted cash, trade receivables and long-term receivables.

The Company’s cash and cash equivalents and restricted deposits are mainly held in U.S. dollars
with major banks in Israel. Management believes that the financial institutions that hold the
Company’s investments are institutions with high credit standing, and accordingly, minimal credit
risk exists with respect to these investments.

F-17

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES (Cont.)

RADA ELECTRONIC INDUSTRIES LTD.
AND ITS SUBSIDIARIES

The Company’s trade receivables are derived from sales to large and solid organizations located
mainly in the United States, Asia, Latin America and Israel. The Company performs ongoing credit
evaluations of its customers and to date has not experienced any material losses. An allowance for
doubtful accounts is determined with respect to these amounts that the Company has determined to
be doubtful of collection. The allowance is computed for specific debts and the collectability is
determined based upon the Company’s experience.

Comprehensive income (loss):

The Company accounts for comprehensive income in accordance with ASC 220, “Comprehensive
Income”. This statement establishes standards for the reporting and display of comprehensive
income and its components.

Comprehensive income generally represents all changes in shareholders’ equity during the period
except those resulting from investments by, or distributions to, shareholders. Accordingly, the
Company presents a separate consolidated statement of comprehensive income (loss).

The following table summarizes the changes in accumulated balances of other comprehensive
income, net of taxes for the years ended December 31, 2017 and 2016:

Balance as of December 31, 2015
Net current period other comprehensive loss

Balance as of December 31, 2016
Net current period other comprehensive income

Balance as of December 31, 2017

Warranty:

Accumulated
foreign currency
translation
differences

387
(165)

222
170

392

In connection with the sale of its products, the Company provides product warranties for periods
between one to two years. Based on past experience and engineering estimates, the estimated
liability from these warranties is $35 as of December 31, 2017 and 2016.

Revenue recognition:

The Company generates revenues mainly from the sale of products and from long-term fixed price
contracts of defense electronics as follows: data recording and management systems, inertial
navigation systems for air and land applications, avionics solutions, and avionics for UAVs, and land
radar for defense forces and border protection applications.

F-18

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES (Cont.)

RADA ELECTRONIC INDUSTRIES LTD.
AND ITS SUBSIDIARIES

In addition, the Company provides manufacturing, development and product support services.

The Company also generates revenues from repair services using its ATE mainly through CACS
(See Note 1b).

Product revenues:

The Company recognizes revenue from sales of products in accordance with ASC 605-10, “Revenue
Recognition” (Formerly “Staff Accounting Bulletin (“SAB”) No. 104”).

Product revenue is recognized when there is persuasive evidence of an arrangement, the fee is fixed
or determinable, delivery of the product to the customer has occurred and the Company has
determined that collection of the fee is probable. If the product requires specific customer
acceptance, revenue is deferred until customer acceptance occurs or the acceptance provisions lapse,
unless the Company can objectively and reliably demonstrate that the criteria specified in the
acceptance provisions are satisfied.

Revenues from long-term fixed price contracts which provide a substantial level of development
efforts are recognized in accordance with ASC 605-35, “Construction-Type and Production-Type
contracts”, using contract accounting on a percentage of completion method in accordance with the
“Input Method”. The percentage of completion is determined based on the ratio of actual costs
incurred to total costs estimated to be incurred over the duration of the contract. With regard to
contracts for which a loss is anticipated, a provision is made for the entire amount of the estimated
loss at the time such loss becomes evident. As of December 31, 2017 and 2016, the provision for
estimated losses identified is $0.

Revenues from long-term fixed-price contracts that involve both development and production are
recorded using the cost-to-cost method (development phase) and units-of-delivery method
(production phase) as applicable to each phase of the contract, as the basis to measure progress
toward completion.

Estimated gross profit or loss from long-term contracts may change due to changes in estimates
resulting from differences between actual performance and original forecasts. Such changes in
estimated gross profit or loss are recorded in results of operations when they are reasonably
determinable by management, on a cumulative catch-up basis.

The Company believes that the use of the percentage of completion method is appropriate as the
Company has the ability to make reasonably dependable estimates of the extent of progress towards
completion, contract revenues and contract costs. In addition, contracts executed include provisions
that clearly specify the enforceable rights regarding services to be provided and received by the
parties to the contracts, the consideration to be exchanged and the manner and terms of settlement.

F-19

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES (Cont.)

RADA ELECTRONIC INDUSTRIES LTD.
AND ITS SUBSIDIARIES

In all cases, the Company expects to perform its contractual obligations and its customers are
expected to satisfy their obligations under the contract.

Service revenues:

Revenues from services are recognized as the services are performed.

Basic and diluted net income (loss) per share:

Basic net income (loss) per share is computed based on the weighted average number of Ordinary
shares outstanding during each year. Diluted net income (loss) per share is computed based on the
weighted average number of Ordinary shares outstanding during each year, plus dilutive potential
Ordinary shares considered outstanding during the year in accordance with ASC 260, “Earnings per
share”.

For the years ended December 31, 2016 and 2015, all options, convertible notes and warrants have
been excluded from the computation of diluted net income (loss) per share, since their effect is anti-
dilutive.

Derivatives and hedging:

The Company accounts for derivatives and hedging based on ASC 815, “Derivatives and hedging”,
as amended and related Interpretations. ASC 815 requires the Company to recognize all derivatives
on the balance sheet at fair value. If a derivative meets the definition of a hedge and is so designated,
depending on the nature of the hedge, changes in the fair value of the derivative will either be offset
against the change in fair value of the hedged assets, liabilities, or firm commitments through
earnings (for fair value hedge transactions) or recognized in other comprehensive income (loss) until
the hedged item is recognized in earnings (for cash flow hedge transactions).

The ineffective portion of a derivative’s change in fair value is recognized in earnings. If a derivative
does not meet the definition of a hedge, the changes in the fair value are included in earnings. Cash
flows related to such hedges are classified as operating activities.

The Company enters into forward exchange contracts and option contracts in order to limit the
exposure to exchange rate fluctuation associated with payroll expenses mainly incurred in NIS. Since
the derivative instruments that the Company holds do not meet the definition of hedging instruments
under ASC 815, any gain or loss derived from such instruments is recognized immediately as
financial expenses, net.

As of December 31, 2017 and 2016, the fair value of the outstanding forward contracts was $19,
which was recorded in other receivables against financial income and $8, which was recorded in
other accruals against financial expenses, respectively.

F-20

RADA ELECTRONIC INDUSTRIES LTD.
AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES (Cont.)

Recently Issued Accounting Standards:

In May 2014, the FASB issued new standard related to revenue recognition, ASU No. 2014-09,
“Revenue from Contracts with Customers (Topic 606)” and related subsequent updates (collectively,
the “new revenue standard”). Under the new revenue standard, revenue is recognized when a
customer obtains control of promised goods or services and is recognized in an amount that reflects
the consideration which the entity expects to receive in exchange for those goods or services. In
addition, the new revenue standard requires disclosure of the nature, amount, timing, and uncertainty
of revenue and cash flows arising from contracts with customers. The new revenue standard permits
two transition methods: retrospectively to each prior reporting period presented (the “full
retrospective method”), or retrospectively with the cumulative effect of initially applying the new
revenue standard recognized at the date of initial application (the “modified retrospective method”).
The Company will adopt the new revenue standard effective January 1, 2018 using the modified
retrospective method applied to those contracts which were not substantially completed as of January
1, 2018.

The Company did not have any material cumulative-effect adjustment as a result of the adoption. In
addition, the adoption of ASU 2014-09 and the overall Topic 606 will not have any material impact
on our consolidated financial statement line items in the year of adoption. The Company will make
the additional required disclosures under Topic 606, starting with the Company’s consolidated
financial statements that include the initial adoption date.

In February 2016, the FASB issued guidance on the recognition, measurement, presentation and
disclosure of leases for both parties to a contract (i.e, lessees and lessors), ASU 2016-02 - Leases
(Topic 842). The new standard requires lessees to apply a dual approach, classifying leases as either
finance or operating leases based on the principle of whether or not the lease is effectively a financed
purchase by the lessee. This classification will determine whether lease expense is recognized based
on an effective interest method or on a straight-line basis over the term of the lease, respectively. A
lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of
greater than 12 months regardless of their classification. Leases with a term of 12 months or less will
be accounted for in a manner similar to the accounting under existing guidance for operating leases
today. The new standard requires lessors to account for leases using an approach that is substantially
equivalent to existing guidance for sales-type leases, direct financing leases and operating leases.
Topic 842 supersedes the previous leases standard, ASC 840, “Leases”. The guidance is effective for
the interim and annual periods beginning on or after December 15, 2018 (early adoption is
permitted). The Company is currently evaluating the potential effect of the guidance on its
consolidated financial statements.

F-21

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES (Cont.)

RADA ELECTRONIC INDUSTRIES LTD.
AND ITS SUBSIDIARIES

In November 2016, the FASB issued Accounting Standards Update No. 2016-18, Statement of Cash
Flows (Topic 230): Restricted Cash. The ASU requires that the Consolidated Statement of Cash
Flows explain the change in total cash and equivalents and amounts generally described as restricted
cash or restricted cash equivalents when reconciling the beginning-of-period and end-of-period total
amounts. The ASU also requires a reconciliation between the total of cash and equivalents and
restricted cash presented on the Consolidated Statement of Cash Flows and the cash and equivalents
balance presented on the Consolidated Balance Sheet. ASU 2016-18 is effective retrospectively on
January 1, 2018, with early adoption permitted. The Company does not expect this guidance to have
a material effect on its consolidated financial statements at the time of adoption of this standard.

In May 2017, the FASB issued ASU 2017-09, “Compensation – Stock Compensation (Topic 718):
Scope of Modification Accounting.” ASU 2017-09 was issued to provide clarity and reduce both 1)
diversity in practice and 2) cost and complexity when applying the guidance in Topic 718 to a
change in the terms or conditions of a share-based payment award. ASU 2017-09 provides guidance
about which changes to the terms or conditions of a share-based payment award require an entity to
apply modification accounting under Topic 718. The amendments in ASU 2017-09 are effective for
fiscal years, and interim periods within those years, beginning after December 15, 2017. Early
adoption is permitted, including adoption in any interim period. The amendments in ASU 2017-09
should be applied prospectively to an award modified on or after the adoption date. The adoption of
this ASU will not have a material impact on our consolidated financial statements.

In August 2017, the FASB issued ASU 2017-12, “Derivatives and Hedging - Targeted
Improvements to Accounting for Hedging Activities”, which is intended to simplify and amend the
application of hedge accounting to more clearly portray the economics of an entity’s risk
management strategies in its financial statements. The ASU will make more financial and
nonfinancial hedging strategies eligible for hedge accounting, reduce complexity in fair value hedges
of interest rate risk and ease certain documentation and assessment requirements of hedge
effectiveness. It also changes how companies assess effectiveness and amends the presentation and
disclosure requirements. ASU 2017-12 is effective for fiscal years beginning after December 15,
2018. The Company is currently evaluating the impact of adopting the ASU on its consolidated
financial statements.

Recently Adopted Accounting Pronouncements:

In March 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards
Update 2016-09, “Compensation - Stock Compensation (Topic 718)” (“ASU 2016-09”). ASU 2016-
09 permits entities to make an accounting policy election related to how forfeitures will impact the
recognition of compensation cost for stock-based compensation: to estimate the total number of
awards for which the requisite service period will not be rendered or to account for forfeitures as
they occur. Upon adoption of ASU 2016-09, the Company elected to change its accounting policy to
account for forfeitures as they occur. The guidance was applied on a modified, retrospective basis in
the first quarter of fiscal 2017 and did not have a material impact on the Company’s consolidated
financial results.

F-22

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 3:- CONTRACTS IN PROGRESS

RADA ELECTRONIC INDUSTRIES LTD.
AND ITS SUBSIDIARIES

Amounts included in the consolidated financial statements, which relate to unbilled receivables are
classified as current assets. Billings in excess of costs and estimated earnings on uncompleted
contracts are classified as current liabilities. Summarized below are the components of the amounts:

Costs and estimated earnings in excess of billings on uncompleted contracts:

December 31,

2017

2016

Costs incurred on uncompleted contracts
Estimated earnings

18,184
5,244

21,548*)
9,135*)

Less - billings and progress payments

Costs and estimated earnings in excess of billings on uncompleted
contracts

Less: Long-term portion

23,428
22,433

995

30,683
28,879

1,804

708

Costs and estimated earnings in excess of billings on uncompleted
contracts - Current portion

995

1,096

*) Reclassified.

NOTE 4:- OTHER ACCOUNTS RECEIVABLE AND PREPAID EXPENSES

Prepaid expenses
Government authorities
Advance payments to vendors
Deposits
Other accounts receivable

F-23

December 31,

2017

2016

176
92
13
30
19

330

225
51
50
23
-

349

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 5:- INVENTORIES

Raw materials
Work in progress, net
Finished goods

RADA ELECTRONIC INDUSTRIES LTD.
AND ITS SUBSIDIARIES

December 31,

2017

2016

3,277
3,093
1,540

2,873
3,032
1,197

7,910

7,102

Write-offs of inventories for the years ended December 31, 2017, 2016 and 2015 amounted to $122,
$144 and $153, respectively. The write-offs were due to slow-moving items and excess inventories
and were recorded in cost of revenues.

NOTE 6:- LONG TERM RECEIVABLES AND OTHER DEPOSITS

Costs and estimated earnings in excess of billings on uncompleted
contracts (see Note 3)
Leasing deposits

NOTE 7:- PROPERTY, PLANT AND EQUIPMENT, NET

Cost:

Factory building
Machinery and equipment *)
Office furniture and equipment
Leasehold improvements

Accumulated depreciation:

Factory building
Machinery and equipment *)
Office furniture and equipment
Leasehold improvements

December 31,

2017

2016

-
68

708
34

742

December 31,

2017

2016

2,054
10,400
771
386

13,611

1,990
7,242
317
147

9,696

1,989
8,821
657
241

11,708

1,974
6,658
296
130

9,058

Depreciated cost

3,915

2,650

F-24

RADA ELECTRONIC INDUSTRIES LTD.
AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 7:- PROPERTY, PLANT AND EQUIPMENT, NET (Cont.)

*) As of December 31, 2017, $736 relates to construction-in-process of production infrastructure.

Write-offs of machinery and equipment (cost and accumulated depreciation) for the years ended December
31, 2017, 2016 and 2015 amounted to $0, $0 and $191, respectively. The write-offs were due to fully
depreciated assets that are no longer in use.

Depreciation expense amounted to $638, $554 and $548 for the years ended December 31, 2017, 2016 and
2015, respectively.

NOTE 8:- BANK CREDIT AND LOANS

A. Loans and convertible note from shareholders

Convertible note from shareholders
Less: Beneficial conversion feature

December 31,

2017

2016

-
-

3,175
(103)

3,072

In May 2016, as part of the investment transaction (see Note 1c), the Investor agreed to grant the Company
an option, exercisable in the discretion of either the Investor or the Company, to obtain a convertible loan
from the Investor in the principal amount of up to $3,175, which may be used solely for the purpose of the
repayment of the outstanding convertible loan and accrued interest to its former controlling shareholder due
on August 31, 2016. In June 2016, the Company exercised the option and repaid the outstanding loan
balance due to its former controlling shareholder in the amount of $2,988 including accrued interest of $247.

The interest payable on the convertible loan was LIBOR+6%, payable on a quarterly basis.

During the term of the loan, the Investor had the right, but not the obligation, at its sole discretion, to
convert the then remaining convertible loan amount into Ordinary shares, par value NIS 0.03, at a price per
share equal to the lower of: (i) $2.40, or (ii) a five percent (5%) discount to the FMV (the average of the
closing prices of the Company’s Ordinary shares over the 5 consecutive trading days ending on the last
trading day prior to the date of conversion), but in no event less than $0.47.

The Company recorded a beneficial conversion feature related to the June 2016 convertible loan as debt
discount in the amount of $123. The discount was amortized over the term of the convertible loan using the
interest method.

In August 2017, the Investor converted the loan into 1,322,917 Ordinary shares at a conversion price of
$2.40 per share. As a result of the conversion, the company recognized the balance of the debt discount
which amounted to $103 as finance expenses (see also Note 13).

F-25

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 8:- BANK CREDIT AND LOANS (Cont.)

B. Bank Credit

Bank Credit

RADA ELECTRONIC INDUSTRIES LTD.
AND ITS SUBSIDIARIES

December 31,

2017

2016

575

The Company may secure borrowing with one of its banks against specific accounts receivables of up to
$2,250, out of which, $0 was utilized as of December 31, 2017. The Company has a line of credit for
customer’s guarantees of $500, which was utilized as of December 31, 2017 in the amount of $421. The
guarantees were secured by a first priority floating charge on all of the Company’s assets and, unpaid share
capital and insurance rights (rights to proceeds on insured assets in the event of loss).

The agreements with the banks prohibit the Company from: (i) selling or otherwise transferring any assets
except in the ordinary course of business, (ii) placing a lien on the Company’s assets without the bank’s
consent, or (iii) declaring dividend to its shareholders.

NOTE 9:- OTHER ACCOUNTS PAYABLE AND ACCRUED EXPENSES

Payroll and related accruals
Accrued expenses - agents commissions
Accrued expenses
Royalties to IIA
Others

December 31,

2017

2016

1,787
109
512
406
-

1,269
129
364
83
142

2,814

1,987

NOTE 10:- COMMITMENTS AND CONTINGENT LIABILITIES

As of December 31, 2017, the Company was not a party to any material legal proceedings.

The Company’s research and development efforts have been partially financed through royalty-
bearing programs sponsored by the IIA. In return for the IIA’s participation, the Company is
committed to pay royalties at a rate ranging from 3% to 5% of sales of the products whose research
was supported by grants received from the IIA, up to 100% of the amount of such participation
received linked to the U.S. dollar. The obligation to pay these royalties is contingent on actual sales
of the products and in the absence of such sales, no payment is required. As of December 31, 2017,
the Company received total grants from the IIA in the amount of $5,543.

F-26

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 10:- COMMITMENTS AND CONTINGENT LIABILITIES (Cont.)

RADA ELECTRONIC INDUSTRIES LTD.
AND ITS SUBSIDIARIES

The total amount of royalties charged to operations for the years ended December 31, 2017, 2016
and 2015, were approximately $569, $130 and $55, respectively. As of December 31, 2017, the
Company’s contingent liability for royalties, net of royalties paid or accrued, totaled approximately
$683.

The Company’s offices in Netanya, Israel, are leased under a non-cancelable operating lease expiring
on February 28, 2022. In addition, the Company’s motor vehicles are leased under operating leases.

Annual minimum future rental commitments under these leases, at exchange rates in effect on
December 31, 2017, are approximately as follows:

2018
2019
2020
2021
2022

752
688
527
381
60

2,408

Lease expenses for the years ended December 31, 2017, 2016 and 2015, were $888, $707 and $761,
respectively.

Floating charges have been recorded on all of the Company’s assets and specific charges have been
recorded on certain assets in respect of the Company’s liabilities to its banks and other creditors.

The Company provides bank guarantees to its customers and others in the ordinary course of
business. The guarantees are to secure advances received at the commencement of a project or to
secure performance of operational milestones. The total amount of bank guarantees provided to
customers and others as of December 31, 2017, is approximately $421.

NOTE 11:- SHAREHOLDERS’ EQUITY

Share capital:

Ordinary shares confer upon their holders voting rights, the right to receive cash dividends and the
right to share in excess assets upon liquidation of the Company.

In May 2016, the Company’s shareholders had approved an increase of the Company’s authorized
share capital by NIS 675,000 and as a result the authorized share capital is equal to NIS 1,125,000
divided into 37,500,000 Ordinary shares, par value NIS 0.03 each (adjusted to reflect the shares
reverse share split effected in September 2016).

F-27

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 11:- SHAREHOLDERS’ EQUITY (Cont.)

RADA ELECTRONIC INDUSTRIES LTD.
AND ITS SUBSIDIARIES

In May 2016, the Company’s shareholders approved an investment transaction with the Investor
according to which the Investor became the controlling shareholder of the Company and the
Company issued 8,510,638 Ordinary shares and Warrants (see Note 1c), in consideration for the
aggregate amount of approximately $4,000. Offering costs amounted to $169.

In August 2016, a shareholder of the Company converted the outstanding loan balance in the amount
of $102 and accrued interest of $11 into 115,700 Ordinary shares.

In August 2016, the Company held an Extraordinary General Meeting of Shareholders at which
shareholders approved the consolidation of the registered (authorized) share capital of the Company
as follows: every two (2) Ordinary shares with a nominal (par) value of NIS 0.015 each will be
consolidated into one (1) Ordinary share with a nominal (par) value of NIS 0.03 each. All Ordinary
shares, options, warrants, convertible loan, conversion options and per share amounts have been
adjusted to give retroactive effect to this reverse split for all periods presented.

In August 2017, the Company entered into agreements with several Israeli institutional investors to
purchase 4,604,500 ordinary shares at price per share of $2.15, for a total consideration of $9,900.
Offering costs amounted to $174.

Stock option plans:

In April 2015, the Company’s Board of Directors adopted the “2015 Share Option Plan” (the
“Plan”), which authorized the grant of options to purchase up to an aggregate of 1,500,000 Ordinary
shares to officers, directors, consultants and key employees of the Company and its subsidiary.
Options granted under the Plan expire within a maximum of ten years from adoption of the plan.

In June 2016, the Company granted options to certain employees and officers of the Company, to
purchase a total 984,375 Ordinary shares at an exercise price of $0.9 per share. The options will vest
as follows: 25% of the options granted to each employee will vest in June 2017; additional 75% shall
vest in three equal annual installments of 25% each until June 2020. These options shall be
exercisable for 48 months following the date of the vesting. As part of the grant, the Company’s
former CEO was granted options to purchase 168,750 Ordinary shares at an exercise price of $0.90
per Ordinary share. The former CEO resigned in November 2016.

In November 2016, the Company’s Audit Committee (in its capacity as the Compensation
Committee) and Board of Directors determined, subject to shareholders approval, to extend until
January 2017, the exercise date of the former CEO’s options by accelerating the vesting of 126,563
Options as of December 31, 2016. Pursuant to the terms of the plan, the former CEO was eligible to
exercise such number of the options (or any part thereof) within 90 days of the date of his
resignation. The company recognized $71 share based compensation related to this acceleration.

F-28

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 11:- SHAREHOLDERS’ EQUITY (Cont.)

RADA ELECTRONIC INDUSTRIES LTD.
AND ITS SUBSIDIARIES

In November 2016, the Company’s Audit Committee (in its capacity as the Compensation
Committee) and Board of Directors determined, subject to shareholders approval to grant its newly
appointed CEO (i) options to purchase 68,750 Ordinary shares at an exercise price of $1.16 per
Ordinary share that will vest ratably over a period of four (4) years and (ii) options to purchase
150,000 Ordinary shares at an exercise price of $1.16 per Ordinary share that will vest immediately
in lieu of 99 vacation days that were accrued and redeemable for his benefit. These options are
exercisable for 48 months. On January 15, 2017, the Company’s shareholders approved the grant of
the options to the CEO and the acceleration of the option grant to the former CEO.

In December 2016, the Company granted options to purchase 40,000 Ordinary shares at an exercise
price of $1.17 per Ordinary share, that will vest immediately in lieu of 36 vacation days that were
accrued and redeemable for an employee benefit. These options are exercisable for 48 months.

In February 2017, the Company granted options to a new officer of the Company to purchase a total
37,500 Ordinary shares at an exercise price of $1.26 per share. The options will vest as follows: 25%
of the options granted will vest in February 2018; 75% of the options will vest in three equal annual
installments of 25% each until June 2021. These options will be exercisable for 48 months following
the date of the vesting.

In March 2017, the Company granted options to a consultant to the Company to purchase a total of
222,000 Ordinary shares at an exercise price of $1.22 per share. The options will vest in six equal
semi-annual installments of 37,000 options starting August 2018 until February 2020. These options
will be exercisable for 48 months following the date of the vesting.

On May 24, 2017, the company’s Board of Directors approved an increase in the framework of the
stock option plan to 2,000,000 shares.

In May 2017, the Company granted options to certain employees and officers of the Company to
purchase a total of 100,000 Ordinary shares at an exercise price of $1.14 per share. The options will
vest as follows: 25% of the options granted will vest in May 2018; 75% of the options will vest in
three equal annual installments of 25% each until June 2021. These options will be exercisable for 48
months following the date of the vesting.

In September 2017, the Company granted options to certain employees and officers of the Company
to purchase a total of 613,750 Ordinary shares at an exercise price of $2.96 per share. The options
will vest as follows: 25% of the options granted will vest in February 2018; 75% of the options will
vest in three equal annual installments of 25% each until June 2021. These options will be
exercisable for 48 months following the date of the vesting.

In November 2017, the Company granted options to one of its officers to purchase a total of 200,000
Ordinary shares at an exercise price of $3.39 per share. The options will vest as follows: 25% of the
options granted will vest in November 2018; 75% of the options will vest in three equal annual
installments of 25% each until June 2021. These options will be exercisable for 48 months following
the date of the vesting.

F-29

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 11:- SHAREHOLDERS’ EQUITY (Cont.)

RADA ELECTRONIC INDUSTRIES LTD.
AND ITS SUBSIDIARIES

As of December 31, 2017, options to purchase 21,250 Ordinary Shares are available for future grant
under the Plan.

A summary of the Company’s activity for options granted to employees and directors under the Plan
is as follows:

Outstanding at the beginning of the
period
Granted
Exercised
Cancelled and forfeited

Number of
options

986,875 $

1,170,000
(131,250)
(178,125)

Outstanding at the end of the period

1,847,500 $

Exercisable

415,781 $

Year ended
December 31, 2017

Weighted
average
exercise
price

Weighted
average
remaining
contractual
term

Aggregate
Intrinsic
Value Price

0.91
2.49
0.90
0.90

1.91

1.03

7.58 $
-
-
-

246
-
-
-

8.88 $

2,159

7.36 $

852

Intrinsic value of exercisable options (the difference between the closing share price of the
Company’s Ordinary shares on the last trading day in the period and the exercise price, multiplied by
the number of in-the-money options) represents the amount that would have been received by the
employees and directors option holders had all option holders exercised their options on December
31, 2017. This amount changes based on the fair market value of the Company’s Ordinary share.

As of December 31, 2017, there was approximately $1,924 of unrecognized compensation expense
related to non-vested stock options, expected to be recognized up to four years.

F-30

RADA ELECTRONIC INDUSTRIES LTD.
AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 11:- SHAREHOLDERS’ EQUITY (Cont.)

The total equity-based compensation expense related to all of the Company’s equity-based awards,
recognized for the year ended December 31, 2017 and 2016, was comprised as follows (no equity-
based compensation expense recognized for the year ended December 31, 2015):

Cost of revenues
Marketing and selling
General and administrative

Warrants:

Year ended December 31,

2017

2016

104
149
306
559

70
12
29
111

On May 18, 2016, the Company issued Warrants to the Investor (see Note 1c) to purchase: (i)
4,255,319 additional Ordinary shares at an exercise price per Ordinary share of $0.47 (having an
aggregate exercise price of $2,000), exercisable for a period of 24 months following the date of the
Initial Investment and (ii) 3,636,363 Ordinary shares at an exercise price per Ordinary share of $0.55
(having an aggregate exercise price of $2,000), exercisable for a period of 48 months following the
date of the Initial Investment. During 2016, the Investor exercised Warrants to purchase 2,659,575
Ordinary shares at an exercise price per share of $0.47 for an aggregate total consideration of $1,250.
During 2017, the Investor exercised Warrants to purchase 1,595,744 Ordinary shares at an exercise
price per share of $0.47 for an aggregate total consideration of $750, and an additional 2,181,818
Ordinary shares at an exercise price per share of $0.55 for an aggregate total consideration of $1,200.
As of December 31, 2017, 1,454,545 Warrants are outstanding at an exercise price per Ordinary
share of $0.55, exercisable through May 18, 2020.

On May 18, 2016, as part of the investment transaction, the Company issued to a consultant 510,638
Warrants to purchase Ordinary shares at an exercise price per Ordinary share of $0.47, exercisable
for a period of 18 months following the date of the Initial Investment. During 2016, the consultant
exercised Warrants to purchase 106,383 Ordinary shares at an exercise price per share of $0.47, for
an aggregate total consideration of $50. During 2017, the consultant exercised Warrants to purchase
404,255 Ordinary shares at an exercise price per share of $0.47, for an aggregate total consideration
of $190.

F-31

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 12:- TAXES ON INCOME

RADA ELECTRONIC INDUSTRIES LTD.
AND ITS SUBSIDIARIES

The Israeli corporate tax rate and real capital gains tax was 26.5% in 2015, 25% in 2016 and 24% in
2017.

In December 2016, the Israeli Parliament approved the Economic Efficiency Law 2016 (Legislative
Amendments for Applying the Economic Policy for the 2017 and 2018 Budget Years), which
reduces the corporate income tax rate to 23% effective from January 1, 2018.

In accordance with the tax laws, tax returns submitted up to and including the 2012 tax year can be
regarded as final.

The Company’s subsidiary is incorporated in China is subject to corporate tax rate of 25% in 2017
and 2016.

Tax benefits under the Law for the Encouragement of Industry (Taxes), 1969:

The Company qualifies as an “Industrial Company” under the Law for the Encouragement of
Industry (Taxes), 1969 (the “Industrial Encouragement Law”). The Industrial Encouragement Law
defines an “Industrial Company” as a company that is resident in Israel and that derives at least 90%
of its income in any tax year, other than income from defense loans, capital gains, interest and
dividends, from an enterprise whose major activity in a given tax year is industrial production.

The principal benefit from the above law is the deduction of expenses in connection with a public
offering. Also, under the industrial Encouragement Law an “Industrial Company” is entitled to
special rates of depreciation for industrial equipment and in addition to amortization of the cost of
purchased know-how and patents over an eight year period for tax purposes and an accelerated
depreciation rate on equipment.

Eligibility for the benefits under the Industry Encouragement Law is not subject to receipt of prior
approval from any governmental authority.

As of December 31, 2017, the net operating tax loss carryforward relating to the Company in Israel
amounted to approximately $72,876, not including a carryforward capital loss amounting to
approximately $3,827. Carryforward losses in Israel may be carried forward indefinitely and may be
offset against future taxable income.

As the Company believes that it is more likely than not that the deferred tax assets in respect of these
carryforward losses will not be utilized, the Company recorded a full valuation allowance for the
entire balance of the deferred tax asset relating to the carryforward losses.

The main reconciling items between the statutory tax rate of the Company and the effective tax rate
is the valuation allowance recorded in respect of the deferred tax assets relating to net operating loss
carryforward and other temporary differences due to the uncertainty of the realization of such tax
assets.

F-32

RADA ELECTRONIC INDUSTRIES LTD.
AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 12:- TAXES ON INCOME (Cont.)

Deferred income taxes:

Deferred income taxes reflect the net tax effects of temporary differences between the carrying
amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax
purposes. Significant components of the Company’s deferred tax assets are as follows:

Net operating loss carryforward
Capital loss carryforward
Allowances and reserve

Total deferred tax assets before valuation allowance
Valuation allowance

Net deferred tax assets

December 31,

2017

2016

17,490
918
342

18,750
(18,750)

16,920
862
325

18,107
(18,107)

As of December 31, 2017 and December 31, 2016, the Company has provided valuation allowances
in respect of deferred tax assets resulting from the tax loss carryforward and other temporary
differences, since it has a history of operating losses and the current uncertainty concerning its ability
to realize these deferred tax assets in the future.

The Company accounts for its income tax uncertainties in accordance with ASC 740, which clarifies
the accounting for uncertainties in income taxes recognized in a company’s financial statements and
prescribes a recognition threshold and measurement attribute for the financial statement recognition
and measurement of a tax position taken or expected to be taken in a tax return.

As of December 31, 2017 and 2016, there were no unrecognized tax benefits that if recognized
would affect the annual effective tax rate.

F-33

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 13:- FINANCIAL EXPENSES, NET

Income:

Foreign currency exchange differences
Interest on cash equivalents and restricted deposits
Other

Expenses:

Amortization of shareholders’ convertible loans
discount and BCF
Interest on shareholders’ convertible note and loans
Withholding taxes on interest of convertible note and
loans from shareholders

Bank commissions and others
Foreign currency exchange differences
Interest on loans from banks and other credit balances

RADA ELECTRONIC INDUSTRIES LTD.
AND ITS SUBSIDIARIES

Year ended
December 31,
2016

2015

2017

130
50
34

214

103
164

82
9
12

8
9
-

1,116
270

100
25
27

131
4
-

135

2,684
575

119

152
161
21

370

1,538

3,712

Total financial expenses, net

156

1,521

3,577

NOTE 14:- RELATED PARTY BALANCE AND TRANSACTIONS

For the year ended December 31, 2017, the Company incurred $164 interest expense on loans
received from its shareholders.

In January 2017, the Company’s shareholders approved that in addition to the directors’ fees to be
paid to all of the Company’s directors commencing as of January 1, 2017, the Company will pay the
Investor (see Note 1c) an additional monthly payment of approximately $4.6 (NIS 17,500) for time
devoted to the Company by the Executive Chairman of the Board of Directors, who is also a co-
owner of the Investor. In 2017 the Company’s consolidated audited financial statements reflect net
income (before taxes), so such additional payment increased to approximately $9 (NIS 35,000).

F-34

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 14:- RELATED PARTY BALANCE AND TRANSACTIONS (Cont.)

RADA ELECTRONIC INDUSTRIES LTD.
AND ITS SUBSIDIARIES

In addition, the Company’s shareholders approved a new engagement letter with a director of the
Company (the “Director”), according to which the Director will be entitled to receive a commission
of 2.5% of the net revenues received by the Company with respect to specific transactions introduced
to the Company by the Director, subject to a detailed agreement to be entered into by the Director
and the Company and the prior approval of any such transactions by the Company and the Audit
Committee. As of December 31, 2017 no revenues were generated as a result of this agreement,
therefore no commission paid.

See also Notes 8 and 11 for transactions with the Company’s shareholders.

Balances with related parties:

Accrued expenses

Loan from Shareholders, net

Related parties’ expenses:

Directors and management fees

Amortization of shareholders’ convertible loans
discount and BCF

Interest on shareholders’ convertible note and loans

December 31,

2017

2016

3,072

Year ended
December 31,
2016

2015

2017

170

103

164

1,116

270

2,684

575

NOTE 15:- MAJOR CUSTOMERS AND GEOGRAPHIC INFORMATION

In accordance with Statement of ASC 280, “Segment Reporting”, the Company is organized and
operates as one business segment, which develops, manufactures and sells land radar for defense
forces and border protection applications, avionics equipment and aviation data acquisition and
debriefing systems.

F-35

RADA ELECTRONIC INDUSTRIES LTD.
AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 15:- MAJOR CUSTOMERS AND GEOGRAPHIC INFORMATION (Cont.)

Revenues by geographic areas:

Revenues are attributed to geographic area based on the location of the end customers as follows:

North America
Israel
Asia
Latin America
Europe
Australia

Total

Major customers:

Year ended
December 31,
2016

2015

2017

14,446
6,363
4,372
514
281
206

1,553
7,358
2,499
1,289
122
-

3,558
6,062
2,692
1,614
148
-

26,182

12,821

14,074

Revenues from single customers that exceed 10% of the total revenues in the reported years as a
percentage of total revenues are as follows:

2017

Year ended
December 31,
2016
%

2015

7
9
2
3
5
13
-
35

20
17
16
13
11
6
-
1

24
9
7
10
13
8
13
1

Customer A
Customer B
Customer C
Customer D
Customer E
Customer F
Customer G
Customer H

F-36

RADA ELECTRONIC INDUSTRIES LTD.
AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands, except share and per share data

NOTE 15:- MAJOR CUSTOMERS AND GEOGRAPHIC INFORMATION (Cont.)

Long-lived assets (property, plant and equipment) by geographic areas:

Israel
China

NOTE 16:- SUBSEQUENT EVENTS

December 31,

2017

2016

3,915
319

2,650
266

4,234

2,916

As part of the Company’s strategy to expand its activities in the USA, on January 2018, the company
incorporated RADA Sensors Inc, a fully owned subsidiary of the Company. RADA Sensors Inc is
holding 75% of interests in RADA Technologies LLC, also organized in January 2018, together with
ZASE Technologies LLC, holding 25% of interests in RADA Technologies LLC.

In January 2018, the Investor exercised warrants to purchase an additional 1,454,545 Ordinary shares
at an exercise price per share of $0.55 in consideration of $800.

- - - - - - - - - - - - - - - - - -

F-37

SIGNATURES

The registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and
authorized the undersigned to sign this annual report on its behalf.

RADA ELECTRONIC INDUSTRIES LTD.

/s/Dov Sella

By:
Name:Dov Sella
Title: Chief Executive Officer

Dated: March 28, 2018

Beijing Huarui Aircraft Components Maintenance and Services Co., an 80%-owned subsidiary organized in China.

LIST OF SIGNIFICANT SUBSIDIARIES

Exhibit 8.1

Exhibit 12.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as amended

I, Dov Sella, certify that:

I have reviewed this annual report on Form 20-F of RADA Electronic Industries Ltd.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material
fact necessary to make the statements made, in light of the circumstances under which such statements were made,
not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly
present in all material respects the financial condition, results of operations and cash flows of the company as of, and
for, the periods presented in this report;

4. The company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting
(as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be
designed under our supervision, to ensure that material information relating to the company, including its
consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in
which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to
be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting
and the preparation of financial statements for external purposes in accordance with generally accepted
accounting principles;

(c) Evaluated the effectiveness of the company’s disclosure controls and procedures and presented in this report our
conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered
by this report based on such evaluation; and

(d) Disclosed in this report any change in the company’s internal control over financial reporting that occurred
during the period covered by the annual report that has materially affected, or is reasonably likely to materially
affect, the company’s internal control over financial reporting.

5. The company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control
over financial reporting, to the company’s auditors and the audit committee of the company’s board of directors (or
persons performing the equivalent function):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial
reporting which are reasonably likely to adversely affect the company’s ability to record, process, summarize and
report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in

the company’s internal control over financial reporting.

Dated: March 28, 2018

/s/ Dov Sella *
Dov Sella
Chief Executive Officer
(Principal Executive Officer)

The originally executed copy of this Certification will be maintained at the Company’s offices and will be made
available for inspection upon request.

Exhibit 12.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER
Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as amended

I, Avi Israel, certify that:

I have reviewed this annual report on Form 20-F of RADA Electronic Industries Ltd.;

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in

the company’s internal control over financial reporting.

Dated: March 28, 2018

/s/Avi Israel*
Avi Israel
Chief Financial Officer
(Principal Financial Officer)

The originally executed copy of this Certification will be maintained at the Company’s offices and will be made
available for inspection upon request.

Exhibit 13.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of RADA Electronic Industries Ltd. (the “Company”) on Form 20-F for the period
ending December 31, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I,
Dov Sella, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of
the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of

1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and

result of operations of the Company.

By:/s/ Dov Sella *
Dov Sella
Chief Executive Officer
(Principal Executive Officer)

Dated: March 28, 2018

The originally executed copy of this Certification will be maintained at the Company’s offices and will be made
available for inspection upon request.

Exhibit 13.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of RADA Electronic Industries Ltd. (the “Company”) on Form 20-F for the period
ending December 31, 2017, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I,
Avi Israel, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of
the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of

1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and

result of operations of the Company.

By:/s/Avi Israel*
Avi Israel
Chief Financial Officer
(Principal Financial Officer)

Dated: March 28, 2018

The originally executed copy of this Certification will be maintained at the Company’s offices and will be made
available for inspection upon request.

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the Registration Statements on Form F-3 (File Nos. 333-212643, 333-
216973 and 333-220304) and related prospectus and Form S-8 (File No. 333-213284) of RADA Electronic Industries Ltd.
of our report dated March 28, 2018, with respect to the consolidated financial statements of RADA Electronic Industries
Ltd. included in its Annual Report on Form 20-F for the year ended December 31, 2017.

Exhibit 15.1

/s/ Kost Forer Gabbay and Kasierer
A Member of Ernst & Young Global

Tel-Aviv, Israel

March 28, 2018